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ABSTRACT OF DISSERTATION

IMMUNE EVASION BY DIVISION OF LABOR:
THE TROPHIC LIFE CYCLE STAGE OF PNEUMOCYSTIS MURINA SUPPRESSES
INNATE IMMUNITY TO THIS OPPORTUNISTIC, FUNGAL PATHOGEN
Pneumocystis species are opportunistic fungal pathogens that cause severe
pneumonia in immunocompromised hosts, including AIDS patients. Pneumocystis
species have a biphasic life cycle consisting of single-nucleated trophic forms and ascuslike cysts. Both stages live within the host, and, thus, must contend with threats from the
host immune system. The cyst cell wall β-glucans have been shown to stimulate immune
responses in lung epithelial cells, dendritic cells and alveolar macrophages. Little is
known about how the trophic life forms, which do not have a fungal cell wall, interact
with immune cells. In this study, the immune response to the life cycle stages of
Pneumocystis murina was evaluated.
Here, we report differences in the immune response of immunocompetent mice to
the trophic and cystic life cycle stages of P. murina. Upon infection with purified trophic
forms, wild-type adult mice developed a delayed innate and adaptive immune response
compared to inoculation with the normal mixture of trophic forms and cysts. Cysts, but
not trophic forms, stimulated Th1-type responses in the lungs of infected mice.
Surprisingly, trophic forms are sufficient to generate protective adaptive
responses, leading to clearance in immunocompetent mice. We report that CD4+ T cells
primed in the presence of trophic forms are sufficient to mediate clearance of trophic
forms and cysts. In addition, primary infection with trophic forms is sufficient to prime B
cell memory responses capable of clearing a secondary infection with Pneumocystis
following CD4+ T cell depletion. While trophic forms are sufficient for initiation of
adaptive
immune
responses
in
immunocompetent
mice,
infection
of
immunocompromised RAG2-/- mice with trophic forms in the absence of cysts does not
lead to the severe weight loss and infiltration of innate immune cells associated with the
development of Pneumocystis pneumonia.
Dendritic cells screen the alveolar spaces for pathogens, and are in a prime
position to initiate the immune response against lung pathogens, including Pneumocystis.
Our data demonstrate that trophic forms broadly dampen the ability of dendritic cells to
respond to pathogen-associated molecular patterns. Bone marrow-derived dendritic cells
were stimulated with trophic forms, a mixture of trophic forms and cysts, and various

other inflammatory materials, including β-glucan. Trophic forms inhibited multiple
components involved in antigen presentation by dendritic cells, including secretion of
inflammatory cytokines and expression of MHC class II and costimulatory molecules on
the cell surface. Furthermore, trophic forms suppressed or failed to induce the expression
of multiple genes related to activation and maturation in dendritic cells. Dendritic cells
silenced by trophic forms are unable to induce CD4+ T cell responses. These data suggest
that immune evasion by trophic forms is dependent on the suppression of innate
responses, and the development of adaptive immunity represents a “point of no return” at
which the trophic forms are no longer able to escape clearance.
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Chapter 1: Introduction

I. Overview
Pneumocystis species are opportunistic fungal pathogens that cause severe
pneumonia in immunocompromised hosts, including HIV/AIDS patients. Clearance of
Pneumocystis organisms is dependent on effective CD4+ T cell, B cell and macrophage
responses (1-4). Failure to clear Pneumocystis organisms leads to severe alveolar damage
due to an exaggerated inflammatory immune response (5). In spite of a reduced incidence
of Pneumocystis pneumonia (PcP) in HIV-infected individuals due to improved highly
active antiretroviral therapy (HAART), the mortality rate for patients with PcP has not
improved (6). Additional studies are required to inform novel approaches to reduce
morbidity and mortality due to Pneumocystis pneumonia.
Outbreaks of PcP were first described in malnourished or premature infants in
orphanages

following

the

second

world

war

(7).

Evidence

suggests

that

immunocompetent individuals of all ages are capable of mounting protective immune
responses to Pneumocystis jirovecii that prevent progression to pneumonia. Most children
encounter this opportunistic fungus at a young age, as indicated by the presence of
specific antibodies in the serum of 85% of individuals by three years of age (8). Previous
work from our lab has shown that the neonatal mouse immune response to Pneumocystis
murina is delayed due in part to an anti-inflammatory lung environment (9-12). The
neonatal lung environment is characterized by anti-inflammatory mediators, including
transforming growth factor beta 1 (TGF-β1) and interleukin-10 (IL-10), and immature
immune cells (9-12). Neonatal alveolar macrophages and T cells adoptively transferred to
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an adult lung environment are competent to resolve P. murina pneumonia in mice (9, 12).
In addition, neonatal alveolar macrophages are deficient in nuclear factor kappa B (NFκB) translocation following stimulation with Pneumocystis organisms (9). Neonatal
alveolar CD11c+ cells demonstrate delayed trafficking to the draining lymph nodes (11).
Together, these data indicate that both the neonatal lung environment and intrinsic
immune cell deficits contribute to the delayed clearance of P. murina in neonatal mice.
Pneumocystis species have a biphasic life cycle (Fig 1.1 and Fig 1.2). Trophic
forms are proposed to undergo asexual reproduction, whereas cysts are formed by sexual
reproduction (13). Trophic forms are single-nucleated organisms that are typically found
in clusters surrounded by a biofilm-like substance consisting of a conglomeration of
DNA, β-glucan, and other sugars (14). Cysts are ascus-like structures that consist of
multiple nuclei surrounded by a fungal cell wall. β-1,3 glucan and β-1,6 glucan serve as
the structural components of the cyst wall (15, 16). β-glucan is not detected on the
surface of trophic forms (15, 17). Both stages express surface glycoproteins and
mannoproteins that may serve as pathogen-associated molecular patterns (PAMPs) that
could interact with receptors on phagocytic cells (18-20). Neither life form produces the
classical fungal components ergosterol, chitin or α-glucans (21, 22).
Dendritic cells are the principal antigen presenting cells in the lung. However, their
role in initiating the adaptive response to Pneumocystis species has been understudied.
Previous work has demonstrated that dendritic cells respond to β-glucans derived from
the Pneumocystis cell wall (23). Dendritic cells activated by Pneumocystis cell wallderived β-glucans increase costimulatory molecule expression and drive T cell
polarization towards a T helper 1 (Th1) -type response, as characterized by the production
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of the proinflammatory cytokine interferon gamma (IFNγ) (23). The mechanism for
dendritic cell recognition of Pneumocystis trophic forms, which do not express β-glucans,
is unknown.
An improved understanding of innate immune interactions with the cystic and
trophic life cycle stages has the potential to inform future treatment of Pneumocystis
pneumonia. Recently, it was reported that treatment of mice with the β-1,3-D-glucan
synthase inhibitor anidulafungin resulted in depletion of P. murina cysts (24). The mice
were able to control the remaining trophic burden in the absence of an excessive
inflammatory response, however, the details of how trophic forms are recognized and
cleared are not known.
This dissertation examines the role of the life cycle stages of P. murina in shaping
the immune response to this fungal pathogen. The work herein demonstrates that
infection with the cyst stage provokes proinflammatory immune responses, including the
early recruitment of innate and effector immune cells into the lungs. Conversely, the
trophic life cycle stage inhibits critical components of the dendritic cell response to
infection, including cytokine expression, proinflammatory signaling, and antigen
presentation. The rapid establishment of a trophic population may be critical for this
fungal pathogen to avoid preemptive clearance of the transmitted cyst stage.

II. Populations at risk
Severely immunocompromised patients are at risk for Pneumocystis infection that
progresses to pneumonia. The history of Pneumocystis is closely tied to the expansion of
susceptible populations in the past century. Early observations by Carlos Chagas in 1909
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and by Antonio Carini in 1910 identified the cyst stage of Pneumocystis in association
with Trypanosoma species ((25, 26), reviewed in (27)). The organisms were recognized
as a separate species, Pneumocystis carini, by Pierre and Mme Delanoë in 1912 (27, 28).
However, Pneumocystis was not associated with human disease until 1942, when M.G.
van der Meer and S.L. Brug identified the organism in two infants and one young adult
(27, 29). In 1951, Josef Vanek demonstrated that Pneumocystis was the causative agent
of an epidemic of interstitial plasma cell pneumonia in preterm or malnourished infants in
orphanages (27, 30). Otto Jírovec reported additional cases of PcP in neonates in 1952
(27, 31). Sporadic reports of PcP followed, including a handful of cases in the United
States in the 1950s (7). The disease was most commonly associated with premature,
malnourished, or otherwise immunocompromised infants 6 weeks to 4 months of age (7).
The development of chemotherapy and immunosuppressive drug treatments
expanded the populations at risk for PcP. Long-term cortisone therapy has been reported
in association with PcP since the 1960s (32). A report from 1968 in which an adult male
who had received radiotherapy, cytotoxic agents, and steroids for chronic lymphatic
leukemia was diagnosed with PcP illustrates the potential complexity of such cases (33).
Early surveys of infection in bone marrow transplant patients identified Pneumocystis as
an organism of concern (34).
Pneumocystis continued to be a sporadic cause of disease in severely
immunocompromised patients through the 1970s. However, in the early 1980s, an
increase in the incidence of PcP in young, homosexual men alarmed the medical
community

(35).

The

HIV/AIDS

epidemic

resulted

in

a

new

pool

of

immunocompromised patients susceptible to PcP. The development of HAART has
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significantly reduced the incidence of PcP in HIV patients. A dramatic 80% reduction in
the incidence of PcP among HIV/AIDS patients in the United States and Canada was
observed from 2004 to 2010 (36). These improvements are attributed to improved
management of HIV/AIDS with HAART, including improved CD4+ T cell counts and
lower viral titer (36). Despite improved management of HIV/AIDS, P. jirovecii remains
the most common opportunistic infection associated with the disease (36). The risk
remains significant among individuals who are unaware of their HIV-positive status or
lack access to HAART (36).
The development of novel immunosuppressive therapies continues to expand the
range of populations at risk for PcP. The rise of the use of biologics in the treatment of
cancer and autoimmune disease has been associated with increased risk of PcP. Examples
include anti-CD20 antibody therapy for non-Hodgkin’s lymphoma (37, 38), and antitumor necrosis factor alpha (TNFα) antibody therapy for rheumatoid arthritis (39) or
Crohn’s disease (40).
P. jirovecii may serve as a co-factor in other diseases. Colonization has been
correlated with chronic obstructive pulmonary disease (COPD) (41, 42). It has been
proposed that Pneumocystis may fuel lung inflammation, including recruitment of Th1 T
cells (43), and promote the progression of COPD (44). The presence of Pneumocystis
organisms has also been correlated with sudden infant death syndrome (SIDS) in some
studies (45, 46). However, the correlation does not appear to be absolute, and it is
unlikely that P. jirovecii is a direct cause of SIDS (47). Rather, colonization may
contribute to SIDS by promoting excess mucus production in the lungs of infants (48).
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Mortality due to PcP may range from as low as 10-20% in mild-to-moderate cases
(49) to 65% in patients requiring artificial ventilation (50). Factors associated with death
due to PcP include older age of the patient, time to diagnosis, and the need for oxygen
therapy or invasive mechanical ventilation (51). The death rate in patients with AIDS
diagnosis or solid organ transplant is lower than that of patients with other immune
deficiencies (51). This may be partially attributed to a decreased time to diagnosis in
these patients (51).

III. Pneumocystis biology
Pneumocystis species are members of the fungal phylum Ascomycota. The genus
was originally described as a single species, Pneumocystis carinii. However, the
discovery that individual host species were infected with unique species of Pneumocystis
promoted changes in the taxonomy (52). The name Pneumocystis carinii is now reserved
for one of the two species that infects rats. The human pathogen was renamed
Pneumocystis jirovecii, while the species that infects mice was named Pneumocystis
murina (52-54). Additional Pneumocystis species have been identified in host species as
diverse as rabbits (P. oryctolagi), dogs, horses, bats, and chickens (55-59). While a single
host species may be infected with multiple species of Pneumocystis (see P. carinii and P.
wakefieldiae in rats), a given Pneumocystis species does not infect multiple host species
(60, 61).
The factors that determine the strict host restrictions of Pneumocystis species are
unknown. However, recent genome analysis of P. jirovecii, P. carinii, and P. murina
suggest that these species evolved in close association with their respective hosts (21).
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The sizes of the genomes were remarkably reduced compared to other extracellular fungi,
with notable losses in ribosomal RNA genes, transcription factors, nutrient transporters,
and metabolic pathways. Conversely, the number of genes encoding peptidases is
expanded in Pneumocystis species compared to related fungi, and the genes encoding
proteins related to endocytosis and the proteasome are preserved. These data suggest that
Pneumocystis species have made significant adaptations to acquire nutrients from their
respective hosts.
Pneumocystis species have a biphasic life cycle consisting of trophic forms and
cysts (Fig 1.1, Fig 1.2 and reviewed in (62)). The trophic forms were formerly known as
trophozoites, with the newer name reflecting their fungal, rather than protozoan identity.
Trophic forms are single-nucleated organisms that may replicate asexually by binary
fission. Trophic forms are also proposed to undergo conjugation to form a diploid precyst (or sporocyte), which then undergoes multiple rounds of sexual reproduction to form
the cyst life cycle stage. Comparative genomics suggest sexual reproduction in
Pneumocystis involves a single mating type (primary homothallism) rather that multiple
mating types (heterothallism) or mating type switching (secondary homothallism) (63).
Trophic forms may be found in clusters surrounded by a biofilm-like substance
consisting of a conglomeration of DNA, β-glucan, and other sugars (14). It has been
proposed that previously-lysed cysts provided the bulk of this biofilm-like substance.
Trophic forms lack a fungal cell wall, and do not express β-glucan (15). Ultrastructural
studies revealed that the trophic forms tightly adhere to the luminal surface of alveolar
epithelial cells via microprotusions or invaginations of the trophic plasma membrane
(64). Attachment is mediated by host cell fibronectin and other extracellular matrix
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components, and does not involve fusion of host-Pneumocystis cell membranes or
invasion of the host cell (64-66).
The cyst stage of the species is more properly termed an ascus; however, this
nomenclature is not yet the norm within the field. A mature cyst contains eight daughter
spores, which are believed to develop into trophic forms upon lysis of the cysts. The cyst
is surrounded by a fungal cell wall, with β-1,3 glucan and β-1,6 glucan serving as the
major structural components (15, 16). Recent evidence indicates that cysts are the
transmittable life cycle stage of Pneumocystis species (17).
Both the trophic forms and cysts express surface glycoproteins and mannoproteins
that may serve as PAMPs that could interact with receptors on phagocytic cells (18-20).
Ten antigenic glycoproteins common to both lifeforms were identified in the cell wall
fractions of P. carinii trophic forms and cysts separated by counterflow centrifugal
elutriation and sequential microfiltration (20). Gas chromatography-mass spectrometry
(GC-MS) demonstrated that all ten glycoproteins contained some degree of mannose,
glucose, galactose, and N-acetylglucosamine (GlcNAc), while some contained traces of
fucose. As a whole, the glycoproteins on the cysts contained more mannose, while the
trophic glycoproteins contained more xylose.
Neither life cycle stage produces the classical fungal components ergosterol, chitin
or α-glucans (21, 22). While capable of de novo cholesterol synthesis, Pneumocystis
species also use cholesterol scavenged from the host cell (67). It has recently been
demonstrated that Pneumocystis species lack the enzymes required for the addition of
outer chain N-mannans to the N- and O-linked glycan core structure (21). Tandem mass
spectrometry confirmed that Pneumocystis cell wall proteins were glycosylated with
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chains of mannose no longer than nine residues, with the majority comprised of six
residues (21). Hyper-mannosylation is required for optimal C-type lectin receptor
recognition of C. albicans, prompting Ma, et al. to propose that the lack of outer chain Nmannans may permit Pneumocystis organisms to escape detection by the immune system
(21, 68, 69).
Transmission of Pneumocystis species occurs by the airborne route (70). It was
initially hypothesized that suppression of the immune system would permit reactivation
of a latent, subclinical infection in previously healthy adults. However, more recent
evidence suggests that transient, subclinical infections in healthy hosts serve as a
reservoir for Pneumocystis organisms that may be transmitted to susceptible
immunocompromised hosts. Immunocompetent adult mice cohoused with P. murinainfected severe combined immunodeficiency (SCID) mice develop a subclinical infection
that resolves in 5 to 6 weeks (71). Studies in mice infected with P. murina demonstrated
that a healthy host may transmit the organisms to both healthy and immunocompromised
hosts (72-74).
Clusters of PcP cases have been observed in both inpatient and outpatient facilities
caring for immunocompromised patients. Several studies suggest nosocomial
transmission of P. jirovecii in outbreaks of PcP in kidney transplant recipients (reviewed
in (75)). Such outbreaks were often caused by a predominant or a single Pneumocystis
strain, as confirmed by genotyping by comparison of the internal transcribed spacer (ITS)
regions 1 and 2 or by multilocus sequence typing (MLST). The genotypes of reference
samples were different that the strains associated with such outbreaks. One such cluster
was identified at a nephrology outpatient clinic in which transplant patients shared a
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common waiting room, suggesting that minimal patient-to-patient contact is sufficient for
transmission (76).
Exposure to P. jirovecii appears to be extremely common, with the first encounter
occurring early in life. In a study of 74 healthy Chilean infants, P. jirovecii DNA was
detected in the nasopharyngeal aspirates of 32% of the participants, and seroconversion
developed in 85% of the infants by 20 months of age (77). Genotyping of P. jirovecii has
demonstrated that the organisms may be transmitted from healthy, colonized caretakers to
infants (78). Such evidence suggests that healthy hosts may serve as an infectious
reservoir in the community. An environmental reservoir has not yet been identified. The
severely constricted genome of Pneumocystis, as well as the lack of interspecies
transmission, suggest that replication of P. jirovecii outside of the human host is unlikely.

IV. Treatment of Pneumocystis jirovecii infection
The first choice treatment for PcP is trimethoprim-sulphamethoxazole (TMP-SMX)
(79, 80). Unfortunately, allergic responses to the sulfa component or other adverse effects
may demand the use of alternative therapies (80). Pentamidine is a second-line therapy
for severe PcP, but may also have serious side effects, including nephrotoxicity.
Clindamycin in combination with primaquine or trimethoprim with dapsone are used as
alternative therapies in patients who are unable to tolerate TMP-SMX and/or pentamidine
(79). Atovaquone may also be used to treat less severe cases of PcP (79). Corticosteroids
are given in addition to antifungals to reduce the damage due to lung inflammation in
moderate to severe cases of PcP (79). Pneumocystis species do not produce ergosterols,
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therefore, drugs that interfere with ergosterol synthesis, including azole antifungals, are
not effective (22).
Prophylaxis for PcP is recommended for HIV/AIDS patients with fewer than 200
CD4+ T cells/µL or patients with oropharyngeal candidiasis (20, 80). TMP-SMX is the
preferred prophylactic agent for PcP, and provides additional protection against
toxoplasmosis and certain bacterial infections (80, 81). Dapsone or atovaquone may be
used in patients who are unable to tolerate TMP-SMX, including those with sulfa allergy
(20, 80). Prophylaxis may be discontinued in patients receiving HAART if their viral
load is below the limit of detection and their CD4+ T cell count is greater than 200
cells/µL for more than three months (80). Prophylaxis is also recommended for certain
patients with cancer (including acute lymphocytic leukemia), patients with certain
primary immunodeficiency, patients undergoing prolonged or strong glucocorticoid
usage, and patients undergoing solid organ transplant or hematopoietic stem cell
transplant (82).
Recently, it was reported that treatment of immune-reconstituted mice with the β1,3-D-glucan synthase inhibitor anidulafungin results in depletion of Pneumocystis
murina cysts, and the remaining trophic burden stimulate a much reduced inflammatory
response (24). Anidulafungin belongs to a drug class known as the echinocandins, which
have been used in combination with other antifungals, including TMP-SMX, in the
treatment of PcP in human patients (83). Linke et al., propose that depletion of
Pneumocystis cysts by echinocandins would reduce inflammation-induced lung damage
in patients, especially in patients undergoing immune-reconstitution syndrome (24).
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V. Host response to Pneumocystis
A. Immune response in immunocompetent hosts
The diverse range of immunocompromised states associated with the development
of PcP illustrate the range of immune processes that are critical for the clearance of
Pneumocystis. The clearance of the normal mixture of Pneumocystis organisms (i.e.,
trophic forms and cysts) from the lungs requires the participation of innate and adaptive
immune cells, including macrophages, CD4+ T cells, and B cells (1-4). The alveolar
epithelium provides a thin barrier for gas exchange between the lung alveoli and lung
capillaries. The lung immune response to infection must be carefully controlled to avoid
excessive thickening of the epithelium due to inflammation, edema, and recruitment of
immune cells.

i. Dendritic cells
Dendritic cells are the principal antigen presenting cells in the lung, and are critical
for optimal B cell and T cell activation in response to pathogens (reviewed in (84)).
Immature lung dendritic cells reside in the alveolar interstitium, where they project their
dendritic extensions through the epithelial-tight junctions into the alveolar spaces.
Encounters with antigen promote a complex maturation process that prepares the
dendritic cell to serve as an antigen-presenting cell. Unlike macrophages, which remain
in the periphery in response to infection, activated dendritic cells migrate to the draining
lymph nodes to present antigen to lymphocytes. The involvement of dendritic cells is
critical to the recruitment of T and B cells into the airway lumen, particularly as these
spaces are largely free of lymphocytes prior to infection.
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While the interaction between dendritic cells and Pneumocystis organisms has been
understudied, the scarce pertinent publications suggest a complex and unusual
relationship. Macagno et al. found that human monocyte-derived dendritic cells
stimulated in vitro with a ratio of two P. carinii organisms per DC failed to increase
surface expression of the activation marker CD83, and only minimally increased
expression of MHC class II, CD40, CD80 and CD86 compared to cells stimulated with
lipopolysaccharide (LPS) (85). However, the authors suggest that the DCs were sensitive
to P. carinii, as they observed aggregation of the DCs during co-culture. These data
prompted the authors to speculate that Pneumocystis organisms may actively suppress the
maturation process of DCs, and other host-derived factors, particularly cytokines, may be
critical for the activation of DCs during infection.
Kobayashi et al. demonstrated that phagocytosis of a mixed population of P. murina
organisms by murine bone marrow-derived dendritic cells (BMDCs) was partially
inhibited by the addition of mannan, implying that mannose-binding C-type lectin
receptors such as mannose receptor or dectin-2 may recognize Pneumocystis organisms
(86). Co-culture of murine BMDCs with a ratio of 10 P. murina organisms per BMDC
failed to induce various markers of activation, including production of proinflammatory
cytokines (IL-12p40, TNFα, IL-6) and surface expression of major histocompatibility
(MHC) class II, CD40, CD54, CD80, and CD86 (86). P. murina-pulsed BMDCs were
sufficient to induce P. murina-specific proliferation of CD4+ T cells in vitro (86). For this
experiment, Zheng et al. employed CD4+ T cells isolated from the spleens of mice treated
3 days prior with P. murina-pulsed BMDCs (86). Likewise, P. murina-pulsed BMDCs
promoted production of P. murina-specific immunoglobulin G (IgG) in vivo (86, 87).
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Despite suboptimal activation, dendritic cells stimulated with a mixture of P. murina
trophic forms and cysts appear to serve as effective antigen-presenting cells to CD4+ T
cells and B cells.
While stimulation with a mixed population of intact Pneumocystis organisms
appears to poorly stimulate dendritic cell responses, Carmona et al. demonstrated that
human dendritic cells respond strongly to β-glucans derived from the Pneumocystis cyst
cell wall (23, 88). DCs activated by cyst cell wall-derived β-glucans display increased
costimulatory molecule expression (CD40, CD80, CD86) and drive T cell polarization
towards a Th1/Th17-type response (23, 88). In addition, the DCs express CCR7, a
chemokine receptor that directs migration to the draining lymph nodes (23). Intriguingly,
human

dendritic

cells

stimulated

with

Pneumocystis

β-glucans

produce

the

proinflammatory cytokines TNFα and IL-1β (23). The mechanism for dendritic cell
recognition of Pneumocystis trophic forms, which do not express β-glucans, is unknown.

ii. Macrophages
Alveolar macrophages are the primary phagocyte involved in the clearance of
Pneumocystis organisms. Alveolar macrophages bind Pneumocystis organisms in vitro,
and traffic the fungi to the phagolysosomes for degradation (2, 89-91). Alveolar
macrophages phagocytose Pneumocystis organisms using pattern recognition receptors
(PRRs) including mannose receptor and the β-glucan receptor dectin-1(92, 93).
Opsonized organisms may be also be phagocytosed by the receptors FcγRII and FcγRIII
(93).
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The role of reactive oxygen species in the killing of Pneumocystis organisms is
unclear. Rat alveolar macrophages stimulated with P. carinii release NO2- and H2O2 in
vitro (94, 95). H2O2 appears to be partially responsible for the killing of Pneumocystis
within the phagosome (93). However, Pneumocystis organisms may have mechanisms for
evasion of direct killing by reactive oxygen species, as stimulation with the fungus
impairs the dimerization (and thus the activation) of iNOS (96).
In addition to direct killing of Pneumocystis organisms, alveolar macrophages also
contribute to the inflammatory environment of the lungs by releasing proinflammatory
cytokines to promote adaptive responses. Recognition of Pneumocystis organisms by
human alveolar macrophages triggers the production of proinflammatory cytokines
associated with classically activated macrophages, including IL-1β, IL-6, IL-8 and TNF-α
(97, 98). However, a proportion of macrophages in the lungs of mice infected with P.
murina display characteristics of alternatively activated cells, including increased
expression of mannose receptor, CD23, CCR7, and arginase (99). Polarization of
macrophages towards the alternatively activated phenotype results in improved clearance
of Pneumocystis organisms and decreased immunopathogenesis (100, 101).
Alveolar macrophages are not sufficient for clearance of Pneumocystis in the
absence of T helper cells (102). Intriguingly, Pneumocystis infection promotes expression
of reactive oxygen species and the proinflammatory cytokines interferon gamma (IFNγ),
TNFα, and IL-12 in the lungs of T cell-deficient mice (102). This suggests that alveolar
macrophages may be dependent on additional cues from CD4+ T cells to mediate
clearance of Pneumocystis.
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iii. Alveolar epithelial cells
Alveolar epithelial cells, or pneumocytes, compose a thin barrier between the
alveolar lumen and lung capillaries. The integrity of this barrier is essential to effective
gas exchange. Pneumocystis trophic forms bind intimately to type I alveolar epithelial
cells (64). This interaction is a risky endeavor for the trophic forms, as alveolar epithelial
cells are capable of producing proinflammatory cytokines. Rat alveolar epithelial cells
stimulated with Pneumocystis cell wall β-glucans produce macrophage inflammatory
protein-2 (MIP2) and TNFα (103-105). Alveolar epithelial cells do not express the βglucan receptor dectin-1. Rather, the production of cytokines in response to Pneumocystis
β-glucan is dependent on NF-κB-dependent signaling pathways initiated by
glycosphingolipids (105). Further work demonstrated that human airway epithelial cells
stimulated with Pneumocystis cell wall β-glucans produce IL-8 in glycosphingolipiddependent mechanism triggered by an increase in calcium influx (106).
Stimulation of human alveolar epithelial cells with mixed Pneumocystis organisms
also induces expression of the proinflammatory cytokine IL-6 (107). Surprisingly, preincubation of the cells with IL-6 promoted the production of fibronectin, and led to
increased Pneumocystis attachment (107). These data suggest that trophic forms may
manipulate the immune response with alveolar epithelial cells to promote fungal growth.

iv. T lymphocytes
The susceptibility of HIV/AIDS patients to PcP highlights the critical role of CD4+
T cells in the immune response to this fungus. A CD4+ T cell count below 200 cells/µl is
associated with an increased risk for PcP in this population (20). Transfer of CD4+ T cells
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from P. murina infected immunocompetent mice into SCID mice is sufficient to mediate
clearance of infection (108). Effective costimulation of CD4+ T cells is required for
control of Pneumocystis infection, as loss of CD40 ligand or the costimulatory receptor
CD28 results in acute infection in mice (109, 110). While Th17 responses are critical for
control of many fungal infections, including candidemia, a mixed T helper response is
observed in response to Pneumocystis infection. This mixed response appears to be
largely redundant, as Th1-, Th2-, and Th17-type responses have all been associated with
clearance of P. murina organisms (24, 111-115).
The role of CD8+ T cells in the response to Pneumocystis is less clear. In the
immune reconstitution model, depletion of CD8+ T cells did not hinder clearance of
Pneumocystis infection, but instead led to a prolonged CD4+ T cell response with an
increased frequency of Th1 CD4+ T cells compared to the untreated, infected controls
(116). In contrast, transfer of CD8+ T cells from P. murina infected immunocompetent
mice into immunocompromised mice led to increased lung damage rather than control of
infection (116, 117). These negative inflammatory effects are associated with CD8+ T
cell-dependent TNFα-mediated effects on lung parenchyma cells (117, 118). In contrast,
IFNγ production by CD8+ T cells is associated with protective responses against
Pneumocystis (119). While CD8+ T cells are not normally sufficient to mediate clearance
of infection, overexpression of IFNγ in the lungs of mice depleted of CD4+ T cells led to
clearance of P. murina organisms and increased proliferation of IFNγ-expressing CD8+ T
cells (119).
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v. B lymphocytes
B cells are required for the clearance of Pneumocystis organisms (3, 4). B cells are
capable of playing multiple roles within the immune response, including antigenpresentation to T cells and production of antibody and proinflammatory cytokines. The
immune response to Pneumocystis incorporates each of these functions to a varying
degree of importance.
Antibody-mediated opsonization enhances phagocytosis of Pneumocystis organisms
by alveolar macrophages, and mediates clearance of Pneumocystis organisms in vivo (3,
93, 112, 120). Clearance is delayed in the absence of antibody class switching, indicating
that P. murina-specific IgG enhances, but is not required for, control of Pneumocystis
infection (3). In the absence of CD4+ T cells, a memory humoral response is sufficient to
clear Pneumocystis organisms during a secondary infection (121, 122). This response
requires the participation of CD8+ T cells and alveolar macrophages, which phagocytose
antibody-coated organisms (122). P. murina-specific antibody composed of isotypes
produced by either Th1- or Th2-like responses are sufficient for mediating clearance of
secondary infection (IgG1 or IgG2a/IgG2b/IgG3, respectively) (112).
B cells are required for the generation of protective effector and memory CD4+ T
cell responses to Pneumocystis (3, 123, 124). B cells expressing both MHC class II and
Pneumocystis-specific B cell receptor are required for effective priming of CD4+ T cells
and clearance of Pneumocystis infection (123, 124). Production of TNFα by B cells in the
draining lymph nodes is essential for CD4+ T cell expansion and clearance of P. murina,
and anti-TNFα therapy for rheumatoid arthritis and Crohn’s disease is associated with an
increased risk for PcP (39, 40, 125).
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It has recently become apparent that B cells participate in the suppression of
systemic inflammation due to Pneumocystis infection in the lungs (126). In the absence
of type I interferon signaling and B cells, systemic inflammation due to Pneumocystis
infection in the lungs leads to bone marrow failure due to increased turnover of maturing
cells and decreased bone marrow progenitor function (126). The protective contribution
of B cells is mediated in part by the expression of IL-10 and IL-27 (126). Increased
systemic inflammation and bone marrow dysfunction has been observed in patients with
chronic pulmonary diseases and HIV/AIDS (127-130). Hoyt et al propose that
Pneumocystis infection may be a comorbidity factor for damage due to systemic
inflammation in these patients, particularly as these populations are at an increased risk
for PcP (126).

vi. Summary of protective responses in immunocompetent hosts
Dendritic cells, macrophages, and alveolar epithelial cells serve as early sentinels of
Pneumocystis infection. Upon encountering antigen, dendritic cells undergo maturation
and travel to the draining lymph nodes to present antigen to lymphocytes. CD4+ T cells
and B cells are recruited to the lungs, where they may serve as helper cells that direct the
killing of Pneumocystis by other immune cells, including macrophages. However, the
exact mechanisms of macrophage killing of Pneumocystis organisms are unclear.

B. Neonatal response to Pneumocystis
While malnourished, premature, or otherwise immunocompromised infants are at
risk for PcP, evidence suggests that immunocompetent individuals of all ages are capable
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of mounting protective immune responses to Pneumocystis jirovecii. However, the
neonatal immune response to Pneumocystis is delayed during the first three weeks of
infection (9-12).
The delayed clearance of P. murina in neonatal mice may be partially attributed to
the tolerogenic phenotype of the neonatal lung. The neonatal lung environment is
characterized by decreased expression of granulocyte-macrophage colony-stimulating
factor (GM-CSF) and increased expression of anti-inflammatory mediators, including
TGF-β-1 and IL-10, and immature immune cells (9-12, 131). Neonatal alveolar
macrophages and T cells adoptively transferred into the immunogenic environment of
adult lungs are competent to resolve P. murina infection without delayed kinetics (9, 12).
Treatment of neonatal mice with exogenous GM-CSF and IL-4 promotes enhanced
clearance of Pneumocystis organisms amidst increased expression of proinflammatory
cytokines in the lungs (131).
The immature phenotype of neonatal immune cells also contributes to delayed
immune responses to Pneumocystis infection compared to adults. Ex vivo experiments
demonstrate that neonatal alveolar macrophages are deficient in NF-κB translocation
following stimulation with Pneumocystis organisms (9). In addition, neonatal alveolar
CD11c+ cells demonstrate delayed trafficking to the draining lymph nodes (11).
Together, these data indicate that both the neonatal lung environment and intrinsic
immune cell deficits contribute to the delayed clearance of P. murina in neonatal mice.
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C. Immunopathogenesis due to Pneumocystis
Pneumocystis infection causes asymptomatic or subclinical infections in healthy
hosts. The severely reduced genome of Pneumocystis species and the lack of an
environmental reservoir strongly suggest that the organisms have evolved to live as
obligate commensals within the healthy host (21).
It is possible that Pneumocystis organisms contribute to mild damage to the
structure of the alveoli, as binding of Pneumocystis carinii organisms to type I alveolar
epithelial cells leads to cell necrosis and increased permeability of the alveolar-capillary
membrane (132). However, the bulk of the lung damage that occurs during PcP is
associated with rampant, non-productive inflammation in immunocompromised hosts
(133, 134). Severe lung damage during PcP is more closely correlated with inflammation
and increased recruitment and proliferation of immune cells within the lungs, rather than
the fungal burden (5, 134, 135). The recruitment of neutrophils is correlated with a poor
prognosis in humans with PcP (134, 136, 137), but animal studies suggest neither
neutrophils nor reactive oxygen species directly cause lung damage (138). Rather,
damage appears to be strongly related to the adaptive immune response, especially CD8+
T cells (134, 135). Respiratory impairment is attributed to direct damage to the alveoli, as
well as impaired gas exchange due to accumulation of immune cells in the alveolar
spaces. Fungal growth can contribute to impaired gas exchange in the later stages of PcP,
especially in mice that lack adaptive immune cells (139).
Myeloid-derived suppressor cells (MDSCs) accumulate in the alveolar spaces of
immunocompromised mice and rats with PcP (140). Recent evidence suggests that
MDSCs may contribute to pathogenesis and impede fungal clearance by suppressing key
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effector cells. MDSCs isolated from the lungs of immunocompromised rodents with PcP
suppress CD4+ T cell proliferation ex vivo (140). Alveolar macrophages co-cultured with
MDSCs from mice with PcP exhibited reduced phagocytic capacity (141). In addition,
MDSCs may directly contribute to lung injury, as adoptive transfer of MDSCs from
rodents with PcP to healthy hosts resulted in increased lung albumin and lactate
dehydrogenase (LDH) (140).
The restoration of the immune system in previously immunocompromised patients
increases the risk for lung damage due to PcP. Bone marrow transplant patients are at
increased risk for PcP following engraftment and the restoration of the inflammatory
capacity of immune cells (142). Initiation of HAART in HIV/AIDs patients may provoke
an overexuberant return of inflammatory responses, known as immune reconstitution
inflammatory syndrome (IRIS). IRIS increases the risk for lung damage associated with
PcP, and is associated with a population of rapidly expanding CD8+ T cells (135).
Corticosteroids are given in addition to antifungals to reduce the damage due to lung
inflammation in moderate to severe cases of PcP (79).

D. Recognition of fungal pathogens by the immune system
i. Role of PRR and PAMPs in fungal immunity
Pattern recognition receptors (PRRs) expressed by cells of the innate immune
system are responsible for detecting pathogen-associated molecular patterns (PAMPs)
and initiating anti-microbial mechanisms including phagocytosis, production of reactive
oxygen species, and the release of inflammatory cytokines. Conserved fungal cell wall
PAMPs include β-glucans, α-glucans, chitin, and mannoproteins. The major classes of
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pattern recognition receptors involved in recognition of fungal pathogens include the tolllike receptors (TLR), the C-type lectin receptors (CLR), and Nod-like receptors (NLR)
(143). Toll-like receptors are type I transmembrane proteins with cytosolic Toll-IL-1
receptor (TIR) domains that trigger downstream signaling cascades (144). TLR1, TLR2,
TLR4 and TLR6 are commonly implicated in the response to fungal pathogens, including
Candida albicans, Aspergillus fumigatus, and Cryptococcus neoformans (145).
CLRs are transmembrane proteins with at least one C-type lectin-like domain
capable of binding carbohydrate (144). Dectin-1 is a CLR expressed on macrophages and
dendritic cells that is highly specific for β-1,3-glucans (146, 147). The cytoplasmic tail of
dectin-1 contains a single tyrosine-based activation-like motif, or “hemi-ITAM” (148).
Activation of dectin-1 triggers phagocytosis and Syk-and CARD9/Bcl10/MALT1dependent signaling cascade resulting in production of reactive oxygen species (ROS),
the NF-κB- or NFAT-mediated production of inflammatory cytokines, and the
upregulation of costimulatory molecules on dendritic cells (149). β-glucan has been
shown to stimulate NLRP3 inflammasome-mediated production of the inflammatory
cytokine IL-1β (26). These responses promote the polarization of Th1 and Th17 cells, the
effector responses of cytotoxic CD8+ T cells, and antibody production (149, 150). Other
C-type lectin receptors that may play a role in fungal immunity by targeting mannose,
fucose, glycolipids or chitin include mannose receptor, DC-SIGN, SIGNR1, SIGNR3,
dectin-2, mincle, langerin, LSECtin, Mgl1, Mgl2, and DEC-205 (Fig 1.3 and (151)).
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ii. Synergistic interactions between PRR:
Synergistic interactions between pattern recognition receptors may further influence
the initiation of the innate immune response. Dectin-1 and TLR2 are recruited to
phagosomes containing unopsonized zymosan, a Saccharomyces cerevisiae cell wall
preparation consisting of β-glucans, mannans, mannoproteins and chitin (147). TLR2
activation in the absence of dectin-1 is insufficient to induce phagocytosis or the
production of ROS in response to zymosan, but does result in the production of
inflammatory cytokines (147). Dectin-1 enhances TLR2-mediated production of
inflammatory cytokines in response to zymosan by sustaining the degradation of IκB,
which increases NF-κB nuclear translocation (147, 152). TLR2 activation does not play a
direct role in the tyrosine phosphorylation of dectin-1, and direct physical contact
between the receptors is not believed to occur (147). Both dectin-1-mediated Syk
signaling and the TLR adaptor molecule MyD88 are required for this synergistic effect,
suggesting that signal integration is responsible (152). Similar collaboration has been
observed between dectin-1 and TLR4, TLR5, TLR7, and TLR9 (152).
Other pattern recognition receptors may collaborate to shape the innate immune
response. For example, the association of dectin-1 with the carbohydrate binding receptor
galectin-3 has been shown to enhance the TNF-α response to Candida albicans (153).
Similarly, the association of dectin-1 with DC-SIGN, a C-type lectin receptor that binds
mannose, enhances the pro-inflammatory arachidonic acid cascade in dendritic cells
(154).
While dectin-1 is capable of binding soluble β-glucan, activation of downstream
signaling is dependent on the recognition of immobilized, particulate β-glucan (147, 148).
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This recognition causes dectin-1 to cluster in synapse-like structures that exclude
regulatory tyrosine phosphatases CD45 and CD148 (148). This “phagocytic synapse”
forms prior to internalization of particulate β-glucan and likely facilitates downstream
signaling (148). It is not known whether other PRR are specifically clustered at the site of
contact with particulate β-glucan, but the previously demonstrated physical association
between dectin-1 and DC-SIGN or galectin-3 suggests that the formation of the synapse
may facilitate homologous and heterologous receptor crosstalk (153, 154). Collaboration
between PRRs may allow innate immune cells to differentiate between situations where a
complex inflammatory response is warranted (i.e., a microbe expressing multiple
PAMPs), and situations where tolerance is more ideal (i.e., inhalation of fungal
allergens).

iii. Innate recognition of Pneumocystis:
The Pneumocystis cyst wall is predominately composed of β-1,3-glucan with side
chains of β-1,6- and β-1,4-linked glucose residues (155). Dendritic cells have been shown
to respond to β-glucans derived from the P. carinii cyst wall through dectin-1 (23).
Dendritic cells activated by cyst wall-derived β-glucans increase costimulatory molecule
expression and drive CD4+ T cell activation towards a proinflammatory Th1/Th17
response in a dectin-1-dependent manner (23, 88).
The mechanism for dendritic cell recognition of the trophic life cycle stage, which
expresses glycoproteins but not β-glucans, is unclear. Recently, treatment of rats with the
β-1,3-D-glucan synthase inhibitor echinocandin resulted in depletion of P. carinii cysts
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(24). The rats were able to clear the remaining trophic forms in the absence of an
excessive inflammatory response.
TLR2 and the β-glucan receptor dectin-1 are required for the generation of an
effective response to Pneumocystis (69, 156). This suggests that collaboration of TLR2
and dectin-1 may play a role in the induction of the robust response to Pneumocystis
cysts. β-glucan derived from Pneumocystis promotes the formation of dectin-1-containing
lipid rafts at plasma membrane of dendritic cells. Lipid rafts are glycosphingolipidenriched microdomains that promote signaling via the clustering of receptors with ITAM
domains. This rearrangement of the plasma membrane is likely analogous to the
“phagocytic synapse” previously observed in macrophages (148). Glycosphingolipid
cluster formation in human dendritic cells stimulated with cyst cell wall-derived β-glucan
promotes classical NFκB activation and expression of the Th17-type cytokine, IL-23 (88).
Other C-type lectin receptors may play a role in immunity to Pneumocystis by
targeting mannose, fucose, or glycolipids (20, 151). Among these, mannose receptor has
been the most rigorously studied in the context of Pneumocystis infection. Mannose
receptor, a C-type lectin receptor with carbohydrate recognition domains capable of
binding mannose, fucose and GlcNAc, binds the antigenic glycoprotein A (gpA, or major
surface glycoprotein, MSG) on the cell wall of Pneumocystis organisms, triggering
phagocytosis, ROS production, NFκB translocation, and production of IL-1, IL-6, IL-8,
and TNF-α (92, 97, 98, 157).
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iv. CLR-mediated suppression of immune responses
Recently, it has become evident that signaling via C-type lectin receptors is highly
context-specific, and, in certain situations, engagement of C-type lectin receptors may
lead to suppression of proinflammatory immune responses. This phenomenon may reflect
the capacity of C-type lectin receptors to shape the balance between tolerance and
inflammation based on the composition, density, and architecture of the ligand. For
example, arabinogalactan isolated from the dust of traditional farms is protective against
allergy responses. It was recently demonstrated that arabinogalactan interacts with
mannose receptor and DC-SIGN on human dendritic cells and inhibits NF-κB activation
following stimulation with the TLR4 ligand LPS (158). High-molecular-weight or
complex β-glucans such as curdlan promote dectin-1-mediated proinflammatory
signaling, while the low-molecular-weight, soluble glucan laminarin acts as an antagonist
of dectin-1.
Recent evidence suggests that fungal pathogens may manipulate interactions with
C-type lectin receptors to suppress proinflammatory responses. Engagement of the Ctype lectin receptor mincle by the fungal skin pathogen Fonsecaea monophora was
shown to suppress the proinflammatory Th1- and Th17-type immune responses induced
by dectin-1-mediated signaling (159). Opposing roles for dectin-2 and mincle have been
observed in the recognition of Fonsecaea pedrosoi (160).
Hyper-mannose glycosylation is required for optimal C-type lectin receptor
recognition of C. albicans (68, 69). The lack of outer chain N-mannans may permit
Pneumocystis organisms to escape detection by the immune system (21). While mannose
receptor is associated with proinflammatory responses to Pneumocystis (92, 98, 157),
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Zhang et al. demonstrated that blockage or knockdown of mannose receptor on rat
alveolar macrophages resulted in elevated TNFα production in response to unopsonized
mixed Pneumocystis organisms (161). In the absence of a strong proinflammatory signal
from the cysts (β-glucan), the interaction of weakly mannosylated proteins on the surface
of trophic forms with a C-type lectin receptor such as mincle or mannose receptor may
suppress proinflammatory responses.

VI. Current limitations in Pneumocystis research
Despite repeated effort, a long term culture system for Pneumocystis organisms has
not yet been developed. In the absence of an in vitro culture system, predictions have
been made about the life cycle and reproduction of Pneumocystis species based on
methods such as genome analysis, ultrastructural imaging of fungi from host lung
isolates, and complementation of probable genes in related fungi including
Saccharomyces cerevisiae. Recent genomic studies of P. jirovecii, P. murina, and P.
carinii suggest that Pneumocystis species are obligate extracellular parasites that must
scavenge nutrients, including amino acids, from their hosts (21, 162-164). In addition, the
stable environment of the host lung may have permitted Pneumocystis species to lose
genes involved in pH sensing, osmotic and oxidative stress responses (21). Such
information will likely be critical to the success of future attempts to devise in vitro
culture systems for Pneumocystis organisms.
The inability of P. jirovecii to live outside of a human host has limited research on
this medically important parasite and opportunistic pathogen. Rat and mouse models have
driven critical advances in understanding the immune responses to P. carinii and P.
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murina, respectively. The transmission of Pneumocystis organisms and the progression of
disease, including the development of interstitial pneumonia, in immunocompromised
rodents appear to be homologous to that experienced in humans. Patients with specific
immunodeficiencies, including defects in immune cell populations, signaling pathways,
and cytokines, have provided evidence regarding the components of the immune response
that are essential for clearance of Pneumocystis organisms. These observations have been
substantiated by a large body of research exploring the immune response to Pneumocystis
in rodent models. In addition, rhesus macaques have been used in studies that explore
Pneumocystis and simian immunodeficiency virus (SIV) co-infection or the development
of vaccines against Pneumocystis.
Currently, there is no reliable method for isolation of pure P. murina cyst
organisms, though enrichment of P. carinii cysts from the lungs of infected rats via
counterflow centrifugal elutriation has been reported (20). Cysts are relatively rare in the
lungs of infected hosts (approximately 10% of the fungal lung burden), and the lungs of
an infected mouse may contain only a tenth of the Pneumocystis organisms found in the
lungs of an infected rat. The scarcity of cysts relative to trophic forms, in the context of
the lower fungal burden in the lungs of mice compared to rats, may explain our inability
to isolate pure cysts from mice.
Several additional factors have likely contributed to this inability to isolate cysts,
regardless of host species, including considerable overlap between the sizes of trophic
forms and cysts, and the lack of unique surface markers. Our attempts to isolate
organisms using density gradients or recombinant His-tagged murine dectin-1 (R&D
Systems, Minneapolis, MN) were unsuccessful (unpublished data). In addition, De
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Stefano et al demonstrate that there is a high degree of conservation in the surface
glycoproteins expressed by trophic forms and cysts (20). We have found a similar degree
of conservation in the lectin-staining profile of trophic forms and cysts (Zhan Ye,
unpublished). Our attempts to isolate the organisms by lectin-binding resulted in a slight
enrichment of cysts, but insufficient yield (Zhan Ye, unpublished).

VII. Project Overview
Prior research in the field has overwhelmingly focused on the immune response to
infection with a mixture of the trophic and cystic life cycle stages. Certainly, such studies
provide valuable information, as the typical immune response to Pneumocystis organisms
is shaped in the context of infection with both trophic forms and cysts. However, such
studies do not provide a nuanced understanding of the distinct roles of the trophic and
cystic life cycle stages in the development of the immune response to Pneumocystis
infection. Here, our goal was to explore the biology of the immune response to these life
cycle stages. In addition to providing answers to basic research questions, these efforts
may provide critical insights for vaccine development or identification of new drug
targets.
There is not a reliable method for isolation of pure P. murina cyst organisms. For
this project, we have employed three general tools for modeling the exposure of the
immune system to Pneumocystis lifeforms: 1) isolation of purified trophic forms, 2)
depletion of cysts, and 3) substitution of the cyst form with materials that are homologous
to cystic PAMPs.
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We are able to employ differential centrifugation to isolate a population of purified
trophic forms from the standard mixed population isolated from infected RAG2-/- mice.
We routinely recover enriched trophic forms with ratios of at least 100 trophic organisms
per cyst, in contrast to the standard mixture of 10 trophic forms per cyst found in infected
mice. Differential centrifugation removes less than 10% of the trophic forms from the
mixed population, and therefore has a negligible effect on the proportions of trophic
forms and cysts that remain in the mixture.
Trophic forms encyst in vivo. In this report, we use the β-1,3-D-glucan synthase
inhibitor anidulafungin to analyze the in vivo immune response to infection with trophic
forms in the absence of cysts. Treatment with anidulafungin results in rapid depletion of
the cyst life cycle stage, which expresses β-1,3-glucan, but leaves the trophic burden
intact (17, 24).
Finally, in lieu of purified cysts, we will treat immune cells with various materials
that are homologous to PAMPs on the surface of the cysts. Included in this list of
surrogates are curdlan (a β-glucan preparation from Alcaligenes faecalis), zymosan (a
Saccharomyces cerevisiae cell wall preparation consisting of β-glucans, mannans,
mannoproteins and chitin), and depleted zymosan (zymosan that has been treated with
hot alkali to denature proteins).

Central Hypothesis: The life cycle stages of Pneumocystis murina have a differential
interaction with immune cells. Our initial goal was to characterize the immune response
generated in response to trophic forms, or a mixture of trophic forms and cysts. Multiple
reports from Limper et al. indicated that β-1,3-D-glucan from the cyst wall was sufficient
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to drive secretion of proinflammatory chemokines and cytokines by alveolar epithelial
cells and dendritic cells (23, 103, 104, 106). Furthermore, β-1,3-D-glucan-treated
dendritic cells promoted CD4+ T cell proliferation and Th1 polarization (23). Conversely,
it was unclear which types of immune responses might be elicited by the trophic forms,
which do not express β-glucan. To address this hypothesis, three aims were explored:

Aim I: To determine if optimal innate and adaptive primary immune responses to
Pneumocystis species are dependent on stimulation with the cyst life cycle stage. We
initially hypothesized that infection of immunocompetent mice with trophic forms would
lead to differential immune response compared to infection with mixed P. murina
organisms due to the absence of β-glucan. Early data indicated that inoculation with
trophic forms lead to the delayed initiation of innate and adaptive responses compare to
inoculation with mixed P. murina organisms (Fig 3.1-6). Despite the absence of βglucan, trophic forms express multiple glycoproteins that have the potential to interact
with pattern recognition receptors (20, 165). Therefore, if trophic forms induce a less
robust immune response than the cyst, it is possible that trophic forms employ some
mechanism(s) to evade or dampen innate responses to the potentially inflammatory
PAMPs expressed on their surface. We address this Aim in Chapter 3.

Aim II: To evaluate the role of trophic forms in the generation of protective
adaptive immunity, as measured by clearance of infection. While Linke et al.
demonstrate that depletion of cysts results in diminished inflammatory responses in the
model of immune reconstitution inflammatory syndrome, it is unclear if trophic forms are
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capable of eliciting any degree of an immune response. There is no evidence to suggest
that Pneumocystis species have adaptive features associated with long-term immune
escape, such as withdrawal to sites hidden from immune pressure. Indeed, infection of
rodents with their respective Pneumocystis species results in clearance of the infection,
albeit after several weeks. These data suggest that both trophic forms and cysts are
susceptible to CD4+ T cell and B cell-mediated clearance. Since trophic forms may
encounter immune cells and may be cleared by T cell and B cell-mediated responses, we
hypothesize that trophic forms may, independently of the cyst stage, elicit immune
responses. We address this Aim in Chapter 4.

Aim III: To determine if trophic forms promote inflammation-mediated pneumonia
in immunocompromised mice. While adaptive immunity is required for clearance of
Pneumocystis infection, inflammation-mediated lung damage is deleterious in many
models of PcP. Linke et al. propose that depletion of Pneumocystis cysts by β-1,3-glucan
synthase inhibitors would reduce inflammation-induced lung damage in patients
undergoing immune-reconstitution syndrome (24). RAG2-/- mice are not able to develop
an adaptive response to Pneumocystis, and thus progress to PcP within 8 weeks postinfection. We predict that treatment with the β-1,3-glucan synthase inhibitor
anidulafungin would extend the life of the RAG2-/- host, as the trophic forms would elicit
less inflammation-induced lung damage. We address this Aim in Chapter 4.

Aim IV: To determine if trophic forms hamper the response to P. murina by
preventing dendritic cell activation. The alveolar spaces of the uninfected host are
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relatively free of immune cells. Clearance of Pneumocystis infection requires activation
of alveolar macrophages, and the recruitment of CD4+ T cells and B cells into the lungs.
Thus, dendritic cells, which extend their processes beyond the alveolar epithelium into
the alveolar spaces, are in a prime position to raise the alarm against Pneumocystis
infection. It is possible that the ability of trophic forms to broadly dampen immune
responses is dependent on silencing this alarm. To prime protective T cell responses,
dendritic cells must undergo activation and prepare to present antigen, costimulatory
molecules, and inflammatory cytokines to T cells in the draining lymph nodes of the
lungs. We hypothesize that Pneumocystis trophic forms may impair one or more steps
involved in the communication between dendritic cells and T cells. We address this Aim
in Chapter 5.

Copyright © Heather Marie Evans 2017
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Figure 1-1 Proposed Pneumocystis life cycle.
Asexual reproduction of trophic forms probably occurs during acute infection. Sexual
reproduction probably occurs when haploid trophic forms conjugate to form a diploid
precyst. The precyst matures through the early, intermediate and late phase to form a
mature cyst which ultimately releases young trophic forms.
Reproduced with permission from Skalski JH, Kottom TJ, Limper AH. 2015.
Pathobiology of Pneumocystis pneumonia: life cycle, cell wall and cell signal
transduction. FEMS Yeast Research 15: fov046. DOI: 10.1093/femsyr/fov046.
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Figure 1-2 P. murina trophic forms and cysts.
Brightfield images (60 X magnification, oil objective, Nikon Eclipse E600 microscope)
of DiffQuik-stained P. murina (A) purified trophic forms and (B) mixture of trophic
forms (arrowhead) and cysts (arrow).
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Figure 1-3 C-type lectin receptor signaling.
Engagement of DC-SIGN with fucose or highly-mannosylated structures induces
acetylation of the NF-κB subunit p65 via the serine/threonine kinase Raf-1 (166).
Mannose receptor (MR) is indicated in phagocytosis of Pneumocystis organisms (92). In
human alveolar macrophages, nuclear translocation of canonical NF-κB molecules (p65,
p50) and cytokine production have been shown to utilize MR (98, 167). Upon ligation
with β-glucans, Syk associates with the ITAM motif within Dectin-1 to initiate
downstream signaling through both the canonical and non-canonical NF-κB pathways.
Dectin-2 and Mincle recognize α-mannans and require association with the FcRγ chain to
initiate downstream signaling through the canonical NF-κB pathway.
Reproduced with permission from Kurkjian CJ. 2013. Environmental and intrinsic factors
influence alveolar macrophage function in the neonatal immune response to
Pneumocystis. Available from ProQuest Dissertations & Theses Global (1513271303).

37

Chapter 2: Materials and Methods

I. Materials
A. Reagents
Hanks Balanced Saline Solution (HBSS), Roswell Park Memorial Institute 1640
(RPMI) medium, Penicillin/Streptomycin (P/S), gentamicin reagent solution, Lglutathione, TrpLE Express cell dissociation buffer, Trypan blue, pHrodo Green
Zymosan Bioparticles and Prolong Gold antifade reagent were purchased from Thermo
Fisher Scientific (Waltham, MA).
DDAO-SE was purchased from Molecular Probes, Invitrogen (Grand Island, NY).
Dulbecco’s Phosphate Buffered Saline (PBS), albumin from bovine serum (BSA),
DNase, Collagenase, glutathione, ethylenediaminetetraacetic acid (EDTA), formalin
(neutral buffered, 10%), saponin, sodium azide (NaN3), ionomycin, brefeldin A, dimethyl
sulfoxide (DMSO), 2-Mercaptoethanol (2-ME), Tween-20, and sulfuric acid (H2SO4)
were purchased from Sigma-Aldrich (St. Louis MO).
Heat-inactivated fetal bovine serum (HIFBS) was purchased from Atlas Biologicals
(Fort Collins, CO). Methanol was purchased from BDH Chemicals (Poole Dorset, UK).
MEM nonessential amino acid solution was purchased from ATCC (Manassas, VA).
mGM-CSF was purchased from Peprotech (Rocky Hill, NJ). CD4 (L3T4) microbeads
were purchased from (Miltenyi Biotec, San Diego, CA). DiffQuik was purchased from
Siemens Healthcare Diagnostics, Inc. (Deerfield, IL). Foxp3 transcription factor staining
kit and all ELISA kits were purchased from eBioscience (San Diego, CA). DNase easy
kits were purchased from Qiagen (Germantown, MD). Transwell plates were purchased

38

from Corning Inc. (Corning NY). CFSE was purchased from Tonbo Biosciences (San
Diego, CA). Direct-zol RNA miniPrep kit was purchased from Zymo Research (Irvine,
CA). nCounter Mouse Immunology CodeSet was purchased from NanoString (Seattle,
WA).

B. Mice
Six-week old BALB/cJ, C57BL/6, dectin-1 knockout (B6.129S6-Clec7atm1Gdb/J ),
and mannose receptor knockout (MR-/-, B6.129P2-Mrc1tm1Mnz/J) mice were purchased
from the Jackson Laboratory (Bar Harbor, ME) and bred in our animal facilities. Male
and female pups were used in the neonatal experiments. Six-week old female BALB/cJ
and C57BL/6 mice were purchased from the Jackson Laboratory and infected at eight
weeks of age for either the adult experiments or to generate CD4+ T cells for the in vitro
experiments. Uninfected adult female BALB/cJ, C57BL/6, dectin-1-/-, MR-/-, and
B6.129P2 mice from the Jackson Laboratory were used to generate BMDCs for the in
vitro experiments. Mice were maintained at the University of Kentucky Department of
Laboratory Animal Resources (DLAR) under specific-pathogen-free conditions.
C.129S6(B6)-Rag2tm1Fwa N12 (Rag2-/-) mice, originally from Taconic (Germantown, NY)
were used to maintain a source of P. murina and were bred at DLAR in sterile
microisolator cages with sterilized food and water. The University of Kentucky
Institutional Animal Care and Use Committee approved all protocols regarding animal
use. Femurs and tibias from Muc1-/- mice were generously provided by Dr. Sandra
Gendler (Mayo Clinic, Scottsdale, AZ).
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II. Methods
C. P. murina isolation
Lungs were excised from P. murina-infected Rag2-/- mice and pushed through
stainless steel mesh in HBSS containing 0.5% glutathione at pH 7.3. Cell debris was
broken up by aspirating through 20 and 26-gauge needles, then removed by
centrifugation at 100 X g for 3 min. Trophic forms were isolated by removing the
supernatant following centrifugation at 400 X g for 7 min. This preparation results in
greater than 99% pure trophic forms (168). The pellet from the 400 X g spin contained a
mixed population of cysts and trophic forms, at a typical ratio of 10:1 trophic forms to
cysts. Erythrocytes in the pellet were lysed with water, and organisms suspended in an
equal volume of 2X phosphate-buffered saline (PBS). Organisms were incubated with
200 U DNase at 37°C for 30 min. Clumps were broken up by aspirating through a 26gauge needle. The remaining cell debris was removed by centrifugation at 100 X g for 3
min, followed by passage over a 70 µm filter. Aliquots of mixed P. murina organisms or
purified trophic forms were diluted, and 100 µl aliquots were spun onto a 28.3 mm2 area
of glass slides. Slides were fixed in methanol and stained with DiffQuik (as shown in Fig
1.2). Organism numbers were determined microscopically using the 100X oil immersion
objective of a Nikon microscope.
Purified and separated Pneumocystis lifeforms were pelleted by centrifugation at
1300 X g for 15 min, then resuspended in RPMI containing 10% HIFBS and 7.5%
DMSO at a concentration of 107-108 Pneumocystis nuclei per 1ml media per cryovial.
Frozen purified Pneumocystis was stored at -80C. As required for experiments, frozen
purified Pneumocystis was thawed on ice and washed twice in HBSS with 1% P/S, 0.1%
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gentamicin. Thawed P. murina was recounted (as described above) prior to inclusion in
an experiment. It should be noted that the net effect of these centrifugation and wash
steps would be expected to remove any matter with subcellular size. These washes,
combined with the initial slow spin to remove lung debris, provide a reasonable degree of
assurance that the trophic and mixed P. murina populations were free of any material that
may confound the immunological assays employed in this dissertation. The visualization
of the populations with DiffQuik stain (as seen in Fig 1.2) provides further assurance that
the organisms were free of contamination from lung debris or bacteria.

D. Infection of mice with P. murina
Mice were lightly anesthetized with isoflurane to suppress the diver’s reflex.
Neonatal mice (24-72 hours old) were inoculated intranasally with up to 106 trophic or
mixed P. murina organisms in 10 µl HBSS containing 10 units/ml penicillin, 10 µg/ml
streptomycin, and 1 µg/ml gentamicin. Adult mice (6 – 8 weeks old) were inoculated
intratracheally with up to 107 trophic or mixed P. murina organisms in 100 µl HBSS
containing antibiotics. The adult mice were placed on an upright support rack, and the
inoculations were performed using a blunted intratracheal needle designed with a curve to
accommodate the trachea.

E. Adoptive transfer of CD4+ T cells
Adult (8 weeks old) BALB/cJ mice were treated with saline or 1mg/kg
anidulafungin (Pfizer, New York, NY) by the intraperitoneal route one day prior to
infection and three times per week thereafter. Mice were anesthetized lightly with
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isoflurane anesthesia to suppress the diver’s reflex and inoculated intratracheally with a
dose of enriched trophic forms or mixed P. murina equivalent to 106 total nuclei in 100 µl
HBSS containing 10 units/ml penicillin, 10 µg/ml streptomycin, and 1 µg/ml gentamicin.
The mice were placed on an upright support rack, and the inoculations were performed
using a blunted intratracheal needle designed with a curve to accommodate the trachea.
Infected mice were euthanized at 14 days post-infection. Tracheobronchial lymph nodes
(TBLN) were collected from the infected mice followed by passage over a 70 µm filter.
Erythrocytes were removed using hypotonic ammonium-chloride-potassium (ACK)
lysing buffer (169). CD4+ T cells were isolated with mouse CD4+ T cell enrichment
columns (positive selection, R&D Systems, Minneapolis, MN). CD4+ T cells were
washed, resuspended, and split for phenotyping or adoptive transfer. Greater than 90% of
recovered cells were CD4+ T cells, as determined by flow cytometry. 105 CD4+ T cells
were adoptively transferred by the intravenous retro-orbital route to RAG2-/- mice
(“recipients”).
Three days after adoptive transfer, the recipient mice were treated with either
1mg/kg anidulafungin or saline by the intraperitoneal route. This treatment continued
three times per week throughout the course of the experiment. One day after the initiation
of drug or saline treatment, the recipient mice were infected with a dose of enriched
trophic forms or mixed P. murina organisms equivalent to 5 X 105 total nuclei. Animals
were euthanized at 15 and 30 days post-infection.
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F. Rechallenge with P. murina in CD4+ T cell-depleted mice
Adult BALB/cJ mice were treated with 1mg/kg anidulafungin by the intraperitoneal
route one day prior to intratracheal infection with 3 X 106 enriched trophic forms.
Animals were treated with anidulafungin three times per week throughout the primary
infection. Following clearance of the primary infection, anidulafungin treatment was
stopped at day 34 post-infection to permit clearance of the drug prior to reinfection. At
day 40 post-infection, 0.15 mg anti-CD4 antibody (clone GK1.5, Bio X Cell, Lebanon,
NH) in 200 µl sterile saline was administered to deplete CD4+ T cells. The anti-CD4
antibody treatment was administered every four days for the remainder of the study. One
day after CD4+ T cell depletion, mice were treated with either anidulafungin or saline
followed by re-infection with a dose of enriched trophic forms or mixed P. murina
organisms equivalent to 5 X 106 total nuclei. The anidulafungin or saline treatment was
administered three days per week for the remainder of the study. Animals were
euthanized at day 15 post-infection.

G. Isolation of cells from alveolar spaces, lungs, and lymph nodes
Mice were exsanguinated under deep isoflurane anesthesia, and lungs were lavaged
with 5 washes of HBSS containing 3 mM EDTA. Bronchial alveolar lavage fluid (BALF)
was centrifuged to obtain cells, and cell-free supernatant from the first wash was frozen
for subsequent cytokine assays. Right lung lobes were excised, minced, and digested in
RPMI containing 3% heat-inactivated fetal calf serum, 1 mg/ml collagenase A, and 50
U/ml DNase for 1 h at 37 °C. Digested lungs were pushed through 70 µm nylon mesh
screens to obtain single-cell suspensions, and aliquots were taken for enumeration of P.
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murina. Tracheobronchial lymph nodes (TBLN) were also excised and pushed through
70 µm nylon mesh screens in HBSS. Erythrocytes were removed using hypotonic
ammonium-chloride-potassium (ACK) lysing buffer. Cells were washed and counted by
hemocytometer.

H. Flow cytometric analysis for in vivo experiments
BALF, lung digest, and TBLN cells were washed with PBS containing 0.1% bovine
serum albumin and 0.02% NaN3 and stained with appropriate concentrations of
fluorochrome-conjugated antibodies specific for murine surface proteins (anti-CD4 clone
GK1.5, anti-CD8a clone 53-6.7, anti-CD19 clone 1D3, anti-CD44 clone MEM-85, antiCD62L clone MEL-14, anti-CD11c clone N418, anti-CD11b clone M1/70, and antiF4/80 clone BM8).Antibodies were purchased from BD Biosciences (San Jose, CA) or
eBioscience (San Diego, CA). Expression of these molecules on the surface of the cells
was determined by multiparameter flow cytometry using a LSRII flow cytometer (BD
Biosciences). 50,000 events were routinely acquired and analyzed using FlowJo software
(TreeStar, USA).

I. Analysis of P. murina-specific IgG in serum
Blood was collected from rechallenged mice following euthanasia at day 15 postrechallenge (n = 3 mice per group). Blood samples were centrifuged to pellet cells, and
serum was collected and frozen at -80°C for later use. P. murina-specific
immunoglobulin G (IgG) was measured by enzyme-linked immunosorbent assay
(ELISA). A sonicate of P. murina trophic forms or mixed organisms (10 μg protein/ml)

44

was coated onto 96-well plates, and wells were blocked with 5% dry milk in HBSS
containing 0.05% Tween-20. Sera were diluted and incubated on plates overnight. Serum
collected from an uninfected mouse was used as a negative control. Plates were
extensively washed, and bound IgG was detected using alkaline phosphatase-conjugated
anti-mouse IgG (Sigma). Plates were washed and secondary antibodies detected using pnitrophenylphosphate at 1 mg/ml in diethanolamine buffer. Optical density was read at
405 nm using a plate reader equipped with KC Junior software (Bio-Tek Instruments,
Inc., Winnoski, VT). An OD of 0.1 was considered a cutoff value based on previous
results from sera collected from uninfected mice. The OD of the negative control serum
employed in these experiments remained below the 0.1 cutoff value.

J. Enumeration of Pneumocystis in the lungs of mice
Aliquots of lung homogenates were diluted in HBSS, and 100 µl aliquots were spun
onto a 28.3 mm2 area of glass slides. Slides were fixed in methanol and stained with
DiffQuik. Organism numbers were determined microscopically using the 100X oil
immersion objective of a Nikon microscope. The number of P. murina trophic forms or
cysts in 50 microscopic oil immersion fields was used to calculate fungal burden. Lung
burden is expressed as the number of P. murina organisms per right lung lobe, and the
limit of detection was Log10 3.12 nuclei per neonatal right lung lobe and Log10 3.42
nuclei per adult right lung lobe.
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K. Generation of BMDCs and CD4+ T cells for in vitro assays.
BMDCs were generated from uninfected BALB/cJ, B6.129P2, dectin-1-/-, and
MR-/- adult female mice. BMDCSs were produced by flushing cells from the bone
marrow of the tibias and femurs of female adult mice with PBS + 5% heat-inactivated
fetal bovine serum. Erythrocytes were removed using ACK lysing buffer (169). Cells
were washed and resuspended in culture media containing RPMI with 10% heatinactivated FBS, 0.5 mM 2-mercaptoethanol, 1% MEM nonessential amino acid solution,
100 units/ml penicillin, 100 μg/ml streptomycin, and 50 μg/ml gentamycin. Cells were
plated in 100 mm Petri dishes at a cell density of 4 X 106 in 10 ml of culture media with
20 ng/ml recombinant murine granulocyte-macrophage colony-stimulating factor. Plates
were cultured at 37°C, 5.0% CO2. An additional 10 ml culture media with 20 ng/ml
recombinant murine GM-CSF was added to cells after 24 h of growth. Every 48 h
thereafter, non-adherent cells were removed and replaced with 10 ml of fresh media
containing recombinant murine GM-CSF. Cells were cultured for nine to twelve days.
BMDCs were collected by vigorously washing plates with media to remove loosely
adherent cells. BMDCs were washed, resuspended, and split for phenotyping or cytokine
assay. Greater than 80% of recovered cells were CD11c+.
CD4+ T cells were generated by infecting adult BALB/cJ mice with 107 mixed P.
murina organisms as described previously. TBLN were excised ten to fourteen days postinfection and pushed through 70 µm nylon mesh screens in HBSS. Erythrocytes were
removed using ACK. Cells were washed and counted. CD4 (L3T4) microbeads were
used for positive selection of CD4+ cells. Greater than 90% of recovered cells were CD4+
T cells.
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L. In vitro cytokine production assays.
104 BMDCs and/or 5 X 104 CD4+ T cells in 96-well plates were stimulated with 10
µg/ml

curdlan

(β-1,3-glucan

from

Alcaligenes

faecalis),

20µg/ml

zymosan

(Saccharomyces cerevisiae cell wall), 20µg/ml depleted zymosan, 10µg/ml lipoteichoic
acid (LTA), 100ng/ml lipopolysaccharides (LPS from Escherichia coli 0111:B4, purified
by gel filtration to remove lipoproteins, per Sigma-Aldrich), 5 X 105 trophic forms and/or
5 X 105 mixed P. murina at 37°C, 5.0% CO2 for 72 h in BMDC culture media.
Supernatants were collected, centrifuged at 2700 X g for 1 min to remove organisms, and
frozen for subsequent analysis of cytokine levels using IL-1β, IL-6, TNFα and IFN-γ
ELISA. Trypan blue was used to evaluate viability of BMDCs following stimulation with
10 µg/ml curdlan, 5 X 105 trophic forms and/or 5 X 105 mixed P. murina at 37 °C, 5.0%
CO2 for 72 h in BMDC culture media.

M. In vitro phagocytosis assays
105 CFSE-labeled BMDCs were pre-incubated in chamber slides for one hour at 37
°C, 5.0% CO2 in BMDC culture media. 2 X 105 DDAO-SE-labeled trophic forms or 2 X
105 DDAO-SE-labeled mixed P. murina were incubated with the BMDCs for 60 min.
Samples were washed three times in PBS, followed by fixation in 10% neutral buffered
formalin for 10 min. Slides were washed in PBS, and coverslips were mounted with
Prolong Gold. Slides were cured for 48 h at room temperature. Slides were examined for
internalization of P. murina organisms by BMDCs using a Nikon A1RSi microscope and
NIS-Elements software. A minimum of 100 cells were analyzed per group.
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105 BMDCs were incubated in round-bottom polystyrene tubes or on chamber
slides for one hour at 37 °C, 5.0% CO2 in BMDC culture media. 2 X 105 DDAO-SElabelled trophic forms, 2 X 105 DDAO-SE-labelled mixed P. murina, and/or 100µg/ml
pHrodo Green-labeled zymosan bioparticles were incubated with the BMDCs for 60 min.
These bioparticles are labeled with a pH-sensitive dye that fluoresces within the acidic
environment of the phagosome. Samples were washed three times in PBS. For confocal
microscopy, chamber slides were fixed in 10% neutral buffered formalin for 10 min at
room temperature. Slides were washed in PBS, and treated with 300nM DAPI for 30 min.
Slides were washed in PBS, and coverslips were mounted with Prolong Gold. Slides were
cured for 48 hr at room temperature. Slides were examined with a Nikon A1RSi
microscope and NIS-Elements software. A minimum of 100 cells were analyzed per
group. For flow cytometry, samples in round-bottom polystyrene tubes were washed
twice in cold PBS. Samples were resuspended in 300ul cold HBSS. The phagocytic
capacity of the cells was determined by flow cytometry using a LSRII flow cytometer.
1,000 dendritic cell events were acquired and analyzed using FlowJo software.

N. In vitro MHC class II and CD40 assays
105 BMDCs were stimulated with 20 µg/ml zymosan (Saccharomyces cerevisiae
cell wall), 106 trophic forms and/or 106 mixed P. murina at 37 °C, 5.0% CO2 for 24 h in
BMDC culture media. Adherent cells were collected from the plate using TrypLE
expression dissociation reagent. Cells were washed with PBS containing 0.1% bovine
serum albumin and 0.02% NaN3 and stained with appropriate concentrations of
fluorochrome-conjugated antibodies specific for innate immune cells (anti-CD11c clone
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N418, anti-Iad clone AMS-32.1, and anti-CD40 clone 3/23). Antibodies were purchased
from eBioscience (San Diego, CA). Expression of these molecules on the surface of the
cells was determined by multiparameter flow cytometry using a LSRII flow cytometer
(BD Biosciences). 1,000 CD11c+ events were routinely acquired and analyzed using
FlowJo software (TreeStar, USA).

O. In vitro CD4+ T cell proliferation and polarization assays
105 BMDCs and/or CFSE-labelled 5 X 105 CD4+ T cells were stimulated with 20
µg/ml zymosan (Saccharomyces cerevisiae cell wall), 5 X 105 trophic forms and/or 5 X
105 mixed P. murina at 37°C and in 5.0% CO2 for 6 days in BMDC culture media. Media
was collected from the plates and spun at 400 X g for 7 min to separate cells from the
supernatant. Supernatant was stored at -80°C for use in IFNγ, IL-13, and IL-17A cytokine
ELISAs (eBioscience, San Diego CA). Adherent cells were collected from the plate using
TrypLE Express dissociation reagent. Dissociated cells were combined with cell pellet
from the plate media and washed in fresh culture media.
Cells were washed in sterile PBS and stained with Fixable Viability Dye eFluor780
(eBioscience, San Diego, CA). Cells were washed with PBS containing 0.1% bovine
serum albumin and 0.02% NaN3 (PBA) and stained with PerCP-efluor710-conjugated
anti-CD4 clone GK1.5. Cells were washed with PBA and resuspended in 300µl HBSS.
CD4+ T cell proliferation was evaluated by multiparameter flow cytometry using a LSRII
flow cytometer. 1,000 lymphocyte events were routinely acquired and analyzed using
FlowJo software.
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P. NanoString gene expression assay
3 X 104 BMDCs in 96-well Stripwell plates were stimulated with 10 µg/ml curdlan
(β-1,3-glucan from Alcaligenes faecalis), 1.5 X 106 trophic forms, or 1.5 X 106 mixed P.
murina at 37 °C, 5.0% CO2 for 2, 4, and 8 h in BMDC culture media. Additional
controls, including BMDCs treated with curdlan and trophic forms, were allowed to
incubate for 72 h. The control supernatants were screened for IL-1β, IL-6, and TNFα
cytokine production by ELISA, as described above.
At the conclusion of the 2, 4, and 8 h timepoints, the appropriate Stripwell segments
were removed from the plate structure. Strips were washed once with PBS. Cells were
lysed in TriReagent and RNA was extracted with the Direct-zol RNA MiniPrep kit
(Zymo Research, Irvine CA). The Direct-zol RNA MiniPrep kit permitted optimal
hybridization of samples to the NanoString probes, presumably due to reduced
contamination of chaotropic salts compared other RNA extraction protocols.
RNA concentration was confirmed by using a NanoDrop machine, and purity was
evaluated by using an Agilent 2100 Bioanalyzer. More than 50% of the RNA fragments
from each sample were larger than 300 bp, satisfying the quality requirements for
NanoString. The RNA integrity number (RIN) for all samples was above 8.0. 200 ng of
each sample was sent to the Microarray Core at the University of Kentucky for
NanoString processing. The NanoString nCounter Mouse Immunology kit was used to
quantify the expression of 561 genes related to the murine immune response. Briefly,
samples were hybridized to a panel of capture probes and reporter probes labeled with
fluorescent barcodes. Hybridized samples were immobilized and aligned on the nCounter
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cartridge. Reporter probes were read using the nCounter Analysis System, and counts
were tabulated for each target transcript.
Analysis and normalization of the raw NanoString data were conducted using
nSolver Analysis Software 2.0. Raw counts were normalized to the internal positive
controls and to the following housekeeping genes: Alas1, Eef1g, G6pdx, Gapdh, Gusb,
Hprt, Oaz1, Polr1b, Polr2a, Ppia, Rpl19, Sdha, Tbp, Tubb5. Heat maps and principal
component analysis were prepared with the nSolver Analysis Software 2.0.

Q. Transwell contact assay
1 X 105 BMDCs, 10 µg/ml curdlan, and/or 5 X 106 trophic forms were plated in the
upper or lower compartments of Transwell plates with a polyester membrane with 0.4µm
pores. Cells were incubated at 37°C in 5.0% CO2 for 72 h in BMDC culture media.
Cytokine levels were analyzed as described above. To confirm that trophic forms did not
cross the membrane, samples were centrifuged directly onto slides, DiffQuik stained, and
50 fields were screened.
Additional Transwell replicates were screened for P. murina DNA by quantitative
PCR. Briefly, DNA was isolated from both the top and bottom compartments of the
Transwell dishes using the Qiagen QIAamp Mini Kit. Presence of P. murina DNA was
detected using primers designed to amplify a portion of the 18S rRNA gene of P. murina.
Sequences of the primers are: forward 5’-GGGCTTCTTAGAGGGACTGTTGG-3’,
reverse 5’-CGTGCGGCCCAGAACATCTA-3’ (IDT, Coralville, IA). The control
plasmid for quantification of P. murina DNA contains the region of the 18S rRNA gene
amplified by these primers (GenScript USA Inc., Piscataway, NJ). DNA was also isolated
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from 104, 105 and 106 P. murina trophic forms. The quantitative PCR amplification was
performed with DNA samples in triplicate for 39 cycles of 95°C for 5 seconds and 57°C
for 30 seconds using a C1000 Thermal Cycler with a CFX96 real-time PCR detection
system (Bio-Rad, Hercules, CA). The amount of trophic DNA calculated to have crossed
from the Transwell insert to the bottom chamber would be equivalent to 2 X 103
organisms. Pneumocystis trophic forms reside in a biofilm-like substance consisting of a
conglomeration of DNA, β-glucan, and other sugars (14). It is possible that the trophic
DNA detected across the Transwell represents shed DNA rather than intact organisms.
Therefore, fewer than 2 X 103 trophic forms may have crossed the Transwell barrier.
The number of organisms required to suppress cytokine expression in the Transwell
system was determined by incubating 1 X 105 BMDCs, 10 µg/ml curdlan, and increasing
numbers of trophic forms (ranging from 103 to 106 organisms) in the lower compartments
of Transwell plates. Plates were incubated 37 °C, 5.0% CO2 for 72 h in BMDC culture
media. Cytokine levels were analyzed as described above.

R. Heat-killed trophic forms
Trophic forms were heat-killed by incubation at 56 °C for 1 hr. Non-viability of the
organisms was confirmed by inoculation of immunocompromised Rag2-/- mice. 104
BMDCs were stimulated with 10 µg/ml curdlan, 5 X 105 trophic forms and/or 5 X 105
heat-killed trophic forms at 37 °C, 5.0% CO2 for 72 h in BMDC culture media. Cytokine
levels were analyzed as described above.
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S. Statistical analysis.
Analysis and normalization of the NanoString data were conducted using nSolver
Analysis Software 2.0. Differences among the groups were identified by two-way
ANOVA followed by pairwise comparisons using the Least Significant Difference
Method. Five biological replicates were used per group. A change was deemed
significant if the p-value was < 0.01.
All other data were analyzed utilizing the SigmaStat statistical software package
(SPSS Inc., Chicago, IL). Student’s t-test, one way or two way analysis of variance
(ANOVA) was used to determine differences between groups, with Student-NewmanKeuls or Holm-Sidak multiple comparisons post hoc tests. Kruskal-Wallis one-way
ANOVA on ranks was used to analyze differences between groups when the data were
nonparametric. Data were determined to be significantly different when the p-value was
< 0.05.

Copyright © Heather Marie Evans 2017
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Chapter 3: Robust innate and adaptive immune responses to Pneumocystis murina
are dependent on stimulation with the cyst life cycle stage, while the trophic forms
suppress proinflammatory responses.

The following chapter is modified from: Evans HM, Bryant GL, III, and Garvy BA.
2016. The life cycle stages of Pneumocystis murina have opposing effects on the immune
response to this opportunistic fungal pathogen. Infect Immun. 84:3195–3205.

I. Introduction
Prior research in the field has overwhelmingly focused on the immune response to
infection with a mixture of the trophic and cystic life cycle stages. Certainly, such studies
provide valuable information, as the typical immune response to Pneumocystis organisms
is shaped in the context of infection with both trophic forms and cysts. However, a
nuanced understanding of the role of the trophic and cystic life cycle stages in the
development of the immune response to Pneumocystis infection may provide critical
insights for vaccine development or identification of new drug targets. Recently, it was
reported that treatment of mice with the β-1,3-D-glucan synthase inhibitor anidulafungin
resulted in depletion of P. murina cysts (24). The mice were able to control the remaining
trophic burden in the absence of an excessive inflammatory response, however, the
details of how trophic forms are recognized and cleared are not known.
Clearance of infection involving a mixture of Pneumocystis organisms is dependent
on effective CD4+ T cell, B cell, and macrophage responses (1-4). In addition, failure to
clear a mixture of Pneumocystis organisms leads to severe alveolar damage due to the
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exaggerated inflammatory immune response (5). Both the neonatal lung environment and
intrinsic immune cell deficits contribute to the delayed clearance of a mixture of P.
murina organisms in neonatal mice (9-12).
Dendritic cells are the principal antigen presenting cells in the lung. However, their
role in initiating the adaptive response to Pneumocystis has been understudied. Previous
work has demonstrated that dendritic cells respond to β-glucans derived from the
Pneumocystis cell wall (23). Dendritic cells activated by Pneumocystis cell wall-derived
β-glucans increase costimulatory molecule expression and drive T cell polarization
towards a Th1-type response (23). The mechanism for dendritic cell recognition of
Pneumocystis trophic forms, which do not express β-glucans, is unknown.
Here, we demonstrate that both the adult and neonatal immune response to infection
with P. murina trophic forms alone was less robust than the response to infection with a
physiologically normal mixture of cysts and trophic forms. Infection with trophic forms
alone resulted in reduced recruitment of activated CD4+ and CD8+ T cells into the lungs
of both neonatal and adult mice compared to infection with a normal mixture of trophic
forms and cysts. Infection with a mixture of P. murina organisms drove recruitment of
nonresident innate immune cells into the lung parenchyma and alveolar spaces. In vitro,
trophic forms suppressed production of the proinflammatory cytokines IL-1β, IL-6, and
TNFα by bone marrow-derived dendritic cells (BMDCs) stimulated with β-glucan,
zymosan, LTA, or LPS. In addition, trophic form-stimulated BMDCs failed to stimulate
production of the Th1-type cytokine IFN-γ by CD4+ T cells. We report for the first time
that the trophic forms of P. murina suppress proinflammatory responses induced by
multiple PAMPs.
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II. Results

P. murina trophic forms encyst by day 14 post-infection in neonatal mice.
Recent evidence indicates that cysts are the transmittable life cycle stage of
Pneumocystis species (17). However, there is a paucity of data regarding how the
immune system handles the trophic forms of the organisms. We previously published that
alveolar macrophages from either adult or neonatal mice failed to translocate NFκB in
response to trophic forms (9). Therefore, we first wanted to know how the immune
response differed when cysts were absent early in the infection and how quickly after
infection trophic forms transitioned to cysts. To evaluate the differential immune
response to the life cycle stages, we infected wild-type neonatal mice with either pure
trophic forms or a physiologically normal mixture of P. murina trophic forms and cysts
(Fig 1.2). Neonatal mice infected with a normal mixture of P. murina organisms fail to
mount adaptive immune responses until 21 days of age (9). This presents an opportunity
to observe the growth of the life cycle stages of P. murina in the absence of protective
responses.
Trophic forms were detected at day 5 post-infection in the lungs of BALB/cJ
neonates infected with 1 X 106 trophic forms or 1 X 106 mixed P. murina organisms (Fig
3.1A). The mixed P. murina inoculum consisted of 9.01 X 105 trophic forms and 9.90 X
104 cysts. Neonates infected with trophic forms had a higher trophic burden in the lungs
at days 7 and 14 post-infection compared to mice infected with mixed P. murina (Fig
3.1A). However, the trophic lung burdens were similar between the groups by day 21
post-infection (Fig 3.1A-B). The cyst burden was below the limit of detection of Log10
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3.12 organisms per lung during the first week post-infection in BALB/cJ neonates
infected with either trophic forms or mixed P. murina (Fig 3.1C). Cysts were detected at
day 14 post-infection in both groups. Neonates infected with trophic forms had a higher
cyst burden in the lungs at day 14 post-infection compared to mice infected with mixed
P. murina, but there was no statistically significant difference in the cyst burden between
the groups by day 21 post-infection (Fig 3.1C). Neonates infected with trophic forms and
mixed P. murina displayed no differences in the clearance of either trophic forms or cysts
(Fig 3.1B and D).

Cysts drive the early recruitment of activated T cells into alveolar spaces of neonatal
mice.
Based on previously published reports, we predicted that the absence of cysts in the
inoculum of neonatal mice infected with trophic forms would yield a less robust response
than infection with a normal mixture of trophic forms and cysts (24). Clearance of
Pneumocystis organisms requires the generation of effective adaptive immune responses.
We

have

previously

shown

that

adaptive

responses

are

not

observed

in

immunocompetent neonatal mice until week 3 post-infection (9). To determine if the
absence of cysts in the inoculum affects the neonatal adaptive immune response, T and B
cells in the lungs of neonates infected with trophic forms were compared with those of
neonates infected with a normal mixture of P. murina organisms. The numbers of
activated CD44high CD62Llow CD4+ and CD8+ T cells in the alveolar spaces (represented
by cells collected in the BALF) was significantly increased by week 3 post-infection in
pups infected with organisms that included cysts in the inoculum compared to pups
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infected with trophic forms (Fig 3.2A and C). No differences were observed in the
numbers of T cells in the lung parenchyma (lung digest) (Fig 3.2B and D). These data
indicate that the intensity of the early T cell response to P. murina in the alveolar spaces
is dependent on the presence of cysts in the inoculum. The numbers of CD19+ B cells in
the lungs did not differ in pups infected with mixed P. murina organisms compared to
pups infected with trophic forms (Fig 3.2E). The numbers of activated T cells and CD19+
B cells in the alveolar spaces and lung parenchyma were equivalent between the groups
at day 28 and 40 post-infection.
To determine if the absence of cysts in the inoculum affects the neonatal innate
immune response, the expansion or recruitment of alveolar or non-resident innate
immune cells in neonatal mice infected with trophic forms was compared with that of
neonates infected with a normal mixture of P. murina organisms. The recruitment of
CD11c- CD11b+ non-resident innate immune cells to the alveolar spaces (BALF) by
week 3 post-infection was higher in the mice infected with mixed P. murina organisms
compared to trophic forms alone, but these differences were not statistically significant
(Fig 3.2G). The numbers of CD11c+ CD11b+ innate immune cells increased by three
weeks post-infection in the alveolar spaces of neonates infected with either trophic forms
or mixed P. murina (Fig 3.2H). There were no differences in these responses at days 28
and 40 post-infection (Fig 3.2G and H).

P. murina trophic forms will encyst by day 7 post-infection in adult mice.
Quantification of the fungal lung burden in neonatal mice demonstrates that the
cysts were below the limit of detection during the first week post-infection with either
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trophic forms or mixed P. murina organisms. To determine if similar kinetics would be
observed in adults, we infected immunocompetent BALB/cJ adult mice with trophic
forms or mixed P. murina organisms. Trophic forms were detected at day 5 postinfection in the lungs of adults infected with trophic forms or mixed P. murina (Fig 3.3A,
C). Cysts were first detected at day 7 post-infection in the lungs of adults infected with
trophic forms or mixed P. murina (Fig 3.3B, D). The trophic and cystic lung burdens
were similar between the groups at all timepoints, and peaked at day 14 post-infection
(Fig 3.3A-D). The difference in the cyst burden at day 7 post-infection (Fig 3.3B) was
not consistent in a repeat of the experiment (Fig 3.3D). The trophic and cystic lung
burdens were below, or approaching, the limit of detection of Log10 3.42 organisms per
lung by day 21 post-infection, indicating that there were no differences in the clearance
of P. murina organisms by either group (Fig 3.3A-D).

Cysts drive the early recruitment of T and B cells into the lungs of adult mice.
To determine if cysts were required for the early recruitment of T and B cells into
the lungs of immunocompetent adult mice, we infected BALB/cJ adult mice with either
trophic forms or a normal mixture of P. murina organisms (Fig 3.4). The robust early
recruitment of activated CD44high CD62Llow CD4+ and CD8+ T cells into the alveolar
spaces (BALF) was dependent on the presence of cysts in the inoculum (Fig 3.4A-B). An
increase in the numbers of activated CD4+ and CD8+ T cells was also observed at day 5
post-infection in the lung parenchyma of mice infected with a mixture of trophic forms
and cysts compared to mice infected with trophic forms alone (Fig 3.4A-B). Cysts in the
inoculum also promoted the early recruitment of CD19+ B cells into the alveolar spaces
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and an early increase in the number of CD19+ B cells in the TBLN (Fig 3.4C). T and B
cell numbers in mice infected with trophic forms were similar or greater than those in
mice infected with mixed P. murina as the mice approached clearance at week 3 postinfection.

Cysts promote the early infiltration of non-resident innate immune cells in adult
mice.
The recruitment of CD11c- CD11b+ non-resident innate immune cells to the
alveolar spaces (BALF) and lung parenchyma (lung digest) of adult BALB/cJ mice by
day 14 post-infection was higher in mice infected with cysts in the inoculum compared to
trophic forms alone (Fig 3.5A). The numbers of CD11c+ CD11b+ innate immune cells
increased during the first week post-infection in the alveolar spaces and parenchyma of
adults infected with mixed P. murina (Fig 3.5B). The numbers of lung resident CD11c+
CD11b- innate immune cells increased in the lung parenchyma of adults infected with
mixed P. murina at day 5 post-infection, but no statistically significant differences were
observed in the alveolar spaces of the two groups (Fig 3.5C). Surface expression of the
major histocompatibility complex class II molecule I-Ad was higher on both CD11c+
CD11b- and CD11c+ CD11b+ innate immune cells in the alveolar spaces of mice infected
with mixed P. murina compared to mice infected with trophic forms alone (Fig 3.5D-E).
These data indicate that the presence of cysts in the initial inoculum shapes the phenotype
of the early innate immune response in adult mice.
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Cysts drive the early production of IFN-γ in the alveolar spaces of adult mice.
Th1-, Th2-, and Th17-type responses have all been associated with clearance of P.
murina organisms (112, 114, 115). To determine if cysts promoted the early development
of Th1-type responses in the lungs, we evaluated cytokine production following infection
of BALB/cJ adult mice with either trophic forms or a normal mixture of P. murina
organisms. The early production of IFN-γ in the BALF was higher in mice infected with
cysts in the inoculum compared to trophic forms alone (Fig 3.6A). IFN-γ production in
the lungs of mice infected with trophic forms remained low at all timepoints compared to
mice infected with a mixture of P. murina organisms, despite the presence of cysts by
day 7 post-infection (Fig 3.6A). In addition, the proportion of CD4+ T cells producing
intracellular IFN-γ at day 7 post-infection was higher in the lungs of mice infected with
mixed P. murina organisms compared to mice infected with trophic forms (Fig 3.6B).
These data suggest that cysts are required in the inoculum for optimal Th1-type responses.

Trophic forms suppress β-glucan-induced proinflammatory cytokine production by
dendritic cells.
β-glucan from the cell wall of Pneumocystis cysts has been previously shown to
stimulate production of IL-1β, IL-6, and TNFα in dendritic cells and induce IFN-γ
production in cocultured T cells (23). To evaluate whether trophic forms are able to
stimulate proinflammatory cytokines, we measured IL-1β, IL-6, and TNFα production by
bone marrow-derived dendritic cells (BMDCs) following stimulation with trophic forms,
a normal mixture of P. murina organisms, and/or curdlan (Fig 3.7). Curdlan is a highmolecular-weight β-1,3-glucan isolated from Alcaligenes faecalis, and is similar to the β-
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1,3-glucan that composes the P. murina cyst wall (15). IL-1β and IL-6 production was
stimulated by 5 X 105 mixed P. murina organisms and 10 µg/ml curdlan, but not 5 X 105
trophic forms (Fig 3.7A-B). These data demonstrate that cysts are required for production
of IL-1β and IL-6 by BMDCs. Stimulation of BMDCs with curdlan induced IL-1β, IL-6,
and TNFα production (Fig 3.7A-C). Conversely, our data indicate that trophic forms
suppress curdlan-induced IL-1β, IL-6, and TNFα production by BMDCs in a dosedependent manner (Fig 3.7A-C). Interestingly, 106 trophic forms suppressed the IL-6
production induced by 5 X 105 mixed P. murina organisms (Fig 3.7B), but were
insufficient to induce suppression of IL-1β production (Fig 3.7A). In contrast to IL-1β
and IL-6 production, TNFα production was stimulated by curdlan, but not trophic forms
or mixed P. murina organisms (Fig 3.7C). Moreover, incubation of BMDCs with a high
number of trophic forms or mixed P. murina organisms suppressed curdlan-induced
production of TNFα (Fig 3.7C). This reduction in cytokine production was not due to a
toxic effect on the BMDCs (Fig 3.8).
The P. murina cell wall has been shown to contain more complex branching
patterns, including β-1,6-glucan, than those contained in curdlan. The P. murina cell wall
also includes mannosylated proteins. To evaluate the ability of trophic forms to suppress
responses to a fungal cell wall, we measured cytokine production following stimulation
with trophic forms, zymosan, and/or depleted zymosan (Fig 3.9). Zymosan is a proteincarbohydrate preparation from the cell wall of Saccharomyces cerevisiae. Depleted
zymosan is treated with hot alkali to prevent engagement of the toll-like receptors.
Trophic forms suppressed zymosan and depleted zymosan-induced production of IL-1β,
IL-6, and TNFα (Fig 3.9A-F).
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Trophic forms suppress TLR2 and TLR4-induced proinflammatory cytokine
production by dendritic cells.
In addition to C-type lectin receptors such as dectin-1, Pneumocystis species have
been shown to stimulate cytokine production by antigen presenting cells via Toll-like
receptors (TLRs) 2 and 4 (156, 170). We measured IL-1β, IL-6, and TNFα production by
BMDCs following stimulation with TLR2-agonist LTA, TLR4-agonist LPS and/or
trophic forms (Fig 3.10). Stimulation of BMDCs with LTA or LPS induced IL-1β, IL-6,
and TNFα production (Fig 3.10A-F). The addition of 5x105 trophic forms suppressed this
cytokine response to LTA and LPS.

The suppression of the response to curdlan is not mediated by mannose receptor.
Carbohydrate PAMPs on the surface of fungi and other microorganisms may be
recognized by C-type lectin receptors. Mannose receptor and dectin-1 have been
implicated in the immune response to Pneumocystis species (69, 92, 98, 151, 157, 161).
To evaluate the role of mannose receptor and dectin-1 in the response to trophic forms
and β-glucan, we stimulated BMDCs deficient in those C-type lectin receptors with
trophic forms, mixed P. murina organisms, and/or curdlan (Fig 3.11). Surprisingly,
neither mannose receptor nor dectin-1 was required for IL-6 or TNFα production in
response to mixed P. murina. IL-1β production in response to mixed P. murina was
modestly dependent on dectin-1. As expected, mannose receptor was not responsible for
the response to curdlan. Depletion of dectin-1 did not fully abolish the IL-6 and TNFα
response to curdlan. It is possible that other receptors such as complement receptor 3
(CD11b/CD18) or lactosylceramide may recognize curdlan (105, 106, 171-173).
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Alternatively, the curdlan used in this project may have contained additional PAMPs
beyond β-1,3-glucan.
Regardless, our data demonstrate that neither mannose receptor nor dectin-1 was
exclusively required for the trophic form-mediated suppression of IL-1β, IL-6, and TNFα
production. In the absence of mannose receptor or dectin-1 there was a modest increase
in IL-6 production in BMDCs treated with curdlan and trophic forms compared to wildtype BMDCs. Together, these data demonstrate that dectin-1 does not contribute
significantly to the IL-1β, IL-6, or TNFα response to mixed P. murina, but is involved in
signaling β-glucan responses, though not exclusively. Furthermore, mannose receptor has
only a minor role in the inhibitory effects of trophic forms on β-glucan stimulation of IL6 production. These data suggest that other pattern recognition receptors are involved in
signaling both proinflammatory and suppressive functions of P. murina life forms.
Finally, it should be noted that mixed P. murina organisms stimulated modest
TNFα production by BMDCs from the C57BL/6 mouse strain background. TNFα
production was not detected in response to mixed P. murina organisms when cells of a
BALB/cJ background were used. Generally, cells from C57BL/6 mice exhibit a stronger
Th1-type bias than cells from BALB/cJ mice. The immune response of C57BL/6 adult
mice following inoculation with trophic forms or mixed P. murina organisms was similar
to that observed in BALB/cJ mice (data not shown). Regardless, our data suggest that
trophic form-mediated suppression of inflammatory responses is not limited to the
BALB/cJ background.
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Dendritic cells co-cultured with trophic forms fail to induce IFNγ production by
CD4+ T cells.
To evaluate whether dendritic cells are able to induce Th1-type responses when
loaded with trophic forms, we stimulated BMDCs co-cultured with CD4+ T cells with
either mixed P. murina or trophic forms. BMDCs loaded with mixed P. murina, but not
trophic forms, stimulated IFN-γ production in CD4+ T cells (Fig 3.12). The addition of
curdlan did not improve IFN-γ production in response to trophic forms (data not shown).
These data demonstrate that cysts are required for effective Th1-type responses in vitro
and are consistent with our findings in vivo that cysts drive the early T cell response to P.
murina.
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III. Discussion
Our data confirm that cysts drive proinflammatory responses to infection with P.
murina. Cysts promote the early recruitment of activated CD4+ and CD8+ T cells into the
lungs of neonatal and adult mice. Cysts also promote the early recruitment of nonresident
innate immune cells and CD19+ cells into the alveolar spaces of adult mice. Cysts in the
inoculum stimulate the production of IFN-γ. Importantly, we found for the first time that
trophic forms suppress β-glucan-, LTA-, and LPS-induced proinflammatory cytokine
production by dendritic cells. Furthermore, dendritic cells cultured with trophic forms
failed to stimulate production of IFN-γ by CD4+ T cells. Our data is consistent with the
cyst life cycle stage driving proinflammatory responses that direct the early recruitment
of innate and adaptive immune cells. However, the trophic life cycle forms dampen the βglucan and TLR-induced inflammation. This is a novel finding and suggests that the two
life forms of Pneumocystis balance the immune response to the organisms.
We have previously reported that there is a delay in the immune response to P.
murina in neonatal mice compared to adults (9-12). Despite the delay, the immune
response is sufficient to mediate clearance of P. murina organisms. This delayed response
represents a balance between clearance of a pathogen and avoidance of inflammatory
damage during postpartum development. Here, we report that cysts in the inoculum drive
adaptive immune responses to P. murina in neonatal mice by day 21 post-infection. The
fungal burden in neonates infected with trophic forms or mixed P. murina was similar by
day 21 post-infection. These data suggest that the composition of the inoculum shapes the
development of the immune response to P. murina organisms.
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Redundant Th1-, Th2-, and Th17-type responses are associated with clearance of
Pneumocystis organisms (1, 3, 4, 112, 114, 115). Here we report that cysts are required in
the inoculum to stimulate the production of intracellular IFN-γ by CD4+ T cells in adult
mice at day 7 post-infection. CD8+ T cells are not required for clearance of Pneumocystis
organisms, but contribute to the production of proinflammatory cytokines, including IFNγ, that mediate effector responses (119). The concentration of extracellular IFN-γ in the
alveolar spaces of adult mice infected with trophic forms did not change over the course
of infection, despite an eventual increase in the cyst burden and the numbers of activated
CD4+ and CD8+ T cells. This may suggest that trophic forms suppress Th1-type
responses, which would be consistent with our in vitro data.
Mice infected with trophic forms developed detectable cysts by day 7 in adult mice
and day 14 post-infection in neonates. We were unable to discern in our models whether
trophic forms are capable of inducing protective immune responses, or if the response to
trophic forms is merely delayed. The reduced ability of trophic forms to stimulate IFN-γ
expression does not preclude generation of protective responses, as there is redundancy in
the types of T helper responses that can mediate clearance of Pneumocystis organisms
(112, 114, 115). It has been previously reported (24), and our preliminary data using an
echinocandin to prevent formation of cysts suggests, that infection with trophic forms is
sufficient to generate protective CD4+ T cell and antibody responses (Chapter 4).
Clearance of Pneumocystis organisms is also dependent on alveolar macrophage
responses (2). Our data demonstrate that cysts drive increases in the numbers of CD11c+
CD11b+ lung resident innate immune cells. This population includes activated alveolar
macrophages (9). We found that cysts promote MHC class II expression on the surface of
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immune cells in the alveolar spaces. Decreased antigen presentation in the absence of
cysts may have contributed to the less robust T cell response observed in mice infected
with trophic forms. Additionally, cysts drive early infiltration of CD11c- CD11b+ innate
immune cells into the lungs. This population consists of monocytes, small macrophages,
and neutrophils. Neutrophils are not required for clearance, but their accumulation in the
lungs correlates with disease severity in human Pneumocystis pneumonia patients (5,
136). The CD11c- CD11b+ population may also include myeloid-derived suppressor cells
(MDSCs). MDSCs are recruited into the lungs of immunocompromised rodents during
PcP (140). MDSCs isolated from the lungs of mice with PcP suppress key effector cells,
including CD4+ T cells and alveolar macrophages, and may directly contribute to lung
injury (140, 141). The role of MDSCs in the lungs of immunocompetent hosts during
Pneumocystis infection is unclear.
Infection with trophic forms in the absence of cysts leads to the establishment of an
immunosuppressive environment in the lungs that persists for up to one week following
the formation of the cystic stage. If cysts are in the inoculum, the trophic form is unable
to suppress inflammatory responses in the lungs as definitively. We would predict that
infection with pure cysts, in the absence of trophic forms, would lead to accelerated
inflammatory responses compared to infection with a mixture of organisms.
Unfortunately, there is not a reliable method to isolate P. murina cysts in appreciable
quantities.
Other groups report difficulties in stimulating IL-1β, IL-6, and TNFα cytokine
production by antigen presenting cells using unopsonized mixed P. murina organisms
(161). We found that a multiplicity of infection of 50 mixed P. murina organisms to 1
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BMDC was sufficient to induce IL-1β and IL-6 production. We attribute the necessity of
this relatively high multiplicity of infection to the presence of trophic forms in the
mixture, as our data demonstrate that trophic forms suppressed production of the βglucan-induced proinflammatory cytokines IL-1β, IL-6, and TNFα by BMDCs. A
multiplicity of infection of 50 P. murina organisms per dendritic cell is composed of
approximately 5 cysts capable of stimulating positive cytokine responses plus 45 trophic
forms that will act to suppress these responses. Gene expression data demonstrate that
BMDCs stimulated with trophic forms express less express IL-1β, IL-6 and TNF𝑎𝑎
mRNA than cells stimulated with curdlan or mixed P. murina organisms (Chapter V).
This suggests that the trophic forms suppress cytokine production rather than cytokine
secretion.
Interestingly, mixed P. murina organisms failed to induce TNFα in BMDCs in our
model. TNFα production is associated with protection against P. murina, and its
production has been reported in BMDCs following stimulation with β-glucan extracted
from the cell wall of the cyst life cycle stage (23). We propose that trophic forms, which
comprise approximately 90% of the organisms in mixed P. murina infection, are
sufficient to suppress production of TNFα by BMDCs that would otherwise be induced
by β-glucan on the surface of the cysts. Consistent with this contention, we found that
trophic forms inhibited cytokine production by curdlan-stimulated BMDCs.
C-type lectin receptors are transmembrane proteins that bind carbohydrates (144).
Activation triggers phagocytosis, as well as signaling cascades that culminate in the
activation of antigen presenting cells and the production of inflammatory cytokines.
Dendritic cells have been shown to respond to P. carinii cyst wall β-glucans via dectin-1
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(23). Dectin-1 is required for the generation of an effective response to Pneumocystis
infection (69). Previous work has shown that mannose receptor binds glycoprotein A on
the cell surface of Pneumocystis organisms, triggering phagocytosis, reactive oxygen
species production, and NF-κB-mediated production of IL-8 (92, 98, 157). Here, we
demonstrate that neither dectin-1 nor mannose receptor were exclusively required for the
production of IL-1β, IL-6, and TNFα by BMDCs in response to P. murina. Our data
suggest redundancy in the receptors that recognize cysts and trophic forms.
Conversely, some C-type lectin receptors may suppress proinflammatory responses.
Engagement of the C-type lectin receptor mincle by the fungal skin pathogen Fonsecaea
monophora was shown to suppress proinflammatory responses induced by dectin-1mediated signaling (159). Zhang et al. demonstrated that blockage or knockdown of
mannose receptor on rat alveolar macrophages resulted in elevated TNFα production in
response to unopsonized mixed Pneumocystis organisms (161). Here, we demonstrate
that the deletion of mannose receptor on dendritic cells resulted in a modest decrease in
the ability of trophic forms to suppress the production of IL-6 in response to β-glucan,
indicating that suppression is mediated through mechanisms other than mannose receptor.
We are currently examining whether mincle could mediate the suppressive activity of
trophic forms as was found for F. monophora.
Our data indicate that trophic forms suppress cytokine responses to the TLR2
agonist LTA and the TLR4 agonist LPS. In one paper, mice with mutant TLR4 were
shown to have reduced IL-10, IL-12p40, and MIP-2 in the BALF of Pneumocystis
infected mice and enhanced levels of TNF and IL-6 with no difference in clearance of the
organisms (170). In addition, dectin-1 acts synergistically with TLR2 and TLR4 to
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promote cytokine production following stimulation with curdlan (174). Simultaneous
inhibition of dectin-1-, TLR2-, and TLR4-mediated signals may permit the trophic forms
to broadly dampen the proinflammatory response and protect the colonization of
Pneumocystis organisms in the immunocompetent host. Suppression of zymosan and
depleted zymosan-stimulated cytokine production provides evidence that trophic forms
can broadly dampen the response to carbohydrate and protein agonists.
The inflammatory potential of the cysts in the face of a 10-fold excess of
suppressive trophic forms should not be understated. The ability of trophic forms to
suppress cytokine production is dose-dependent, and our data suggest that slight changes
in the ratio of trophic forms to cysts may shift the balance between suppression and
stimulation. Increasing the trophic form to cyst ratio from 10:1 to 12:1 (by the addition of
105 trophic forms) is sufficient for the trophic forms to begin to reduce the IL-6 response
to the mixed population. Our in vivo data indicate that the cyst burden remains low during
the first week post-infection, but that cysts in the inoculum drive the initial inflammation.
The rapid establishment of an immunosuppressive trophic population may be critical to
avoid preemptive detection and clearance in immunocompetent hosts. Conversely,
immunocompromised mice with severe pneumonia experience a final burst of trophic
growth, in which the ratio of trophic forms to cysts reaches as high as 30:1 (unpublished
observation). This population shift may prolong the life of the immunocompromised host
by dampening inflammation, and may extend the window of opportunity for the
transmission of cysts to additional hosts.
The inoculation with trophic forms employed within this paper does not mimic the
natural route of infection, as cysts are the transmittable life cycle stage of Pneumocystis
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species (17). Consistent with our goal, our approach allows conclusions to be formed
about the differential immune responses generated to the life cycle stages of
Pneumocystis species. Recently, it was reported that treatment of immune-reconstituted
mice with the β-1,3-D-glucan synthase inhibitor anidulafungin results in depletion of
cysts, with the remaining trophic burden stimulating a much reduced inflammatory
response (24). Anidulafungin belongs to a drug class known as the echinocandins, which
have been used in combination with other antifungals in the treatment of Pneumocystis
pneumonia in human patients (83). Linke et al., propose that depletion of cysts would
reduce inflammation-induced lung damage in patients (24). Our data corroborates this
suggestion, and highlight the need for a greater understanding of the response to the
trophic stage. We propose that depletion of the immunostimulatory cysts in the presence
of the immunosuppressive trophic forms may hamper the ability of immunocompromised
patients or infants to control the infection. However, the net outcome may be positive, as
lung damage during Pneumocystis pneumonia is predominately due to the inflammatory
immune response.
In summary, our data indicate that cysts are the primary form of Pneumocystis
responsible for provoking adult and neonatal immune responses to infection with P.
murina. These responses include infiltration of nonresident innate immune cells and the
recruitment of CD19+ B cells and activated CD4+ and CD8+ T cells. Cysts are required to
stimulate the production of IFN-γ by CD4+ T cells in vitro, and in the alveolar spaces of
immunocompetent adult mice. We found that trophic forms suppress β-glucan-induced
proinflammatory cytokine production by dendritic cells. We propose that the suppression
of immune responses by the trophic forms promotes the colonization of Pneumocystis in
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immunocompetent hosts and may be beneficial to immunocompromised hosts by
dampening the inflammatory responses that contribute to lung pathology during PcP.
This differential immune response to Pneumocystis trophic forms and cysts is most
certainly a leading contributor to the success of the organisms as human pathogens.
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Figure 3-1 Cysts are undetectable during the first week post-infection in BALB/cJ
neonates infected with P. murina trophic forms.
Neonatal (24-72 h old) mice were infected i.n. with 106 trophic forms or mixed P. murina
organisms. Trophic (A, B) and cystic (C, D) lung burden in the right lung lobes was
determined by enumeration of organisms on DiffQuik stained slides under a microscope.
Data represent the mean ±SD of 3-4 mice per group and are representative of 2 separate
experiments. The limit of detection was Log10 3.12 nuclei per neonatal right lung lobe.
Two way ANOVA with Holm-Sidak post-hoc test was used to compare mean trophic
form or cyst number between the groups, *p ≤ 0.05.
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Figure 3-2 Cysts promote the recruitment of activated T cells in the BALF by day 21
post-infection in neonates.
Neonatal (24-72 h old) BALB/cJ mice were infected i.n. with 106 trophic forms or mixed
P. murina organisms. Flow cytometry was used to phenotype activated CD44high
CD62Llow CD4+ T cells (A, B), activated CD44high CD62Llow CD8+ T cells (C, D), and
CD19+ B cells (E, F) in the BALF and lung digest. Flow cytometry was used to
phenotype CD11c- CD11b+ (G) and CD11c+ CD11b+ (H) non-lymphocytes with high
granularity and size from the BALF. Data represent the mean ±SD of 3-4 mice per group
and are representative of 2 separate experiments. T tests were used to compare mean total
cell number between the groups at individual timepoints, *p ≤ 0.05.
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Figure 3-3 Cysts are undetectable before day 7 post-infection in BALB/cJ adults
infected with P. murina trophic forms.
Adult mice were infected i.t. with 5 X 106 trophic forms or mixed P. murina organisms.
Trophic (A, C) and cystic (B, D) lung burdens from two separate experiments were
determined by enumeration of organisms on DiffQuik stained slides under a microscope.
Data represent the mean ±SD of 5 mice per group. The limit of detection was Log10 3.42
nuclei per adult right lung lobe. T tests were used to compare the mean fungal burden
between the two groups at individual timepoints, *p ≤ 0.05.
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Figure 3-4 Infection with the cyst life cycle stage drives recruitment of T and B cells
into the lungs of adult mice.
BALB/cJ adult mice were infected i.t. with 5 X 106 trophic forms or mixed P. murina
organisms. Flow cytometry was used to phenotype activated CD4+ T cells (A), activated
CD8+ T cells (B), and CD19+ B cells (C) in the BALF, lung digest, and TBLN.
Activation of T cells was evaluated by CD44 and CD62L expression. Data represent the
mean ±SD of 5 mice per group and are representative of 2 separate experiments. T test
was used to compare mean total cell number between the groups at individual timepoints,
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
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Figure 3-5 Cysts promote the early increase in CD11c+ CD11b+ innate immune cells
and infiltration of CD11c- CD11b+ innate immune cells into the alveolar spaces and
lung parenchyma of adult mice.
BALB/cJ adult mice were infected i.t. with 5 X 106 trophic forms or mixed P. murina
organisms. Flow cytometry was used to phenotype CD11c- CD11b+ (A), CD11c+ CD11b+
(B) and CD11c+ CD11b- (C) non-lymphocytes with high granularity and size from the
BALF and lung digest. Flow cytometry was used to compare expression of the MHC
class II molecule I-Ad on CD11c+ CD11b- (D) and CD11c+ CD11b+ (E) cells in the
BALF. Data represent the mean ±SD of 5 mice per group and are representative of 2
separate experiments. T tests were used to compare mean total cell number between the
groups at individual timepoints, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
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Figure 3-6 Cysts stimulate production of the proinflammatory Th1-type cytokine
IFN-γ in the lungs BALB/cJ adult mice.
Adult mice were infected i.t. with 5 X 106 trophic forms or mixed P. murina organisms.
IFN-γ cytokine production in the supernatant of the first BALF wash was quantified by
ELISA (A). Flow cytometry was used to evaluate intracellular IFN-γ expression in CD4+
cells in the lung digest at day 7 post-infection (B). Data represent the mean ±SD of 5
mice per group and are representative of 2 separate experiments. T tests were used to
compare BALF IFN-γ levels between the groups at individual timepoints (A) and to
compare the percentage of CD4+ T cells expressing IFN-γ between the groups (B), **p ≤
0.01.
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Figure 3-7 Cysts, but not trophic forms, stimulate production of the
proinflammatory cytokines IL-1β and IL-6 by BMDCs in vitro.
BMDCs from adult BALB/cJ mice were incubated with 5 X 105 trophic forms or 5 X 105
mixed P. murina organisms for 72 h. Curdlan was included as a positive control for
cytokine production. IL-1β (A), IL-6 (B), and TNFα (C) cytokine production was
quantified by ELISA. Data represent the mean ±SD of 3 biological replicates per group
and are representative of at least 2 separate experiments. One way ANOVA with StudentNewman-Keuls post-hoc test was used to compare supernatant cytokine concentration
between the groups, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, n.s., not statistically significant.
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Figure 3-8 Incubation of BMDCs with trophic and cystic forms of P. murina does
not impact cell viability.
BMDCs from adult BALB/cJ mice were incubated with 5 X 105 trophic forms, 5 X 105
mixed P. murina organisms, 10µg/ml curdlan or curdlan and trophic forms for 72 h.
Trypan blue staining was used to determine the percentage of viable BMDCs. Data
represent the mean ±SD of 3 biological replicates per group and are representative of 2
separate experiments. One way ANOVA with Student-Newman-Keuls post-hoc test was
used to compare the percent of viable BMDCs between the groups, n.s., not statistically
significant.
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Figure 3-9 Trophic forms suppress the zymosan- and depleted zymosan-stimulated
production of proinflammatory cytokines by BMDCs.
BMDCs from adult BALB/cJ mice were incubated with 5 X 105 trophic forms, 20µg/ml
zymosan (A-C) and/or 20µg/ml depleted zymosan (D-F). IL-1β (A, D), IL-6 (B, E), and
TNFα (C, F) cytokine production was quantified by ELISA. Data represent the mean
±SD of 3 biological replicates per group and are representative of 3 separate experiments.
One way ANOVA with Student-Newman-Keuls post-hoc test was used to compare
supernatant cytokine concentration between the groups, **p ≤ 0.01, ***p ≤ 0.001.
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Figure 3-8 Trophic forms suppress LTA- and LPS-mediated cytokine production.
BMDCs from adult BALB/cJ mice were incubated with 5 X 105 trophic forms, 10µg/ml
LTA (A-C), and/or 100ng/ml LPS (D-F) for 72 h. IL-1β (A, D), IL-6 (B, E), and TNFα
(C, F) cytokine production was quantified by ELISA. Data represent the mean ±SD of 3
biological replicates per group and are representative of three separate experiments. One
way ANOVA with Student-Newman-Keuls post-hoc test was used to compare
supernatant cytokine concentration among the groups when the data were parametric (D,
E), ***p ≤ 0.001. Kruskal-Wallis one-way ANOVA on ranks was used to compare
differences among the groups when the data were nonparametric (A, B, C, F), *p ≤ 0.05.
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Figure 3-9 The response to trophic forms and cysts is not exclusively dependent on
the C-type lectin receptors dectin-1 and mannose receptor.
BMDCs from wildtype C57BL/6 littermate controls, MR-/-, and dectin-1-/-adult mice were
incubated with 5 X 105 trophic forms or 5 X 105 mixed P. murina organisms for 72 h.
Curdlan was included as a positive control for cytokine production. IL-1β (A), IL-6 (B),
and TNFα (C) cytokine production was quantified by ELISA. Data represent the mean
±SD of 3 biological replicates per group and are representative of 3 separate experiments.
Kruskal-Wallis one-way ANOVA on ranks was used to compare differences among the
groups when the data were nonparametric, *p ≤ 0.05.

84

Figure 3-10 Cysts, but not trophic forms, stimulate production of the
proinflammatory Th1-type cytokine IFN-γ by CD4+ T cells in vitro.
CD4+ T cells and BMDCs from adult BALB/cJ mice were incubated with trophic forms
or mixed P. murina organisms for 72 h. IFN-γ cytokine production was quantified by
ELISA. Data represent the mean ±SD of 3 biological replicates per group and are
representative of 3 separate experiments. One way ANOVA with Student-Newman-Keuls
post-hoc test was used to compare supernatant IFN-γ concentration between the groups,
**p ≤ 0.01, n.s., not statistically significant.
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Chapter 4. The trophic life cycle stage of Pneumocystis species induces protective
adaptive responses without inflammation-mediated progression to pneumonia.

I. Introduction
There are few reports that address how Pneumocystis trophic forms and cysts shape
the development of the in vivo immune response. Previous studies demonstrate that
dendritic cells treated with β-1,3-glucan from the cyst wall drive Th1/Th17-type CD4+ T
cell responses (23, 88). However, the clearance of Pneumocystis organisms from the host
lung is dependent on a broad range of effector responses, including CD4+ T cell, B cell,
and macrophage activity (1-4). Furthermore, Th2 and Th17-type CD4+ T cell responses
may be generated in response to Pneumocystis infection, and clearance of the infection
may be mediated by any of the T helper phenotypes within the Th1/Th2/Th17 paradigm
(24, 111-115).
In Chapter 3, we report that Pneumocystis trophic forms suppressed the production
of proinflammatory cytokines IL-1β, IL-6, and TNFα by dendritic cells stimulated with a
range of PAMPs, including β-glucan, LPS, LTA, zymosan, and depleted zymosan (168).
Immunocompetent mice inoculated with purified trophic forms failed to initiate early
innate and adaptive immune responses compared to mice inoculated with a mixture of
trophic forms and cysts. Despite these delays, the mice inoculated with trophic forms
were able to clear the infection within a similar period of time as the mice inoculated with
mixed organisms. However, the rapid turnover of trophic forms into cysts in these
previous experiments precludes the formation of conclusions regarding which life cycle
stage(s) initiate the immune responses that led to clearance.
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Basic research into the interactions between this fungal pathogen and the host
immune response has the potential to inform novel approaches to reduce morbidity and
mortality due to Pneumocystis pneumonia. In this Chapter, we sought to determine if
trophic forms were capable of stimulating protective CD4+ T cell and B cell responses to
P. murina infection. Conversely, immune-mediated damage is a major consequence of
Pneumocystis pneumonia. Therefore, we explored the role of trophic forms in the
development of Pneumocystis pneumonia. These models employed the inoculation of
immunocompetent mice with an enriched population of trophic forms coupled with
treatment with a β-1,3-glucan synthesis inhibitor, anidulafungin, to prevent encystment.
Here, we demonstrate that the trophic stage of P. murina is sufficient to provoke
CD4+ T cell- and antibody-mediated responses leading to clearance of infection, but not
progression to PcP. The adoptive transfer of CD4+ T cells generated in the presence of
trophic forms was sufficient to mediate the clearance of both trophic forms and cysts
from the lungs of RAG2-/- mice. In addition, primary infection with trophic forms was
sufficient for the development of antibody-mediated secondary responses leading to
clearance of both trophic forms and cysts following reinfection. Recent studies
demonstrate that protective immunization against Pneumocystis infection is a feasible
goal, even in the context of SIV-induced immunosuppression or CD4+ T cell depletion
(175, 176). Here, our data suggest that trophic form-mediated immune suppression of
innate responses does not impede the development of protective secondary adaptive
responses. Conversely, our data suggest that the depletion of the cyst life cycle stage may
be sufficient for protection against the inflammation-mediated pathology associated with
PcP.
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II. Results

Trophic forms are sufficient to provoke CD4+ T cell-mediated clearance of infection.
Here, we employ an adoptive transfer model to evaluate the role of trophic forms in
the

generation

of

protective

CD4+

T

cell

responses.

Briefly,

we

treated

immunocompetent, wild-type mice (“donors”) with the β-1,3-glucan synthesis inhibitor
anidulafungin followed by infection with 106 purified trophic forms. The mice were
treated with anidulafungin i.p. three times per week to prevent formation of the cystic
stage, as initially described by Linke et al (24). A control group of mice were treated with
saline and infected with a mixture of 106 P. murina trophic forms and cysts. The mixed
P. murina inoculum consisted of 10 trophic forms to 1 cyst. CD4+ T cells were isolated
from the TBLN 14 days post-infection by positive selection. CD4+ T cells were
adoptively transferred by the retro-orbital route to RAG2-/- mice (“recipients”). Recipient
mice were treated with either anidulafungin or saline i.p. followed by infection with 5 X
105 trophic forms or mixed organisms, respectively. Animals were euthanized at 15 and
30 days post-infection.
As expected, cysts were below the limit of detection in recipient mice treated with
anidulafungin (Fig 4.1A). Mice that received trophic form-stimulated CD4+ T cells
followed by infection with trophic forms had more trophic forms in the lungs at day 15
post-infection compared to all other groups (Fig 4.1A). However, all of the recipient mice
infected with trophic forms cleared their trophic burden by day 30 post-infection, while
only one of four mice infected with mixed organisms cleared the infection by day 30
post-infection. A higher number of activated CD4+ T cells were also observed at day 15
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post-infection in the lung parenchyma of the group that received trophic form-stimulated
CD4+ T cells followed by infection with trophic forms compared to all other groups (Fig
4.1B). These differences were resolved by day 30 post-infection, and no differences in
the numbers of activated CD4+ T cells in the alveolar spaces (BALF) or TBLN were
observed among the groups. These data indicate that trophic forms are sufficient to drive
protective CD4+ T cell responses capable of mediating the clearance of trophic
organisms.

Trophic forms promote early CD4+ T cell-mediated IFNγ production in
response to infection with trophic forms in the absence of cysts.
Previous experiments by our lab suggest that co-culture of BMDCs with trophic
forms is not sufficient for stimulation of IFNγ production by CD4+ T cells (Chapter 3).
However, adoptive transfer of CD4+ T cells from trophic form-infected donors led to
increased expression of IFNγ at day 15 post-infection in the alveolar spaces of recipient
mice infected with trophic forms compared to adoptive transfer of CD4+ T cells from
mixed P. murina-infected donors into recipient mice infected with mixed P. murina. (Fig
4.2). Statistically significant differences were not observed amongst the groups in regards
to TNFα, IL-13, and IL-17A production in the alveolar spaces (Fig 4.2). These data
indicate that CD4+ T cells generated in the presence of trophic forms are capable of
mediating proinflammatory responses following adoptive transfer.
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Trophic forms are sufficient to induce B cell-mediated clearance of P. murina
infection.
Immunocompetent mice inoculated with purified trophic forms display delayed
accumulation of B cells into the lungs compared to mice inoculated with a mixture of
trophic forms and cysts (168). B cells are required for clearance of primary P. murina
infection (3, 4). Here, we used a reinfection model with concurrent depletion of CD4+ T
cells to evaluate the role of trophic forms in the generation of protective B cell responses.
We treated immunocompetent, wild-type mice with the β-1,3-glucan synthesis inhibitor
anidulafungin, followed by infection with 3 X 106 purified trophic forms. Animals were
treated with anidulafungin three times per week throughout the primary infection.
Following clearance of the primary infection, anidulafungin treatment was stopped, and
anti-CD4 antibody was administered to deplete CD4+ T cells (Fig 4.3A). Mice were then
treated with either anidulafungin or saline, and re-infected with 5 X 106 purified trophic
forms or mixed P. murina organisms, respectively. Animals were euthanized at day 15
post-infection.
The memory B cell response to trophic forms was sufficient to drive the P. murina
trophic forms and cysts burdens below the limit of detection (Log10 3.42) by day 15 postinfection (Fig 4.3B). No differences in the numbers of CD19+ B cells in the alveolar
spaces, lung parenchyma, and TBLN were observed between the mice rechallenged with
trophic forms or mixed organisms (Fig 4.3C). Likewise, no differences were observed in
the expression of the costimulatory molecules CD80 and CD86 on the surface of B cells
(data not shown). Differences in the numbers of activated CD8+ T cells in the BALF,
lung parenchyma, and TBLN were not observed between the groups (data not shown).
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These data indicate that trophic forms are sufficient to induce B cell-mediated clearance
of trophic forms and cysts.

Serum antibody from trophic form- or mixed P. murina-infected mice binds mixed
P. murina at higher titer than purified trophic forms.
Pneumocystis-specific antibody is protective against secondary infection, even in
the absence of CD4+ T cells (112, 121, 177). To test the specificity of the antibody
produced in our B cell rechallenge model, serum was collected at day 15 postrechallenge. The titer of serum IgG against sonicated mixed P. murina organisms was
1:5000, compared to a titer of 1:1000 against an equal protein concentration of sonicated
trophic forms (Fig 4.4). A similar trend was observed when serum IgG was probed
against an equal organism concentration of sonicated trophic forms vs mixed P. murina
organisms (data not shown). The source of the serum (mice rechallenged with trophic
forms vs mixed organisms), did not have an impact on the titer against trophic forms nor
mixed organisms (Fig 4.4). These data are comparable to the anti-trophic form and antimixed organism titers of serum collected from immunocompetent mice following
primary infection with mixed organisms (data not shown). These data suggest that serum
antibody from P. murina-infected mice binds purified trophic forms with a lower affinity
or avidity than cysts.
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Trophic forms promote early antibody-mediated innate responses to infection with
trophic forms in the absence of cysts.
B cells may enhance innate immunity to Pneumocystis organisms via antibodymediated opsonization of the fungal organisms and by the production of cytokines and
other signals to maximize antifungal responses (3, 178-180). Here, innate immune cells
were phenotyped and quantified at day 15 post-infection in the lungs of CD4-depleted
mice rechallenged with trophic forms or mixed P. murina (Fig 4.5). A 2-fold increase in
activated macrophages and lung dendritic cells (CD11c+ CD11b+ innate immune cells)
was observed at day 15 post-infection in the alveolar spaces of mice rechallenged with
trophic forms (Fig 4.5). Differences in the numbers of immature alveolar macrophages
and lung dendritic cells (CD11c+ CD11b-), and non-resident innate immune cells (CD11cCD11b+) were not observed between the groups (Fig 4.5). These data suggest differences
in the kinetics of the macrophage or dendritic cell response following clearance of the
secondary infection with trophic forms compared to mixed P. murina organisms.

Infection with trophic forms in the absence of cysts is not sufficient for progression
to PcP in immunocompromised mice.
Pneumocystis pneumonia (PcP) is characterized by inflammation-mediated alveolar
damage. Previously, we have shown that trophic forms suppress the production of proinflammatory cytokines by BMDCs (Chapter 3) and alveolar macrophages (multiple
members of the Garvy lab, data not shown). Here, we evaluate the role of the trophic
forms in the development of PcP using mice deficient in T and B cells. We hypothesized
that infection with trophic forms in the absence of cysts would delay the onset of
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inflammation-mediated PcP. Treatment of immune-reconstituted mice with the β-1,3glucan synthase inhibitor anidulafungin results in depletion of Pneumocystis murina cysts
(17). RAG2-/- mice were treated with anidulafungin or saline, followed by infection with
2 X 106 purified trophic forms (Fig 4.6). Anidulafungin or saline treatment was
maintained through the experiment. Saline-treated control mice were euthanized at day
72 post-infection due to symptoms of advanced PcP, including severe weight loss (Fig
4.6A). In contrast, mice treated with anidulafungin had no overt symptoms of PcP, and
continued to gain weight through the end of the study at day 120 post-infection (Fig
4.6A). The lungs of saline-treated control mice contained 8 X 107 trophic forms and 5 X
106 cysts at day 72 post-infection (Fig. 4.6B). No cysts were detected in the lungs of the
anidulafungin-treated mice at day 120 post-infection (Fig 4.6B). A small population of 4
X 105 trophic organisms remained in the lungs of the anidulafungin-treated mice (Fig
4.6B).
T cells and B cells are required for clearance of P. murina organisms (1, 3, 4). In
the absence of adaptive immunity, infection with mixed P. murina organisms induces
non-protective inflammatory responses, including recruitment of innate immune cells
(133, 134). We compared the innate immune responses in the alveolar spaces (BALF)
and lung parenchyma of the saline- and anidulafungin-treated mice following euthanasia
at day 72 and day 120 post-infection, respectively (Fig 4.6C-E). A direct comparison
between the groups is not advisable due to the difference in study endpoints. Rather, the
following data are presented as a snapshot of the lungs at the time of euthanasia. An
average of 119 pg/ml TNFα was detected in the BALF of the saline-treated mice at day
72 post-infection, while the lavage of anidulafungin-treated mice contained an average of
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17 pg/ml TNFα at day 120 post-infection (Fig 4.6C). The majority of the cells in the
alveolar spaces and lung parenchyma of saline-treated mice were CD11c- CD11b+ nonresident innate immune cells (Fig 4.6D). The bulk of cells within this population were
F4/80low neutrophils (Fig 4.6E). In contrast, most of the cells in the alveolar spaces of the
anidulafungin-treated groups were CD11c+ CD11b- immature macrophages or dendritic
cells (Fig 4.6D), and the majority of the CD11c- CD11b+ non-resident cells were
F4/80high, indicating recruitment of monocytes or macrophages rather than myeloidderived suppressor cells (MDSCs) or neutrophils (Fig 4.6E). These data indicate that
cysts are required for the development of inflammatory responses associated with
Pneumocystis pneumonia. Additionally, trophic forms are able to survive in
immunocompromised lungs for extended periods of time in the absence of cysts and
without being able to complete their life cycle.
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III. Discussion
The data reported here confirm that the trophic stage of P. murina is sufficient to
induce CD4+ T cell- and antibody-mediated responses leading to clearance of infection,
but not progression to Pneumocystis pneumonia. We have previously reported that cysts
are required for robust early innate and adaptive immune responses, including
recruitment of CD4+ T cells and B cells into the alveolar spaces (168). While the
magnitude of the early response was reduced in the animals inoculated with trophic forms
alone, both the mice inoculated with trophic forms and the mice inoculated with mixed P.
murina cleared the infection by 30 days post-inoculation (168). Previously we found that
mice infected with trophic forms developed detectable cysts by day 7 in adult mice and
day 14 post-infection in neonates (168). Because of this, we were unable to discern
whether trophic forms failed to induce protective immune responses, or if the response to
trophic forms was merely delayed. Here, we used the β-1,3-glucan synthase inhibitor
anidulafungin to evaluate the adaptive and innate immune responses stimulated by
trophic forms in the absence of cysts.
Both CD4+ T cells and B cells are required for clearance of P. murina during
primary infection, but either CD4+ T cells or antibody are sufficient for clearance during
secondary infection (1, 3, 4, 121, 124, 181). We report here that adoptive transfer of
CD4+ T cells from trophic form- or mixed P. murina-infected animals was sufficient to
mediate clearance of trophic forms in recipient mice. However, adoptive transfer of CD4+
T cells from trophic form- or mixed P. murina-infected animals was sufficient to mediate
clearance of mixed P. murina in only one mouse among the group of four animals by day
30 post-infection. We have previously reported that transfer of CD4+ T cells from mixed
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P. murina-infected animals is sufficient to mediate clearance of mixed P. murina
organisms in RAG1-/- mice (124). Therefore, we predicted that mixed P. murinastimulated CD4+ T cells would eventually mediate clearance of the infection, given
sufficient time.
While macrophages are required for clearance of Pneumocystis organisms, these
cells are not competent to resolve the infection in the absence of adaptive immunity (1-4).
Here, a control population of RAG2-/- mice was infected with mixed Pneumocystis
organisms and treated with saline, but were not given CD4+ T cells. As expected, this
group contained a relatively high average fungal burden of 9.89 X 106 trophic forms and
8.69 X 105 cysts at day 30 post-infection, with an average of 11.4 trophic forms to cysts
(data not shown). This population reconfirms that the adoptive transfer of CD4+ T cells is
required for the control of fungal growth. In addition, this control population
demonstrates that while the majority of the CD4+ T cell recipient mice failed to clear the
mixed P. murina organisms by day 30 post-infection, the adoptive transfer of CD4+ T
cells was sufficient to limit fungal growth. This observation is consistent with our
prediction that the transfer of P. murina-stimulated CD4+ T cells would eventually
mediate clearance of the mixed P. murina infection, given sufficient time. Furthermore,
we and others have reported clearance of mixed P. murina infection following adoptive
transfer of CD4+ T cells in similar models.
Intriguingly, our data suggest that the CD4+ T cell-mediated clearance of trophic
forms during secondary infection occurs more rapidly in the absence of cysts. This
phenomenon occurs independently of the composition of the priming infection. Our
previous evidence indicates that cysts enhance, rather than inhibit the inflammatory
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response (168). Therefore, we suggest that the more efficient clearance of trophic forms
observed in the absence of cysts may be due to slower growth kinetics of trophic forms in
the absence of cysts. Linke et al. demonstrate that anidulafungin does not limit the
expansion of trophic forms during the first two weeks of treatment (24). However, our
long-term anidulafungin model (Fig 4.6) demonstrates poor expansion of the trophic
population due to the prolonged absence of the cyst stage. In the absence of
anidulafungin, a single mature cyst produces eight progeny which develop into trophic
forms. Clearance of the trophic population by immune cells may be accelerated in the
absence of this source of nascent trophic forms.
Previously reported data demonstrate that cysts are required for robust numbers of
activated CD4+ T cells within the alveolar spaces and lung parenchyma of infected
animals (168). However, we report here that the adoptive transfer of trophic formstimulated CD4+ T cells leads to increased numbers of activated CD4+ T cells in the lung
parenchyma of recipient mice at day 15 post-infection compared to transfer of CD4+ T
cells from mixed infection. It is noteworthy that fewer CD4+ T cells were harvested from
the draining lymph nodes of the wild-type donor mice infected with trophic forms
compared to mixed P. murina infection (data not shown). However, the adoptive transfer
of equal numbers of CD4+ T cells reveals that these CD4+ T cells are fully capable of
mediating clearance.
Our previous data indicated that inoculation with trophic forms leads to fewer IFNγ-producing CD4+ T cells and suboptimal IFN-γ concentrations in the alveolar spaces
compared to inoculation with mixed P. murina (168). Furthermore, trophic formstimulated BDMCs failed to produce TNFα, IL-1β, and IL-6 in response to various other
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stimuli, and failed to induce IFNγ production during co-culture with CD4+ T cells (168).
Conversely, the data reported here shows that trophic forms are sufficient to drive CD4+
T cell-mediated TNFα, IFN-γ, and IL-13 production in vivo. These data suggest that
stimulation with trophic forms does not skew the immune response away from Th1 or
Th2-type responses. While Th17 responses are critical for control of many fungal
infections, including candidiasis, a mixed T helper response is observed in response to
Pneumocystis infection. This mixed response appears to be largely redundant, as Th1-,
Th2-, and Th17-type responses have all been associated with clearance of P. murina
organisms (24, 111-115). Cumulatively, our data suggest that trophic forms suppress the
development of innate immunity, and thus delay the initiation of adaptive responses
(168), but trophic forms do not have a direct suppressive effect on CD4+ T cells in vivo.
We have reported that cysts are required for an early increase in B cells in the lungs
of infected mice (168). However, here we report that primary infection with trophic
forms is sufficient to induce antibody-mediated clearance of P. murina trophic forms and
cysts during secondary infection. No differences in B cell count were observed in the
animals rechallenged with trophic forms or mixed P. murina. Rechallenge of CD4+ T
cell-depleted mice with trophic forms promoted increased numbers of activated
macrophages and dendritic cells (CD11c+ CD11b+) in the alveolar spaces compared to
mice rechallenged with mixed P. murina. However, these data were generated by a single
timepoint following clearance (day 15), and differences between the groups may be due
to the kinetics of clearance, rather than differences in the magnitude of the response.
Intriguingly, serum antibody bound sonicated mixed P. murina antigen at higher
titer than trophic antigen. This phenomenon was observed even in serum from
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anidulafungin-treated animals that had never developed cysts. Previous studies suggest
that there is significant overlap in the glycoproteins, including glycoprotein A (gpA,
alternatively, major surface glycoprotein, MSG), on the surface of trophic forms and
cysts (20, 165). Our data suggest that serum antibody raised against trophic forms binds
conserved material on the cyst life cycle stage. We also observe that serum antibody
collected during primary infection in immunocompetent mice bound cysts at higher titer
than trophic form, as confirmed by fluorescent microscopy (data not shown). These data
indicate that treatment of trophic forms or cysts with anidulafungin was not responsible
for the decreased titer of serum antibody against trophic antigen. Rather, these
observations again suggest that there may be differences in the identity or quantity of the
antigenic material present on the trophic forms and cysts. Alternatively, trophic forms
may modulate the T helper response, resulting in the reduction or elimination of a subset
of IgG isotypes, leading to a net reduction of total IgG, but not necessarily a reduction in
protection. Regardless, our data indicate that while serum antibody binds mixed P.
murina antigen at higher titer than trophic forms, antibody-mediated responses are
sufficient for clearance of both trophic forms and cysts.
While the initiation of innate and adaptive responses is required for clearance of
Pneumocystis organisms in immunocompetent hosts, the non-specific provocation of
inflammation leads to immune-mediated damage in immunocompromised hosts that
progress to Pneumocystis pneumonia (133, 134). It has been previously reported that
treatment of immune-reconstituted mice with the β-1,3-glucan synthase inhibitor
anidulafungin results in depletion of cysts and a reduced inflammatory response (24).
Here, we report that long-term anidulafungin treatment of trophic form-infected RAG2-/-
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mice results in the carriage of a relatively small population of trophic forms without
progression to pneumonia. Control RAG2-/- mice developed cysts and progressed to
pneumonia characterized by weight loss, and recruitment of neutrophils into the lungs. In
contrast, the majority of innate immune cells within the alveolar spaces of anidulafungintreated mice were immature alveolar macrophages and lung dendritic cells.
Linke et al., propose that depletion of cysts would reduce inflammation-induced
lung damage in patients, and our data further corroborates this suggestion (24). However,
our data highlight the need for a greater understanding of the impact of trophic forms on
inflammatory responses and host health. While no overt symptoms of pneumonia were
detected in our anidulafungin-treated mice, it has been reported that trophic forms induce
direct damage to alveolar epithelial cells due to attachment to the host cell membrane
(132). Further studies should evaluate the effect of a chronic infection with trophic forms
on the health of alveolar epithelium.
In our model, the fungal lung burden of RAG2-/- mice with severe pneumonia may
consist of as many as 1 X 108 trophic forms. It is unclear why the expansion of trophic
forms was limited in RAG2-/- mice during long-term treatment with anidulafungin.
Cushion et al, demonstrate that a short-term course of β-1,3-glucan synthase inhibitor
therapy does not hamper expansion of trophic forms (17, 24). However, the extended
time course of our study suggests that cysts enhance the growth of the trophic forms.
It is thought that the formation of the cyst requires sexual reproduction, and it is
possible that the growth of the fungus is severely limited when the trophic forms are
restricted to asexual reproduction (13). Meiosis followed by multiple rounds of mitosis
within the maturing cyst results produces eight progeny, which develop into trophic
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forms. In the absence of this rapid expansion of organisms via sexual reproduction, it is
possible that innate immune cells may kill enough of the trophic forms to limit the
growth of the population, but not enough to clear the organisms from the lungs.
Alternatively, a signal or product from the cyst or cyst-stimulated host cells may be
required for expansion of trophic forms. Trophic forms are found clustered within a
biofilm-like substance that includes material from previously ruptured cysts (14).
Depletion of cysts may deprive the trophic forms of this protective shelter, and may
permit killing of trophic forms by innate immune cells.
Whatever the mechanism, it is interesting that in an immunosuppressed
environment the trophic population persists in the absence of cysts. This indicates that
long-term exposure to trophic forms is insufficient to promote widespread activation of
lung immune cells, including macrophages, in the absence of signals from T cells and B
cells. Furthermore, this may suggest that trophic forms also suppress the production of
proinflammatory signals, including cytokines, by alveolar epithelial cells. In Chapter 5,
we will demonstrate that dendritic cells are capable of phagocytosing trophic forms. It is
possible that, in the absence of the cyst, the trophic population may be limited by random
encounters with phagocytes. These encounters may result in the destruction of individual
trophic forms, but may serve to suppress the activation of the immune cell and thereby
protect the trophic population as a whole. It should also be noted that the long-term
carriage of trophic forms results in the infiltration of a population of CD11c- CD11b+
cells that are overwhelmingly F4/80high. This suggests that trophic forms do not mediate
immune suppression by recruiting F4/80low myeloid-derived suppressor cells.
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These observations emphasize the need for an improved understanding of the life
cycle of Pneumocystis species, and the role of the trophic and cystic lifeforms in the
development of protective vs detrimental immune responses. The data presented herein
suggest that disruption of cyst development (and, thus the elimination of the progeny
from sexual reproduction), limits the growth of Pneumocystis trophic form and prevents
the development of Pneumocystis pneumonia. Future studies should evaluate the
consequences of long-term carriage of trophic populations within the host lung.
Relatively few human populations suffer from an immunodeficient state as pronounced
as that modeled in the RAG2-/- mice, thus, additional animal models of
immunodeficiency may be employed to identify patient populations capable of clearing
this small population of trophic forms. In these populations, treatment with anidulafungin
or other echinocandins may remove the threat of immune-mediated lung damage, while
providing an opportunity for the host to develop a more modest, yet effective immune
response to the trophic population, as Linke et al. demonstrated in their model of immune
reconstitution syndrome (24).
We have previously reported that infection with trophic forms in the absence of
cysts leads to the delayed initiation of innate and adaptive responses against
Pneumocystis infection (168). Despite these delays, we found here that the trophic stage
of P. murina is sufficient to induce CD4+ T cell- and antibody-mediated responses
leading to clearance of infection, but not progression to Pneumocystis pneumonia, as
defined by severe weight loss and infiltration of innate immune cells into the lungs.
These data suggest that immune evasion by the trophic forms may hinge on the
suppression of the initiation of the innate immune response. The development of adaptive
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immunity may represent a “point of no return” at which the trophic forms are no longer
able to escape clearance.
Manipulation of the immune response to trophic forms and cysts may provide
new options for the treatment and prevention of Pneumocystis infection, while a failure to
consider these differential responses may hamper future efforts. Here, our data indicate
that trophic forms elicit adaptive responses, but do not provoke the non-protective
inflammation characteristic of Pneumocystis pneumonia. Further evaluation of the
antigenic determinants on trophic forms and cysts may elicit a vaccine that provides
protection while limiting immune-mediated damage, including immune reconstitution
syndrome.

Copyright © Heather Marie Evans 2017
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Figure 4-1 Infection with trophic forms is sufficient to provoke CD4+ T cellmediated clearance of P. murina trophic forms.
CD4+ T cells were adoptively transferred from trophic form or mixed Pneumocystisinfected BALB/c mice (donors) to RAG2KO mice (recipients). Recipient mice were
challenged with trophic forms or mixed Pneumocystis organisms. Both donor and
recipient mice were treated with anidulafungin or saline throughout the study to maintain
trophic or mixed Pneumocystis burdens, respectively. Fungal lung burdens (A) in the
right lung lobes were determined by enumeration of organisms on DiffQuik stained slides
under a microscope. Flow cytometry was used to phenotype activated CD44high CD62Llow
CD4+ T cells (B) in the BALF, lung digest, and TBLN. Data represent the mean ±SD of 4
mice per group and are representative of 2 separate experiments. Kruskal-Wallis one-way
ANOVA on ranks with Student-Newman-Keuls post-hoc test was used to compare
differences among the groups at individual timepoints when the data were nonparametric
(A). Two-way ANOVA with Student-Newman-Keuls post-hoc test was used to compare
cell numbers where the data were parametric (B), *p ≤ 0.05.

104

Figure 4-2 Transfer of CD4+ T cells from trophic form-infected mice promotes
increased production of IFNγ in recipient mice challenged with trophic forms,
compared to challenge with mixed Pneumocystis organisms.
CD4+ T cells were adoptively transferred from trophic form or mixed Pneumocystisinfected BALB/c mice (donors) to RAG2KO mice (recipients). Recipient mice were
challenged with trophic forms or mixed Pneumocystis organisms. Both donor and
recipient mice were treated with anidulafungin or saline throughout the study to maintain
trophic or mixed Pneumocystis burdens, respectively. TNFα, IFNγ, IL-13, and IL-17A
concentrations in the supernatant of the first BALF wash were quantified by ELISA. Data
represent the mean ±SD of 4 mice per group and are representative of 2 separate
experiments. Two-way ANOVA with Student-Newman-Keuls post-hoc test was used to
compare cytokine expression, *p ≤ 0.05.
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Figure 4-3 Infection with trophic forms is sufficient to provoke antibody-mediated
clearance of P. murina trophic forms and cysts.
BALB/c adult mice were infected i.t. with trophic forms. Mice were treated with
anidulafungin one day prior to infection, and three times per week thereafter until d35
post-infection. Anti-CD4 antibody was administered at d40 post-infection to deplete
CD4+ T cells. The depletion of CD4+ T cells was confirmed by flow cytometry three days
after treatment with the first dose of anti-CD4 monoclonal antibody (A). Treatment with
anidulafungin or saline resumed one day prior to rechallenge with trophic forms or mixed
P. murina organisms, respectively. The depletion of CD4+ T cells was confirmed by flow
cytometry on lung homogenate at d43 (A). Animals were euthanized 15 days after
rechallenge. Fungal lung burdens (B) in the right lung lobes were determined by
enumeration of organisms on DiffQuik stained slides under a microscope. The limit of
detection was Log10 3.42 organisms per adult right lung lobe. Flow cytometry was used to
phenotype CD19+ B cells (C) in the BALF, lung digest, and TBLN. Data represent the
mean ±SD of 3 mice per group and are representative of 2 separate experiments. T tests
were used to compare mean fungal burden or total cell number between the groups, *p ≤
0.05.
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Figure 4-4 Serum antibody collected from trophic form or mixed P. murina-infected
mice binds trophic forms at lower titer than mixed P. murina.
BALB/c adult mice were infected i.t. with trophic forms. Mice were treated with
anidulafungin one day prior to infection, and three times per week thereafter until d35
post-infection. Anti-CD4 depleting antibody was administered at d40 post-infection.
Treatment with anidulafungin or saline resumed one day prior to rechallenge with trophic
forms or mixed P. murina organisms, respectively. Animals were euthanized 15 days
after rechallenge, and serum antibody was collected. ELISAs were performed on serum
to determine the level of trophic form- or mixed Pneumocystis-specific IgG. Serum was
probed against equal protein concentrations of sonicated trophic or mixed P. murina
antigen. Data are expressed as the optical density at 405 nm. Data represent the mean
±SD of 3 mice per group and are representative of 2 separate experiments. KruskalWallis one-way ANOVA on ranks with Student-Newman-Keuls post-hoc test was used
to compare mean optical density at 405nm between trophic antigen and mixed antigen
groups at individual dilutions, *p ≤ 0.05.
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Figure 4-5 The antibody-mediated secondary response to trophic forms promotes an
increase in CD11c+ CD11b+ innate immune cells in the alveolar spaces.
BALB/c adult mice were infected i.t. with trophic forms. Mice were treated with
anidulafungin one day prior to infection, and three times per week thereafter until d35
post-infection. Anti-CD4 depleting antibody was administered at d40 post-infection.
Treatment with anidulafungin or saline resumed one day prior to rechallenge with trophic
forms or mixed P. murina organisms, respectively. Animals were euthanized 15 days
after rechallenge. Flow cytometry was used to phenotype CD11c+ CD11b-, CD11c+
CD11b+ and CD11c- CD11b+ non-lymphocytes with high granularity and size from the
BALF and lung digest. Data represent the mean ±SD of 3 mice per group and are
representative of 2 separate experiments. T tests were used to compare mean total cell
number between the groups, **p ≤ 0.01.
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Figure 4-6 Cysts are required for progression to pneumonia in
immunocompromised mice infected with P. murina.
RAG2KO mice were treated with anidulafungin or saline, followed by infection with 2 X
106 purified trophic forms. Anidulafungin or saline treatment was maintained through the
experiment. Saline-treated control mice were euthanized at day 72 post-infection due to
symptoms of advanced PcP. Mice treated with anidulafungin were euthanized at day 120
post-infection. The change in average body weight was recorded (A). Fungal lung
burdens (B) in the right lung lobes were determined by enumeration of organisms on
DiffQuik stained slides under a microscope. TNFα concentrations in the supernatant of
the first BALF wash were quantified by ELISA (C). Flow cytometry was used to
phenotype CD11c+ CD11b-, CD11c+ CD11b+ and CD11c- CD11b+ non-lymphocytes with
high granularity and size from the BALF and lung digest (D). CD11c- CD11b+ cells were
further phenotyped by flow cytometry on the basis of F4/80 expression (E). Data
represent the mean ±SD of 3 mice per group and are representative of 2 separate
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experiments. T tests were used to compare body weight between the groups at individual
timepoints, *p ≤ 0.05.
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Chapter 5: The trophic life cycle stage of the opportunistic fungal pathogen
Pneumocystis murina hinders the ability of dendritic cells to stimulate CD4+ T cell
responses

The following chapter is modified from: Evans HM, Simpson A, Shen S, Stromberg AJ,
Pickett CL and Garvy BA. 2017. The trophic life cycle stage of the opportunistic fungal
pathogen Pneumocystis murina hinders the ability of dendritic cells to stimulate CD4+ T
cell responses. Infect Immun. In press. doi:10.1128/IAI.00396-17.

I. Introduction
In Chapter 3, we have reported that the life cycle stages of Pneumocystis murina
have opposing effects on the immune response (168). The immune response to infection
with P. murina trophic forms alone was less robust than the response to infection with a
physiologically normal mixture of cysts and trophic forms. Infection with trophic forms
alone resulted in reduced numbers of CD11c+ innate immune cells in the lungs, as well as
reduced recruitment of activated CD4+ and CD8+ T cells, compared to infection with a
normal mixture of trophic forms and cysts. In vitro, trophic forms suppressed production
of the proinflammatory cytokines by dendritic cells stimulated with broad range of fungal
and bacterial PAMPs. In addition, trophic form-stimulated BMDCs failed to stimulate
production of the Th1-type cytokine IFN-γ by CD4+ T cells.
In this Chapter, we sought to further characterize the dendritic cell response to
trophic forms. Dendritic cells are the principal antigen presenting cells in the lung.
However, their role in initiating the adaptive response to Pneumocystis has been
understudied. Previous reports indicate that β-glucan from the cyst wall is sufficient to
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induce dendritic cell-mediated proliferation and polarization of Th1/Th17-type CD4+ T
cells(23, 88). The mechanism for dendritic cell recognition of Pneumocystis trophic
forms, which do not express β-glucan, is unknown. Both stages express surface
glycoproteins and mannoproteins that may serve as pathogen-associated molecular
patterns (PAMPs) that could be recognized by receptors on host cells (7-9). However, the
breath of the suppression observed in Chapter 3 suggests that, despite the availability of
PAMPs, trophic forms induce poor activation of dendritic cells. In contrast, the data
presented in Chapter 4 indicate that trophic forms are sufficient to promote CD4+ T cell
responses.
We sought to further evaluate the effects of trophic forms on dendritic cell
activation and antigen presentation. The failure of trophic forms to stimulate key
proinflammatory cytokines (Chapter 3) encouraged us to use the NanoString gene
expression assay to evaluate the dendritic cell response to trophic forms compared to a
mixed population of trophic forms and cysts. NanoString is an array capable of analyzing
the relative expression of a predefined panel of target genes. Herein, we employed the
NanoString nCounter Mouse Immunology CodeSet to evaluate the expression of 561
immunity-related mouse transcripts in dendritic cells treated with trophic forms or a
mixed population of trophic forms and cysts. This technique painted a focused portrait of
the dendritic cell response to trophic forms. The NanoString assay more directly
addressed our research focus than other, more extensive, methods of gene expression
analysis such as RNASeq.
The NanoString assay was a powerful tool to demonstrate the broad failure of
dendritic cells to become activated in response to trophic forms. We demonstrate that P.
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murina trophic forms hinder the ability of dendritic cells to serve in their essential role as
stimulators of CD4+ T cell responses by reducing the capacity of dendritic cells to
produce proinflammatory cytokines, present antigen, and express costimulatory
molecules. Treatment of dendritic cells with trophic forms induced a less robust pattern
of expression of immunity-related genes than treatment with a mixture of P. murina
trophic forms and cysts. In addition, treatment with trophic forms reduced the ability of
dendritic cells to increase surface expression of MHC class II and CD40 in response to
stimulation with mixed P. murina organisms or zymosan. These defects in the expression
of MHC class II and costimulatory molecules corresponded with a reduced capacity for
trophic form-loaded dendritic cells to stimulate CD4+ T cell proliferation and
polarization.
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II. Results

P. murina trophic forms induce a suppressive pattern of gene expression in dendritic
cells.
Pneumocystis trophic forms suppress the production of proinflammatory cytokines
by dendritic cells stimulated with multiple PAMPs (168). These PAMPs are recognized
by a range of pattern recognition receptors that mediate diverse signaling pathways
within the cell, including, in the case of IL-1β, inflammasome activation. These data
suggest that P. murina trophic forms have a broadly suppressive effect on dendritic cells.
To evaluate the activity of dendritic cells in response to trophic forms, we employed a
target gene expression array to analyze the dendritic cell response to P. murina trophic
forms based on the expression of 561 immunity-related mouse transcripts (NanoString
nCounter Mouse Immunology CodeSet). BMDCs from adult BALB/cJ mice were
incubated with trophic forms or mixed P. murina organisms at a dendritic cell to fungal
cell ratio of 1:50. Controls included untreated BMDCs and BMDCs treated with 10
µg/ml of the β-glucan curdlan. Curdlan is a high-molecular-weight β-1,3-glucan isolated
from Alcaligenes faecalis, and is similar to the β-1,3-glucan that composes the P. murina
cyst wall (182, 183). Curdlan is employed in these experiments as a reductive positive
control for β-glucan-induced signaling in BMDCs. RNA was extracted after 2, 4, and 8
hr, and analyzed with the preassembled NanoString panel. Raw NanoString data are
hosted at doi:10.1128/IAI.00396-17 (Data Set S1). Raw counts were normalized to
internal reference transcripts and housekeeping genes.
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The normalized data illustrate that trophic forms induced a broader pattern of
reduced gene expression in dendritic cells, compared to stimulation with a normal
mixture of cystic and trophic forms (“mixed Pc”), or the β-glucan curdlan (Fig 5.1A-D).
The heat map shown in Fig 5.1A depicts the relative values of the 561 transcripts for
each sample (n = 5) within each treatment group, at 8 h post-treatment. Data are shown as
the relative gene expression value compared to the unstimulated control. A large portion
of the immunity-related genes were induced by treatment with curdlan, but
downregulated by treatment with trophic forms (Fig 5.1A). Stimulation with a mixture of
P. murina organisms did not induce total gene expression as robustly as the positive
control, curdlan (Fig 5.1A). However, stimulation with mixed P. murina organisms did
lead to upregulation of a greater number of genes than stimulation with trophic forms
alone (Fig 5.1A). Intriguingly, stimulation with trophic forms and mixed P. murina
organisms led to the upregulation of several genes whose expression was not induced by
curdlan (Fig 5.1A, C).
Experimental data shown in Fig 5.1B represent the principle component analysisbased clustering of the samples within each group after 8 h of treatment. Principle
component analysis plots the data in terms of the directions where the data has the most
variance (the mathematically-defined “principal components”). Here, each of the groups
formed distinct clusters, indicating a unique pattern of gene expression following each
treatment. Experimental data shown in Fig 5.1C-D represent genes upregulated or
downregulated in the treated groups relative to the untreated control. Differences were
identified by two-way ANOVA followed by pairwise comparisons using the Least
Significant Difference Method. A change was deemed significant if the p value was
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<0.01. Notably, BMDCs treated with trophic forms also increased the expression of a
subset of genes relative to unstimulated cells. Of the 561 immunity-related transcripts,
stimulation with trophic forms induced the statistically significant upregulation of 154
genes (Fig 5.1C) and the downregulation of 130 genes (Fig 5.1D) relative to the
unstimulated control. 121/154 (78.6%) of the genes upregulated (Fig 5.1C) by
stimulation with trophic forms and 93/130 (71.5%) of the genes downregulated (Fig
5.1D) by treatment with trophic forms were also upregulated or downregulated
(respectively) in the mixed P. murina- and curdlan-treated groups. The pattern of gene
expression in response to mixed P. murina organisms (a mixture of 10 trophic forms to 1
β-glucan expressing cyst) was similar to the phenotypes induced by either trophic forms
or curdlan with few unique genes either up- or down-regulated (Fig 5.1C-D). The data
shown in Fig 5.1 demonstrate that trophic forms induced a unique pattern of gene
expression in regards to both the identity of gene transcript, and the magnitude of the
change in expression. In contrast, treatment with mixed P. murina organisms induced a
pattern of gene expression that represents an intermediate phenotype between the
comparatively less robust pattern of gene expression that is induced by trophic forms and
the highly inflammatory pattern that is induced by the β-glucan curdlan.

Trophic forms induce the expression of genes encoding chemokines and complement
proteins.
As noted in Fig 5.1C, stimulation with trophic forms induced the statistically
significant upregulation of 154 genes compared to the unstimulated control. The data
shown in Fig 5.2A include all of the genes in the NanoString panel with a statistically
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significant (p < 0.01) four-fold or greater increase in expression between BMDCs treated
with trophic forms compared to unstimulated BMDCs. Several genes on this list are
related to the complement system or encode chemokines. Notably, many of these genes,
including the genes encoding complement system transcripts, are more highly expressed
in cells treated with trophic forms compared to stimulation with curdlan or a mixture of
P. murina organisms.
The data in Fig 5.2B-C represent all genes encoding regulators of inflammation (B)
or immunity-related transcription factors (C) with a statistically significant (p < 0.01)
two-fold or greater increase in expression between BMDCs treated with trophic forms
compared to unstimulated BMDCs. While we have previously reported that trophic forms
fail to induce translocation of NFκB in alveolar macrophages and trophic forms suppress
the production of IL-1β, IL-6, and TNFα protein by dendritic cells, these data indicate
that dendritic cells are responsive to the trophic forms (9, 168). Furthermore, treatment of
dendritic cells with trophic forms induces a distinct pattern of gene expression compared
to stimulation with curdlan and mixed P. murina.

Muc1 is not required for trophic form-mediated suppression of cytokine responses.
A striking finding in our gene expression data is that the expression of Muc1 is 50fold greater in BMDCs treated with trophic forms compared to the unstimulated control
(Fig 5.2A). In contrast, stimulation of BMDCs with mixed P. murina organisms or
curdlan induced a 10-fold increase in Muc1 expression compared to the unstimulated
control (Fig 5.2A). Muc1 encodes a transmembrane mucin-like glycoprotein that is
associated with suppression of TLR-mediated signaling in alveolar epithelial cells (184).
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In addition to CLRs such as dectin-1, Pneumocystis species have been shown to stimulate
cytokine production via TLR2 and TLR4 (156, 170). We previously published that
Pneumocystis trophic forms suppressed the production of proinflammatory cytokines by
dendritic cells stimulated with the TLR2 agonist LTA and the TLR4 agonist LPS. To
evaluate the role of Muc1 in trophic form-mediated suppression of TLR signaling, we
measured cytokine production by Muc1-deficient BMDCs following stimulation with
trophic forms, mixed P. murina organisms, curdlan, LPS, and/or LTA (Fig 5.3). Trophic
form-mediated suppression of IL-6 was similar in wild-type and Muc1-/- BMDCs.

Stimulation with trophic forms leads to attenuated expression of multiple cytokine
genes compared to treatment with a mixture of trophic forms and cysts.
Dendritic cells are the principal antigen presenting cells in the lung, and are critical
for optimal B cell and T cell activation in response to pathogens (reviewed in (84)).
Immature lung dendritic cells reside in the alveolar interstitium, where they project their
dendritic extensions through the epithelial-tight junctions into the alveolar spaces.
Encounters with antigen promote a complex maturation process that prepares the
dendritic cell to serve as an antigen-presenting cell. We previously published that
Pneumocystis trophic forms suppressed the production of proinflammatory cytokines IL1β, IL-6, and TNFα by dendritic cells stimulated with multiple PAMPs (168). A principle
aim of the gene expression array was to identify the extent of the suppressive impact of
trophic forms on dendritic cells.
Data shown in Fig 5.4A represent the relative gene expression at 8 h poststimulation of every cytokine included in the preassembled panel. Gene expression is
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displayed as the log2 value of the quotient of the treated value divided by the untreated
value. Stimulation with trophic forms led to the expression of the vast majority of the
cytokine genes included in the panel. However, the magnitude of this upregulation was
attenuated compared to treatment with mixed P. murina organisms or curdlan. For
example, treatment with trophic forms increased the expression of transcripts encoding
IL-1β and IL6. However, this upregulation was not as great as that observed in cells
stimulated with mixed P. murina or curdlan (Fig 5.4A). In addition, IL-1β and IL-6
protein were not detectable in the supernatant of dendritic cells stimulated with purified
trophic forms (Fig 5.5). Treatment with trophic forms failed to induce gene and protein
expression of TNFα (Fig 5.4A and Fig 5.5). Mixed P. murina and curdlan both induced
expression of the transcript encoding TNFα. However, as previously reported, stimulation
with curdlan but not mixed P. murina induced protein expression of TNFα (168).

Trophic forms induce less robust expression of multiple transcription factors and
positive regulators of inflammation compared to treatment with a mixture of
trophic forms and cysts.
Data shown in Fig 5.4B represent genes that encode positive regulators of
inflammation whose expression was significantly different (greater than 2-fold
difference, p<0.01) between the cells treated with trophic forms and mixed P. murina
organisms at 8 h. Notably, treatment with trophic forms in the absence of cysts lead to
less robust expression of a wide range of mediators of inflammation, including the genes
encoding the dendritic cell maturation marker SLAMF1, compared to stimulation with a
mixed population of trophic forms and cysts. Data shown in Fig 5.4C represent genes
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that encode immunity-associated transcription factors whose expression was significantly
different (greater than 2-fold difference, p<0.01) between the cells treated with trophic
forms and mixed P. murina organisms at 8 h. Conventional dendritic cells (cDCs) may be
divided into two broad subsets: CD8α+ CD103+ cDC1s, which promote Th1 polarization
and CD11b+ cDC2s, which promote Th2 or Th17-type responses (185-190). Treatment
with trophic forms reduced the expression of the transcripts encoding the cDC1associated transcription factors Batf3 and Irf8 and the expression of the cDC2-associated
transcription factor Irf4 below the basal level of expression. In contrast, stimulation with
mixed P. murina organisms enhanced the expression of each of these markers.

Suppression of the cytokine response is not dependent on trophic form viability, but
is partially dependent on direct contact between trophic forms and dendritic cells.
Pneumocystis trophic forms suppress the production of proinflammatory cytokines
IL-1β, IL-6, and TNFα by dendritic cells stimulated with multiple PAMPs (Fig 5.5 and
(168)). We report here that trophic forms are capable of suppressing the expression of
multiple immunity related genes (Fig 5.1 and 5.4) below the basal level of expression.
To determine if suppression requires live participation by the trophic forms, we tested the
ability of heat-killed (Fig 5.6A-C) or sonicated (Fig. 5.6D-F) trophic forms to prevent
IL-1β, IL-6, and TNFα cytokine production in BMDCs treated with curdlan. Live, heatkilled, and sonicated trophic forms suppressed cytokine production, indicating that trophmediated suppression is not dependent on the viability of trophic forms. Surprisingly,
while intact mixed P. murina organisms induce IL-1β and IL-6 production, these data
indicate that sonicated mixed P. murina organisms suppressed these responses. These
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data suggest that intact cysts are required for stimulation of cytokine production, and, in
the absence of this stimulation, the trophic material is able to suppress the response to
other PAMPs.
Immunosuppression by the trophic forms could be mediated by a secreted factor or
by direct contact between the trophic forms and the BMDCs. We measured curdlaninduced IL-1β, IL-6, and TNFα cytokine production by BMDCs separate from trophic
forms by Transwell polyester inserts with 0.4µm pores (Fig 5.6G-I). Direct contact
between the trophic forms and BMDCs was not required for a reduction in IL-1β or
TNFα cytokine production (Fig 5.6G-H). Intriguingly, direct contact was required for the
suppression of IL-6 protein production (Fig 5.6I).
A relatively small amount of P. murina DNA was detected in the lower Transwell
compartment, and quantitative PCR indicated that up to 2 X 103 trophic forms (or
equivalent trophic DNA) may have crossed the Transwell membrane (data not shown).
However, the addition of greater than 106 trophic forms was required to see the level of
suppression that was observed in the Transwell system (Fig 5.7). In addition, a portion of
the supernatant from the lower compartments was cytospun onto slides and examined
under a microscope (limit of detection = 102 organisms, data not shown). No trophic
forms were observed, further confirming that a significant proportion of the trophic forms
did not cross the membrane. These controls indicate that the suppression of TNFα and IL1β observed in Fig 5.6G-I was due to material shed from trophic forms, rather than the
passage of whole trophic forms through the Transwell membrane.
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Trophic forms suppress the expression of multiple factors related to antigen
presentation, including MHC class II and the costimulatory molecule CD40.
We have previously reported that infection of wild-type mice with trophic forms
induces less expression of MHC class II on the surface of CD11c+ CD11b- and CD11c+
CD11b+ cells within the lungs compared to infection with mixed P. murina organisms
(168). This effect was consistent through two weeks post-infection. The reduced capacity
of BMDCs to express MHC class II correlated with less robust CD4+ T cell recruitment
and proliferation in the lungs of mice infected with trophic forms compared to mixed P.
murina organisms (168).
The preassembled NanoString panel included several genes related to antigen
presentation (Fig. 4A). Gene expression is displayed as the log2 value of the quotient of
the treated value divided by the untreated value. These data indicate that trophic forms
suppress the expression of multiple antigen-presentation genes below the basal level of
expression. Ciita encodes the class II transactivator, a master regulator of genes related to
MHC class II expression. The expression of Ciita is 10-fold lower in BMDCs treated
with trophic forms compared to the unstimulated control (Fig 5.8A). In contrast,
stimulation with mixed P. murina led to a 3-fold decrease in Ciita expression compared
to the unstimulated control, while treatment with curdlan did not significantly alter the
expression of Ciita (Fig. 4A). Data shown in Fig 5.8B represent the relative expression of
genes encoding costimulatory molecules. Treatment of BMDCs with trophic forms
induces lower levels of expression of the transcripts encoding the costimulatory
molecules CD40, CD80, CD86, PD-L1 and PD-L2 than stimulation with mixed P.
murina organisms.
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Flow cytometry was used to evaluate protein expression of MHC class II (Fig 5.8CE) and CD40 (Fig 5.8D-F) on the surface of BMDCs treated for 24 hours with trophic
forms, mixed P. murina organisms, and/or zymosan. Zymosan is a protein-carbohydrate
preparation from the cell wall of Saccharomyces cerevisiae, and, unlike curdlan, zymosan
may be processed and presented as protein antigen. Treatment of BMDCs with mixed P.
murina organisms and/or zymosan resulted in increased surface expression of MHC class
II and CD40 compared to the basal level. Treatment with trophic forms failed to induce
surface expression of MHC class II and CD40. Addition of trophic forms to BMDCs
treated with P. murina organisms or zymosan inhibited the expression of MHC class II
and CD40. These data indicate that trophic forms suppress the expression of MHC class
II and the costimulatory molecule CD40 on the surface of dendritic cells. Maturation of
dendritic cells is characterized by an initial burst in antigen presentation and MHC class
II expression followed by a reduction in additional antigen processing and presentation.
However, surface expression of peptide-MHC class II complexes is highly stable in
mature dendritic cells, with a reported half-life of 31 hours observed in dendritic cells
stimulated with LPS (191). Therefore, the observed reduction in MHC class II surface
expression after 24 hours of stimulation suggests that treatment with trophic forms
impedes the maturation of dendritic cells.

Pretreatment of dendritic cells with trophic forms reduces allogenic CD4+ T cell
proliferation in a mixed lymphocyte reaction.
In order to determine the significance of reduced MHC class II on BMDCs treated
with trophic forms, a mixed lymphocyte reaction was used in which T cell proliferation is
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dependent on detection of allogenic MHC class II, but not specific antigen. To test the
effect of trophic forms on allogenic CD4+ T cell proliferation, BMDCs generated from
Iad-expressing BALB/cJ mice were pretreated with trophic forms or mixed P. murina
organisms for one hour (Fig 5.9A). CFSE-stained splenocytes from uninfected Iabexpressing C57BL/6 mice were then added to the wells and co-cultured for 6 days. Flow
cytometry was used to evaluate the proliferation of C57BL/6 CD4+ T cells (Fig 5.9A).
Pretreatment of allogeneic BMDCs with trophic forms, but not mixed P. murina
organisms reduced CD4+ T cell proliferation and IFNγ production in the mixed
lymphocyte reaction (Fig 5.9A). These data are consistent with trophic forms suppressing
MHC class II expression, resulting in the inability of the pretreated dendritic cells to
stimulate antigen-independent allogenic T cell proliferation in a mixed lymphocyte
reaction.

Trophic form-loaded dendritic cells stimulate less robust CD4+ T cell responses.
CD4+ T cell responses are required for the clearance of P. murina (1). We have
previously reported that BMDCs loaded with mixed P. murina, but not trophic forms,
stimulate IFN-γ production by CD4+ T cells in vitro (168). To evaluate whether dendritic
cells are able to present antigen and induce CD4+ T cell responses when loaded with
trophic forms, we broadened our analysis to include proliferation and other T helper
cytokines (Fig 5.9B-E). BMDCs loaded with mixed P. murina, but not trophic forms,
stimulated proliferation in CFSE-labeled CD4+ T cells (Fig 5.9B). To confirm that
trophic forms are phagocytosed by BMDCs, confocal microscopy was used to
demonstrate that DDAO-SE-labeled trophic forms were internalized (Fig 5.10A).

124

Furthermore, confocal microscopy (Fig 5.10B-C) and flow cytometry (Fig 5.10D-E)
confirmed that stimulation of dendritic cells with trophic forms does not reduce the
ability of dendritic cells to phagocytose pHrodo Green-label zymosan bioparticles, which
fluoresce in low pH.
BMDCs loaded with mixed P. murina stimulated higher production of the Th1-type
cytokine IFNγ, the Th2-type cytokine IL-13, and the Th17-type cytokine IL-17A by CD4+
T cells compared to stimulation with trophic forms alone (Fig 5.9C-E). However,
stimulation with trophic forms did induce greater production of IL-13 than the
unstimulated control (Fig 5.9D). These data indicate that while cysts are required for
robust proliferation of CD4+ T cells and production of cytokine in vitro, BMDCs loaded
with trophic forms are capable of driving modest Th2-type T cell polarization. P. murina
organisms did not stimulate CD4+ T cell proliferation and cytokine production in the
absence of BMDCs (data not shown), indicating that these responses are dependent on
antigen presentation by BMDCs.

125

III. Discussion
We have previously reported that the cyst life cycle stage drives proinflammatory
responses that direct the early recruitment of innate and adaptive immune cells. Infection
of adult mice with Pneumocystis trophic forms in the absence of cysts leads to the
establishment of an immunosuppressive environment in the lungs that persists for up to
one week following the formation of the cystic stage (168). If cysts are in the inoculum,
the trophic form is unable to suppress inflammatory responses in the lungs as effectively.
We have reported that the trophic life cycle forms dampen β-glucan and TLR-induced
inflammation compared to stimulation with a mixture of trophic forms and cysts (168).
Here, our data confirm that P. murina trophic forms hinder the ability of dendritic cells to
serve in their essential role as stimulators of CD4+ T cell responses by reducing the
capacity of dendritic cells to produce proinflammatory cytokines, present MHC class II,
and express costimulatory molecules.
We did not define the factor(s) expressed by the trophic forms that induce
suppression. However, experiments were presented that have begun to define the nature
of these factors. Intriguingly, suppression of the dendritic cell cytokine response was not
dependent on trophic form viability and was only partially dependent on direct contact
between trophic forms and dendritic cells. It is plausible that either secreted proteins or
shed glycosylated proteins such as glycoprotein A (gpA, or major surface glycoprotein,
MSG) are responsible for trophic-form mediated suppression. Direct contact between
trophic forms and BMDCs was required for suppression of IL-6, but not IL-1β protein
production, while TNFα suppression was partially dependent on direct contact. This data
may suggest that multiple factors from the trophic forms are responsible for the broad
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suppression of the production of inflammatory cytokines by dendritic cells. Alternatively,
it is possible that the amount of suppressive material that crossed into the lower
compartment is less than the amount that is present when BMDCs are co-cultured with
trophic forms in the lower well. The dose-response curve in Fig 3.7 suggests that
suppression of IL-1β requires the addition of fewer trophic forms compared to the
suppression of IL-6. Therefore, it is possible that the Transwell assay employed here
represents a scenario in which sufficient suppressive material has reached the BMDC to
inhibit IL-1β, but not IL-6, production. Further studies should evaluate the dose-response
of BMDCs treated with increasing amounts of material from the trophic forms.
Dendritic cell activation is dependent on the expression of a wide range of
transcription factors and signaling mediators related to inflammatory responses. Here, we
report that trophic forms induced a differential pattern of gene expression in dendritic
cells compared to treatment with a normal mixture of trophic forms and cysts. Treatment
of dendritic cells with trophic forms induced a less robust pattern of expression of several
immunity-related genes than treatment with a mixture of P. murina trophic forms and
cysts. We previously published that Pneumocystis trophic forms suppressed the
production of proinflammatory cytokines IL-1β, IL-6, and TNFα by dendritic cells
stimulated with multiple PAMPs, including β-glucan, LPS, LTA, zymosan, and depleted
zymosan (168). Here, we demonstrate that transcript levels of these proinflammatory
cytokines were lower in dendritic cells treated with trophic forms compared to mixed P.
murina. These data suggest that the cyst life cycle is required for robust cytokine
production by dendritic cells.

127

Treatment of BMDCs with trophic forms induced the expression of several genes
encoding complement components. The complement protein C3 is not required for
clearance of P. murina infection (123). However, it has been proposed that the
accumulation of complement components during PcP contributes to immune-mediated
lung damage (192). Anaphylatoxins (complement peptides C3a, C4a, and C5a) are
formed during the complement cascade, and may promote neutrophil recruitment (193,
194). It is unclear if complement components contributed to the differential immune
response that we observed following inoculation with trophic forms or mixed P. murina
organisms (Chapter 3).
Stimulation of BMDCs with trophic forms also induced the expression of several
genes that encode chemokines. This list is comprised of chemokines that are
chemoattractant for a range of leukocytes, including monocytes, dendritic cells,
neutrophils, NK cells, T cells, and B cells. However, our in vivo data suggest that
inoculation with trophic forms results in delayed recruitment of leukocytes into the host
lungs (Chapter 3). Our anidulafungin-treated RAG2-/- model demonstrates that the longterm carriage of a trophic population results in the infiltration of a population of CD11cCD11b+ cells that are predominately F4/80high (Fig 4.6). This suggests that trophic forms
promote the recruitment of monocytes or macrophages rather than F4/80low neutrophils or
myeloid-derived suppressor cells. Neutrophils are not required for clearance, but their
accumulation in the lungs correlates with disease severity in human Pneumocystis
pneumonia patients (5, 136). Further work is required to determine which chemokine
proteins are present in the host lung during infection with trophic forms or mixed P.
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murina organisms, and to identify the cell populations recruited in response to trophic
infection of immunocompetent hosts.
The data in Fig 5.2B-C represent all genes encoding regulators of inflammation (B)
or immunity-related transcription factors (C) with a statistically significant (p < 0.01)
two-fold or greater increase in expression between BMDCs treated with trophic forms
compared to unstimulated BMDCs. While we have previously reported that trophic forms
fail to induce translocation of NFκB in alveolar macrophages and trophic forms suppress
the production of IL-1β, IL-6, and TNFα protein by dendritic cells, these data indicate
that dendritic cells are responsive to the trophic forms (9, 168). Furthermore, treatment of
dendritic cells with trophic forms induces a distinct pattern of gene expression compared
to stimulation with curdlan and mixed P. murina.
Trophic forms induce differential regulation of several genes related to
inflammation and transcription compared to stimulation with mixed P. murina. These
genes encompass diverse signaling pathways, including genes encoding members of the
interferon regulatory factors (IRF) and STAT families. Here, we show that treatment with
trophic forms suppressed the expression of Batf3 and Irf8, which mediate the
development of Th1-promoting CD8α+ CD103+ conventional DCs (cDC1). The
expression of Irf4, which mediates the development of Th2/ Th17-promoting CD11b+
cDCs (cDC2) was also suppressed by treatment with trophic forms but induced by
treatment with mixed P. murina. These data suggest that trophic forms may broadly
suppress the development of multiple dendritic cell subsets, and are consistent with the
failure of trophic form-stimulated dendritic cells to induce robust production of T helper
cytokines compared to stimulation with mixed P. murina. It should be noted, however,
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that the BMDCs employed in these experiments more closely resemble monocyte-derived
dendritic cells and are not true conventional dendritic cells, which require Flt3L for
differentiation (195, 196). The ability of trophic forms to suppress Batf3, Irf8, and Irf4
expression in Flt3L-dependent conventional dendritic cells has not been evaluated.
Some fungal pathogens, including Candida spp and H. capsulatum, may prevent
phagosomal maturation and acidification (197-199). However, our data indicate that
stimulation with trophic forms or a mixed P. murina does not reduce the phagocytic
capacity of the dendritic cell. Rather, our data confirm that treatment with trophic forms
reduces the ability of dendritic cells to present antigen. Treatment with trophic forms
reduced the ability of dendritic cells to increase surface expression of MHC class II and
CD40 in response to stimulation with mixed P. murina organisms or zymosan (a
Saccharomyces cell wall preparation). Our data indicate that this suppression occurred at
the level of transcription, as treatment with trophic forms led to downregulation of
several genes associated with MHC class II processing and expression, including the
gene encoding the master class II transactivator, Ciita. Treatment with trophic forms also
resulted in lower expression of the genes encoding the costimulatory molecules CD40,
CD80, and CD86, as well as the immune regulatory molecules PD-L1, and PD-L2
compared to treatment with a mixture of organisms that contained cysts. These defects in
the expression of MHC class II and costimulatory molecules corresponded with a reduced
capacity for trophic form-loaded dendritic cells to stimulate CD4+ T cell proliferation and
polarization. Intriguingly, suppression of the dendritic cell cytokine response was not
dependent on trophic form viability, nor on direct contact between trophic forms and
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dendritic cells. It is possible that this will also be true for expression of MHC class II,
however, these experiments are ongoing.
Modulation of the T helper phenotype of the inflammatory response is a common
strategy employed by infectious fungi for immune evasion (200). In addition to
presentation of antigen, activated dendritic cells produce cytokines that influence the
polarization of the T helper response. Shifts in this balance may elicit an inefficient
adaptive response. For example, the generation of a Th2-type response to the fungal
commensal Candida albicans inhibits Th1 responses, and promotes pathogen survival by
decreasing phagocyte activation (201). However, while Th1 or Th17 responses are critical
for control of many fungal infections, including candidemia, a mixed T helper response is
observed in response to Pneumocystis infection. This mixed response appears to be
largely redundant, as Th1-, Th2-, and Th17-type responses have each been associated with
clearance of P. murina organisms (24, 111-115). Broad suppression of cytokine
production by trophic forms may be necessary to overcome this redundancy and delay the
activation of adaptive immunity against P. murina.
Here, the data indicate that dendritic cells loaded with trophic forms stimulate
production of the Th2-type cytokine IL-13, but not production of the Th1-type cytokine
IFNγ or the Th17-type cytokine IL-17A. These data indicate that trophic forms may
polarize the immune response towards a weak Th2-type response, while suppressing Th1
and Th17-type responses. However, the effectiveness of this response in the absence of
CD4+ T cell proliferation is unclear. In addition, it is unclear how trophic forms, which
suppress IL-6 protein production and fail to induce expression of the genes encoding IL2, IL-4, and IL-13 as robustly as stimulation with mixed P. murina organisms, promote
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Th2 polarization. The CD4+ T cells used in this experiment were generated from the
draining lymph nodes of mixed P. murina-infected donor mice. We expect that this
population included P. murina-specific Th2 CD4+ T cells (113, 115), which may have
continued to produce IL-13, but not proliferate in the presence of trophic form-loaded
dendritic cells. The failure of trophic forms to induce Th1 and Th17 CD4+ T cell
polarization is consistent with the attenuated expression of the genes encoding IL-1β, IL2, IL-6, IL-12, and IL-12β compared to stimulation with mixed P. murina organisms.
In addition, trophic forms are capable of inducing the expression of the genes that
encode the transcription factors T-bet (Tbx21) and Gata3 (Fig. 5.2), which mediate Th1
and Th2-type responses, respectively. T-bet expression in dendritic cells is required for
effective polarization of Th1 T cells (202-204). GATA3 expression in BMDCs is required
for production of the Th2-type cytokines IL-13 and IL-5 (205). This indicates that the
failure of trophic forms to induce robust Th1 and Th2-type responses is not due to direct
suppression of the transcription of these master regulators.
Tolerogenic dendritic cells promote anergic or regulatory T cell responses by
secreting IL-10, TGFβ, and IL-2 and expressing the inhibitory molecules PD-L1 and PDL2. However, our data indicate that treatment of dendritic cells with trophic forms results
in lower levels of gene expression of each of these tolerogenic markers than treatment
with a mixture of trophic forms and cysts. Therefore, trophic forms are not likely to
induce a classical tolerogenic phenotype in dendritic cells. Rather, our data indicate that
treatment with trophic forms broadly reduces the ability of the dendritic cell to provide
activation signals to the CD4+ T cells.
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In summary, our data indicate that the trophic life cycle stage of Pneumocystis
limits the ability of dendritic cells to stimulate CD4+ T cell polarization and proliferation
by reducing the expression of MHC class II, costimulatory molecules, and
proinflammatory cytokines. These defects may be traced back to reduced levels of gene
expression of each of these factors, compared to dendritic cells stimulated with a
physiologically normal mixture of trophic forms and cysts. We propose that the
suppression of immune responses by the trophic forms promotes the colonization of
Pneumocystis in immunocompetent hosts. This differential immune response to
Pneumocystis trophic forms and cysts is most certainly a leading contributor to the
success of the organisms as human pathogens.
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Figure 5-1 Exposure of BMDCs to P. murina trophic forms induces a distinct
pattern of gene expression.
3 X 105 BMDCs from adult BALB/cJ mice were incubated with 1.5 X 106 trophic forms
or 1.5 X 106 mixed P. murina organisms. Controls included untreated BMDCs and
BMDCs treated with 10µg/ml of the β-glucan curdlan. Cells were lysed after 2, 4, or 8 h
of incubation. RNA was extracted. Gene expression analysis was carried out using a
preassembled Nanostring Codeset that measures expression of 561 immunity-related
mouse transcripts (nCounter Mouse Immunology kit). Analysis and normalization of the
raw NanoString data were conducted using nSolver Analysis Software 2.0. Raw counts
were normalized to internal positive controls and reference transcripts. A heat map (A)
was generated to display the treated expression value relative to the untreated value.
Principle component analysis (B) was used to compare the pattern of gene expression
among the untreated and treated groups following 8 h of incubation. Genes upregulated
(C) or downregulated (D) in the treated groups relative to the untreated control were
identified by log transformed two way ANOVA followed by pairwise comparisons using
the Least Significant Difference Method. Five biological replicates were used per group.
A change was deemed significant if the p value was <0.01.
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Figure 5-2 Trophic forms induce the expression of genes encoding chemokines and
complement proteins.
The relative gene expression after 8 h of treatment was calculated as the log2 value of the
quotient of the treated expression value divided by the untreated expression value. The
data in Fig 5.2A represent genes in the NanoString panel with a statistically significant (p
< 0.01) four-fold or greater increase in expression between BMDCs treated with trophic
forms compared to unstimulated BMDCs. The data represent all genes encoding
regulators of inflammation (B) or immunity-related transcription factors (C) with a
statistically significant (p < 0.01) two-fold or greater increase in expression between
BMDCs treated with trophic forms compared to unstimulated BMDCs. Differences in
expression between the groups were identified by log transformed two way ANOVA
followed by pairwise comparisons using the Least Significant Difference Method. Five
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biological replicates were used per group. Genes with differences in expression with p <
0.01 between BMDCs treated with trophic forms vs unstimulated cells are denoted *,
trophic forms vs mixed P. murina organisms are denoted †, and trophic forms vs curdlan
are denoted ‡.
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Figure 5-3 Muc1, a negative regulator of TLR-mediated signaling, is not required
for trophic-form mediated suppression.
1 X 104 BMDCs from Muc-/- and wild-type BALB/cJ mice were incubated with 5 X 105
trophic forms, 5 X 105 mixed P. murina organisms, 10µg/ml curdlan, 100ng/ml LPS, and
10µg/ml LTA for 72 h. IL-6 production was quantified by ELISA. Data represent the
mean ±SD of 3 biological replicates per group and are representative of 2 separate
experiments. Kruskal-Wallis one-way ANOVA on ranks was used to compare
differences among the Muc1-/- BMDCs treated with a stimulus (mixed Pc, curdlan, LPS,
or LTA) compared to a combination of stimulus with trophic forms, *p < 0.05.
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Figure 5-4 Trophic forms induce less robust expression of genes encoding multiple
cytokines, positive regulators of inflammation, and transcription factors compared
to treatment with a mixture of trophic forms and cysts.
The relative gene expression after 8 h of treatment was calculated as the log2 value of the
quotient of the treated expression value divided by the untreated expression value. All
cytokine genes in the preassembled NanoString panel are graphed (A). The data in Fig
5.4B-C represent all genes encoding regulators of inflammation (B) or immunity-related
transcription factors (C) with a statistically significant two-fold or greater difference in
expression between BMDCs treated with trophic forms vs mixed P. murina organisms.
Differences in expression between the groups were identified by log transformed two
way ANOVA followed by pairwise comparisons using the Least Significant Difference
Method. Five biological replicates were used per group. A change was deemed
significant if the p value was <0.01. Genes with differences in expression with p < 0.01
between BMDCs treated with trophic forms vs unstimulated cells are denoted *, trophic
forms vs mixed P. murina organisms are denoted †, and trophic forms vs curdlan are
denoted ‡.
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Figure 5-5 Cysts, but not trophic forms, stimulate production of the
proinflammatory cytokines IL-1β and IL-6 by BMDCs in vitro.
BMDCs from adult BALB/cJ mice were incubated with 3 X 104 trophic forms or 3 X 104
mixed P. murina organisms for 72 h. Curdlan was included as a positive control for
cytokine production. TNFα (A), IL-1β (B), and IL-6 (C) cytokine production was
quantified by ELISA. Data represent the mean ±SD of 3 biological replicates per group
and are representative of 2 separate experiments. One way ANOVA with StudentNewman-Keuls post-hoc test was used to compare supernatant cytokine concentration
between the groups, **p ≤ 0.01, ***p ≤ 0.001, n.s., not statistically significant.
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Figure 5-6 Suppression of the cytokine response is not dependent on trophic form
viability, but is partially dependent on direct contact between trophic forms and
dendritic cells.
1 X 104 BMDCs (A-F) from BALB/cJ mice were incubated with 5 X 105 trophic forms, 5
X 105 heat-killed trophic forms, 5 X 105 sonicated trophic forms, 5 X 105 sonicated
mixed P. murina organisms, and/or 10µg/ml curdlan for 72 h. 1 X 105 BMDCs (G-I)
from BALB/cJ mice were incubated with 5 X 106 trophic forms and/or 10µg/ml curdlan
for 72 h in a Transwell culture plate. TNFα (A, D, G), IL-β (B, E, H), and IL-6 (C, F, I)
cytokine production was quantified by ELISA. Data represent the mean ±SD of 3
biological replicates per group and are representative of 2 separate experiments. One-way
ANOVA with Student-Newman-Keuls post-hoc test was used to compare differences
among the groups where the data were parametric (A-D, G-I), *p ≤ 0.05, ** p ≤ 0.01,
***p ≤ 0.001, n.s., not statistically significant. Kruskal-Wallis one-way ANOVA on
ranks was used to compare differences among the groups where the data were
nonparametric (E-F), *p ≤ 0.05.
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Figure 5-7 A ratio of 10 trophic forms to 1 BMDC is required to for suppression of
cytokine expression.
1 X 105 BMDCs were incubated with 10 µg/ml curdlan, and increasing numbers of
trophic forms for 72 h. TNFα (A), IL-1β (B), and IL-6 (C) cytokine levels in the
supernatant were quantified by ELISA. Data represent the mean ±SD of 3 biological
replicates per group and are representative of 2 separate experiments. One way ANOVA
with Student-Newman-Keuls post-hoc test was used to compare cytokine concentrations
among the groups, *p ≤ 0.05, n.s., not statistically significant.

141

Figure 5-8 Trophic forms suppress the expression of multiple factors related to
antigen presentation, including MHC class II and the costimulatory molecule CD40.
The data in Fig 5.8A-B represent genes in the NanoString panel encoding transcripts
related to antigen-processing and presentation (A) or costimulatory molecules (B) with a
statistically significant (p < 0.01) two-fold or greater increase in expression between
BMDCs treated with trophic forms compared to unstimulated BMDCs. The relative gene
expression after 8 h of treatment was calculated as the log2 value of the quotient of the
treated expression value divided by the untreated expression value. Genes with
differences in expression with p < 0.01 between BMDCs treated with trophic forms vs
unstimulated cells are denoted *, trophic forms vs mixed P. murina organisms are
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denoted *, trophic forms vs mixed P. murina organisms are denoted †, and trophic forms
vs curdlan are denoted ‡. Flow cytometry was used to evaluate surface expression of
MHC class II (C, E) and CD40 (D, F) on the surface of BMDCs following 24 hours of
treatment with trophic forms, mixed P. murina, and/or the fungal cell wall preparation
zymosan. Flow cytometry data represent the mean ±SD of 3 biological replicates per
group and are representative of 2 separate experiments. One way ANOVA with StudentNewman-Keuls post-hoc test was used to compare the surface expression of MHC class
II or CD40 protein among the groups, *p ≤ 0.05, ** p ≤ 0.01, ***p ≤ 0.001.
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Figure 5-9 Trophic forms reduce dendritic cell-dependent proliferation of CD4+ T
cells.
Treatment with trophic forms reduces CD4+ T cell proliferation in response to co-culture
with allogeneic BMDCs in a mixed lymphocyte reaction (A). BMDCs generated from
BALB/cJ mice were pre-treated with trophic forms or mixed P. murina organisms for one
hour. CFSE-stained splenocytes from uninfected C57BL/6 mice were then added to the
wells and co-cultured for 6 days. Flow cytometry was used to identify the CD4+ T cells
144

and evaluate their proliferation (A). BMDCs stimulated with trophic forms induce less
proliferation and cytokine protein expression in CD4+ T cells than cells stimulated with
mixed P. murina (B-E). BMDCs and CFSE-stained CD4+ T cells from adult BALB/cJ
mice were incubated with trophic forms or mixed P. murina for 6 days. Flow cytometry
was used to evaluate proliferation of CD4+ T cells (B). ELISA was used to evaluate the
concentrations of the cytokines IFNγ (A, C), IL-13 (D) and IL17A (E) in the supernatant.
Data represent the mean ±SD of 3 biological replicates per group and are representative
of at least two separate experiments. Cytokine data in the absence of One-way ANOVA
with Student-Newman-Keuls post-hoc test was used to compare the percentage of
proliferating CD4+ T cells or supernatant cytokine concentration among the groups, *p ≤
0.05, ** p ≤ 0.01, ***p ≤ 0.001, n.s., not statistically significant.
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Figure 5-10 Trophic forms do not have a negative impact on the phagocytic capacity
of dendritic cells.
CFSE-stained BMDCs from BALB/cJ mice were incubated with DDAO-SE-stained
trophic forms or mixed P. murina organisms for one hour in a chamber slide (A). Cells
were fixed in neutral buffered formalin, and confocal microscopy was used to identify
internalized trophic forms (A). The z-stacks demonstrate that BMDCs internalize DDAOSE-labeled trophic forms (A). BMDCs were incubated with pHrodo Green zymosan
bioparticles and/or DDAO-SE-stained trophic forms or mixed P. murina organisms for
one hour in chamber slides (B-C) or FACS tubes (D-E). The chamber slides were fixed
in neutral buffered formalin, and stained with DAPI (B-C). Confocal microscopy was
used determine the percentage of BMDCs that had phagocytosed the pH-sensitive
pHrodo Green zymosan bioparticles based on at least 100 events per group (B-C). Flow
cytometry was used to determine the percentage of BMDCs that had phagocytosed the
pHrodo Green zymosan bioparticles based on at least 1000 events per group (D). The
geometric mean fluorescence intensity (MFI) in the FITC channel of the zymosan+
BMDCs was calculated for each group (E). Data represent the mean ±SD of 3 biological
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replicates per group and are representative of 2 separate experiments. One way ANOVA
with Student-Newman-Keuls post-hoc test was used to compare supernatant cytokine
concentration between the groups, n.s., not statistically significant (p > 0.05).
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Chapter 6: Discussion

I. Summary
Pneumocystis species are opportunistic fungal pathogens that cause severe
pneumonia in immunocompromised hosts, including HIV/AIDS patients and patients
undergoing chemotherapy or immunosuppressive therapy. Failure to clear Pneumocystis
organisms leads to inflammation-mediated alveolar damage (5). Prior research in the field
has overwhelmingly focused on the immune response to infection with a mixture of the
trophic and cystic life cycle stages. Certainly, such studies provide valuable information,
as the typical immune response to Pneumocystis organisms is shaped in the context of
infection with both trophic forms and cysts. However, such studies do not provide a
nuanced understanding of the distinct roles of the trophic and cystic life cycle stages in
the development of the immune response to Pneumocystis infection. Here, our goal is to
explore the biology of the immune response to these life cycle stages.
Tropic forms are proposed to represent the asexual stage, and are single-nucleated
organisms that are typically found in clusters surrounded by a biofilm-like substance
consisting of a conglomeration of DNA, β-glucan, and other sugars (13, 14). Cysts are
ascus-like structures formed by mitosis, and consist of multiple nuclei surrounded by a
fungal cell wall. β-1,3 glucan and β-1,6 glucan serve as the structural components of the
cyst wall (13, 15, 16). β-glucan is not detected on the surface of trophic forms (15, 17).
Both stages express surface glycoproteins and mannoproteins that may serve as
pathogen-associated molecular patterns (PAMPs) that could interact with receptors on
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phagocytic cells (18-20). Neither life form produces the classical fungal components
ergosterol, chitin or α-glucans (21, 22).
Ultrastructural studies revealed that the trophic forms tightly adhere to the luminal
surface of alveolar epithelial cells via microprotusions or invaginations of the trophic
plasma membrane (64). This interaction is a risky endeavor for the trophic forms, as
alveolar epithelial cells are capable of producing proinflammatory cytokines. In addition,
this interaction with the alveolar epithelium places the trophic forms at risk for detection
by immature lung dendritic cells, which project their dendritic extensions through the
epithelial-tight junctions into the alveolar spaces. This encounter has the potential to
induce dendritic cell activation and migration to the draining lymph nodes, where the cell
may present antigen to lymphocytes. The involvement of dendritic cells is critical to the
recruitment of T and B cells into the airway lumen, particularly as these spaces are
largely free of lymphocytes prior to infection. Essentially, this slow-growing obligate
parasite has adopted a niche that places it in constant danger of swiftly initiating the
adaptive immune responses that will clear the organisms from the lungs.
Herein, we show that the life cycle stages of Pneumocystis murina differ in their
interactions with the host immune response (Chapter 3). Infection with a normal mixture
of trophic forms and cysts elicits proinflammatory responses, including early infiltration
of T and B cells into the airways. Conversely, the trophic forms of Pneumocystis murina
suppress the proinflammatory response to multiple pathogen-associated molecular
patterns (PAMPs), including β-glucan. Depletion of cysts in immunocompromised
RAG2-/- hosts resulted in a trophic burden that grew slowly over a six month period, but
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did not induce overt symptoms associated with PcP, such as weight loss and infiltration
of innate immune cells into the lungs (Chapter 4).
While cysts are required for robust pro-inflammatory responses, including the early
recruitment of immune cells into the airways, infection with trophic forms in the absence
of cysts is sufficient to drive protective CD4+ T cell and B cell responses (Chapter 4).
Remarkably, our data indicate that CD4+ T cells generated in the absence of cysts
promote faster clearance of infection than CD4+ T cells generated in the presence of
mixed P. murina organisms (Chapter 4). We do not report evidence of a direct
suppressive effect of trophic forms on CD4+ T cells or B cells.
Rather, our data indicate that trophic forms broadly inhibit the ability of dendritic
cells to fulfill their role as antigen-presenting cells by reducing the expression of
cytokines, MHC class II, and costimulatory molecules (Fig 6.1 and Chapter 5). These
data suggest that immune evasion by the trophic forms may hinge on the suppression of
the initiation of the innate immune response, including the inhibition of dendritic cell
communication with CD4+ T cells. The rapid establishment of a trophic population may
be critical for this fungal pathogen to evade innate immune cells and avoid preemptive
clearance of the transmittable, yet inflammatory cyst stage. However, the development of
adaptive immunity to Pneumocystis may represent a “point of no return” at which the
trophic forms are no longer able to escape clearance (Chapter 3).
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II. Significance
This dissertation represents a major advancement in understanding the interactions
between the host immune response and the life cycle stages of Pneumocystis species. Past
research into the host response to Pneumocystis infection has overwhelmingly focused on
the sum of the response to a fungal burden that includes a mixture of trophic forms and
cysts. However, the capacity of the trophic forms to suppress innate immunity provides a
compelling reason for decades of Pneumocystis research to be revaluated in the context
of differential interactions between the life cycle stages and the host immune response.

1. The role of trophic form-mediated suppression during natural infection
Due to technical restrictions, we have not evaluated the immune response to
purified or enriched cysts. However, the data that we have generated regarding the broad,
immunosuppressive capabilities of the trophic forms suggest a corollary: the cysts are
highly inflammatory. Namely, the net inflammation conditions generated in response to
mixed P. murina organisms likely necessitates that the cyst must overcome the
suppressive capabilities of the trophic forms at physiologically normal ratio of 1 cyst per
10 trophic forms.
The inflammatory potential of the cyst in the face of a 10-fold excess of trophic
forms raises questions regarding the relevance of trophic suppression during the tenancy
of the host lung. Here, we demonstrate that trophic form-mediated suppression modulates
the early kinetics of the immune response, and that this delay persists for one week after
the emergence of a population of cysts (Fig 3.3). Despite this delay, the immune response
is able to clear the infection within the same period of time as observed in the group

151

inoculated with mixed P. murina organisms. It should be noted that this dissertation
provides no direct evidence that trophic form-mediated suppression increases the fungal
burden or delays clearance.
To address these concerns, we encourage the reader to consider the ecological niche
of these ubiquitous fungal species. Pneumocystis species have evolved a life cycle
characterized by transient infection of immunocompetent hosts. These species appear to
occupy a niche somewhere in the gray area between “parasite” and “commensal.” We
propose that trophic form-mediated suppression is a host defense that has evolved, and
has been maintained by selection, within Pneumocystis species. If this is true, it would be
expected that a mixed Pneumocystis population arising from the natural route of infection
would benefit from trophic form-mediated suppression. To this effect, we would predict
that the inhibition of trophic form-mediated suppression during mixed P. murina
infection would accelerate the clearance of this population. Conversely, it may be
unreasonable to expect that trophic forms, in the absence of cysts, further delay clearance
(Chapter 3).
We further propose that there may be other benefits to trophic form-mediated
suppression. Inoculation with enriched trophic forms was not sufficient to increase the
fungal burden or delay clearance. However, trophic form-mediated suppression may
serve in other ways to enhance the fitness of the mixed population. Immune suppression
by the trophic forms may improve the early niche within the host lung by dampening the
consequences of inflammation, including the limitation of extracellular nutrient
availability and the release of antimicrobial products, surfactant, and reactive nitrogen or
oxygen species. It is also plausible that inflammatory signals may limit the ability of
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Pneumocystis organisms to scavenge nutrients directly from alveolar epithelial cells.
Alternatively, we demonstrate that trophic forms inhibit cytokine production in response
to a broad range of PAMPs, including bacterial productions such as LPS and LTA. It is
possible that trophic forms promote the maintenance of a tolerogenic state within the lung
during coinfection of Pneumocystis species with bacteria or additional fungal species.
The ultimate aim of trophic form-mediated suppression may not be to delay
clearance per se, but to enhance the transmission of cysts to a new host. To this effect, we
consistently observe a large burst of trophic growth during the first week post-infection
(as seen in Fig 3.3) resulting in a trophic form to cyst ratio in excess of 20:1. Based on
the work presented in this dissertation, it seems plausible that this energy-intensive
expansion of the trophic population may be necessary to preserve favorable conditions
within the alveolar spaces, and thus protect the health of the transmittable cysts.

2. Significance for the development of treatments and vaccines
Protective adaptive responses are required for clearance of Pneumocystis organisms
from the lungs, while, in the absence of protective responses, inflammation-mediated
lung damage causes much of the pathology associated with Pneumocystis pneumonia.
The differential effect of trophic forms and cysts on the host response, therefore, has the
potential to shape both positive and negative outcomes associated with Pneumocystis
infection. Manipulation of this differential response may provide new options for the
treatment and prevention of Pneumocystis infection, while a failure to consider this
differential response may hamper future efforts. Here, our data indicate that trophic forms
elicit adaptive responses, but do not provoke the non-protective inflammation
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characteristic of Pneumocystis pneumonia. Further evaluation of the antigenic
determinants on trophic forms and cysts may elicit a vaccine that provides protection
while limiting immune-mediated damage.
In Chapter 4, we demonstrate that, the absence of the cyst stage, a small trophic
population was maintained in the lungs of RAG2-/- mice without overt evidence of
disease. While further studies are required to evaluate the effects of a low trophic burden
on the host lung, we report no evidence of the inflammatory conditions associated with
Pneumocystis pneumonia, including infiltration of immune cells and accumulation of
proinflammatory cytokines in the BALF. These observations suggest that the depletion of
the cyst stage may provide beneficial treatment options in at-risk patients, particularly
those that retain some means of clearing the remaining trophic forms. These patient
populations

would

include

those

recovering

from

drug-

or

virus-induced

immunosuppression. The potential benefit of cyst-targeted anti-fungal therapies is
highlighted by a report from Linke et al. which demonstrates that treatment of rodents
with echinocandins reduces inflammation in a model of immune reconstitution syndrome
(24). It is our hope that the data presented in this dissertation encourage additional
research regarding the influence of trophic forms and cysts on the detrimental
proinflammatory response that is characteristic of Pneumocystis pneumonia.

3. Pathogen-associated immunosuppression
The identification of the mechanism(s) of trophic form-mediated suppression has
the potential to provide highly valuable data for both basic science and translational
medicine. The characterization of the suppressive material may suggest a list of
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homologous materials expressed by other fungi or, perhaps, other kingdoms of life. These
associations may generate hypotheses regarding the mechanism of interaction between
the suppressive material and the host cell. Such efforts have the potential to enhance our
understanding of immune evasion by a ubiquitous fungal parasite that causes devastating
opportunistic infections in immunocompromised hosts.
Furthermore, our data demonstrate that co-culture with trophic forms broadly
suppresses the ability of dendritic cells to produce proinflammatory cytokines in response
to multiple PAMPs, including LPS, LTA, and zymosan. In addition, we have observed a
similar degree of cytokine suppression in J774 macrophages and alveolar macrophages
(Garvy lab, unpublished data). The identification of the mechanism(s) involved in
suppression may provide pathways or effectors that may be manipulated or mimicked to
develop novel anti-inflammatory therapies. Excessive production of proinflammatory
cytokines, including IL-1, IL-6, and TNFα, contribute to damage during disease states
such as sepsis or influenza-associated cytokine storm (206, 207). Future studies involving
trophic form-mediated suppression may identify mechanisms to reduce cytokine
production without compromising host immunity.

III. Limitations
This dissertation suffers from the universal limitations surrounding Pneumocystis
research. Chief among these restrictions is the lack of a long term ex vivo culture system
for Pneumocystis organisms. The inability of P. jirovecii to live outside of a human host
has limited research on this medically important parasite and opportunistic pathogen. Rat
and mouse models have driven critical advances in understanding the immune responses
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to P. carinii and P. murina, respectively. The transmission of Pneumocystis organisms
and the progression of disease, including the development of interstitial pneumonia, in
immunocompromised rodents appear to be homologous to that experienced in humans.
Patients with specific immunodeficiencies, including defects in immune cell populations,
signaling pathways, and cytokines, have provided evidence regarding the components of
the immune response that are essential for clearance of Pneumocystis organisms. These
observations have been substantiated by a large body of research exploring the immune
response to Pneumocystis in rodent models.
The complexity of immune cell subsets within the lungs also places limitations on
the scope of this dissertation. Dendritic cells are relatively rare within uninfected tissues.
cDCs may represent only 1-2% of the total cells within a single-cell suspension from the
lungs (208). Furthermore, while some common markers to distinguish dendritic cells,
such as CD11c, are applicable in the spleen, the lung is populated by other populations of
CD11c+ immune cells subsets that defy basic attempts at identification and isolation. For
example, Lancelin and Guerrero-Plata report that positive selection of a single-cell
preparation from the lungs yields a mixed population dominated by CD11chi MHC-IIlo
macrophages (>70%) (208). Cell sorting for CD11chi MHC-IIhi cells resulted in a
population consisting of >96% pure dendritic cells, with a typical yield of 5 X 104 cDC
per lung (208).
Dendritic cells are relatively rare within tissues, with the exception of the spleen
and thymus. Several protocols have been developed to generate primary dendritic cells
from bone marrow, permitting researchers to reduce the numbers of animals (and
research effort) required to perform dendritic cell studies. Here, we have employed the
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methodology developed by Lutz et al. (209). Briefly, bone marrow from the tibias and
femurs of adult mice was cultured for nine to twelve days in complete culture media
containing recombinant murine granulocyte-macrophage colony-stimulating factor (GMCSF). Every 48 h thereafter, non-adherent cells (including monocytes) were removed and
replaced with fresh media with additional GM-CSF. BMDCs were collected by
vigorously washing the plates with media to remove loosely adherent cells. In our hands,
greater than 80% of recovered cells were CD11c+, and up to 6 X 107 BMDCs may be
generated from the bone marrow of a single mouse.
However, recent studies have challenged the identity of the BMDCs employed in
this model. It has become appreciated that culture of BMDCs with bone marrow yields a
mixed population of dendritic cells derived from monocytes and common dendritic cell
precursors (210, 211). Neither population may be said to represent bona fide conventional
dendritic cells, which require Flt3L for differentiation (195, 196).
It should also be noted that the culture of bone marrow derived cells does not lead
to the development of a pure population of dendritic cells. Others have determined that
the bone marrow precursors of both dendritic cells and macrophages develop into
CD11c+ MHC-II+ cells in the presence of GM-CSF (210, 211). Both subsets undergo
activation in response to LPS, while the dendritic cell subset alone is capable of inducing
CD4+ T cell responses to OVA antigen (211). The protocol employed here was developed
by Lutz et al. to enrich for CD11c+ dendritic cells (209). It is unclear if this protocol
limits the contamination of CD11c+ MHC-II+ macrophages. While it has been reported
that the addition of Flt3L to the culture media reduces the development of macrophages,
it should be noted that Flt3L promotes the expansion of a small population of monocytes
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in addition to conventional dendritic cells (195, 196). Helft et al. suggest that the practice
of culturing bone marrow-derived dendritic cells remains a viable model for exploring
basic cell function. However, the authors caution researchers to consider the impact of
heterogeneous bone marrow-derived populations in their assays. Current protocols for the
development of bone marrow-derived dendritic cells reduce, but do not eliminate, the
complexity of the heterogeneous cell populations found in vivo.

IV. Future directions
This dissertation has provided significant answers regarding the role of the life
cycle stages of Pneumocystis species in the development of host immunity. It is our hope
that this work encourages future research into the biology of Pneumocystis organisms and
host-pathogen interactions. Perhaps the greatest unanswered questions of this project are:
(1) identification of the trophic form-associated factor(s) that induce suppression and (2)
identification of the dendritic cell regulatory mechanisms involved in the suppressive
response.

4. Identification of the suppressive factor(s):
This dissertation does not identify the suppressive factor(s) on the trophic forms
that induce suppression. However, we have carried out a few preliminary studies
regarding this mechanism. Here, we demonstrate that suppression of the cytokine
response is not dependent on trophic form viability, nor direct contact between trophic
forms and dendritic cells (Chapter 5). Live, heat-killed, and sonicated trophic forms
suppressed cytokine production by β-glucan-treated BDMCs, indicating that suppression
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is not dependent on the viability of trophic forms. Surprisingly, while intact mixed P.
murina organisms induce IL-1β and IL-6 production, these data indicate that sonicated
mixed P. murina organisms suppressed these responses. These data suggest that intact
cysts are required for stimulation of cytokine production, and, in the absence of this
stimulation, the trophic material is able to suppress the response to other PAMPs.
Alternatively, it is possible that trophic forms directly reduce the inflammatory potential
of the cyst by masking or digesting PAMPs on the cyst surface.
Immunosuppression by the trophic forms could be mediated by a secreted factor or
by direct contact between the trophic forms and the BMDCs. Direct contact between the
trophic forms and BMDCs was not required for a reduction in IL-1β or TNFα cytokine
production (Chapter 5). Intriguingly, direct contact was required for the suppression of
IL-6 protein production (Chapter 5). These experiments suggest that the suppressive
effect of trophic forms does not require intact or living organisms, and indicate that
suppression of dendritic cell responses is partially induced by some material, less than 0.4
micron in size, that is passively released from trophic forms.
However, it should be noted that these experiments only examined the suppression
of IL-1β, IL-6, and TNFα supernatant concentrations. The effects of heat-killing,
sonication or separation on trophic-form mediated suppression of other dendritic cell
responses (including antigen presentation) have not been evaluated. The inability of
trophic forms to suppress IL-6 production in the Transwell system suggests that multiple
factors may be required for suppression of certain responses.
The suppressive factor(s) may be a protein or polysaccaharide that is shed from the
surface of the trophic forms. Future work in our laboratory will seek to characterize the
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suppressive factor using mass spectrometry. Sonication of trophic forms produces a
mixture of biomolecules that is too complex for characterization by mass spectrometry.
Proper sample preparation for mass spectrometry will require us to reduce the complexity
of the sample. Various methods, including treatment with proteinases and glucanases,
will be used to digest specific categories of proteins or polysaccharides. Alternatively,
proteins may be isolated from the bulk sonicate on the basis of size. The goal will be to
characterize by mass spectroscopy the least complex material that retains the suppressive
abilities of whole trophic forms.

5.

Identification of the immediate host cell targets of suppression:

Here, we have characterized the suppressive phenotype of dendritic cells stimulated
with trophic forms. However, we have not identified the precise mechanism by which
trophic forms induce this broad suppressive phenotype. It is possible, for example, that
trophic forms induce broad changes in gene expression by manipulating histone
modification within the dendritic cell. Alternatively, trophic forms may target one or a
handful of genes controlling dendritic cell maturation.
Tolerogenic dendritic cells promote anergic or regulatory T cell responses by
secreting IL-10, TGFβ, and IL-2 and expressing the inhibitory molecules PD-L1 and PDL2. However, our data indicate that treatment of dendritic cells with trophic forms results
in lower levels of gene expression of each of these tolerogenic markers than treatment
with a mixture of trophic forms and cysts. Therefore, trophic forms are not likely to
induce a classical tolerogenic phenotype in dendritic cells. Rather, our data indicate that
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treatment with trophic forms broadly reduces the ability of the dendritic cell to provide
activation signals to the CD4+ T cells.
The results of the NanoString assay were compared against systems biology
databases (InnateDB and others) via tools such as pathway analysis. This analysis
assisted in the identification of the antigen presentation genes differentially regulated in
trophic form-treated cells (Chapter 5). However, such analyses have not yet proved
fruitful in the identification of the master regulatory factor(s) targeted by the trophic
forms. A large body of research has recently been produced regarding the mechanisms
involved in the maturation and polarization of dendritic cells. However, the interactions
connecting many of the proteins within the dendritic cell regulome remain unidentified.
As these gaps in our understanding are filled, obvious candidates for the trophic target
may emerge. In the meantime, more classical approaches may provide fruitful leads. For
example, the identification of the suppressive material from the trophic form may permit
future studies (such as co-immunoprecipitation assays) to search for interactions with the
host cell.
Recent evidence suggests that fungal pathogens may manipulate interactions with
C-type lectin receptors to suppress proinflammatory responses. Engagement of the Ctype lectin receptor mincle by the fungal skin pathogen Fonsecaea monophora was
shown to suppress the proinflammatory Th1- and Th17-type immune responses induced
by dectin-1-mediated signaling (159). Opposing roles for dectin-2 and mincle have been
observed in the recognition of Fonsecaea pedrosoi (160). We are currently examining
whether mincle could mediate the suppressive activity of trophic forms, as was found for
F. monophora (159).
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Mycobacterium tuberculosis provides an additional example of pathogen-mediated
manipulation of C-type lectin receptor responses. Pecora et al. have reported that M.
tuberculosis inhibits MHC class II transactivator (Ciita) expression, MHC class II
molecule expression, and antigen presentation on macrophages. Lung dendritic cells
infected with M. bovis BCG express less MHC class II on their surface than uninfected
dendritic cells from the same lung (212). M. tuberculosis uses terminal mannosylated
oligosaccharides to bind mannose receptor and DC-SIGN on host macrophages (213).
Internalization via these receptors suppresses, rather than triggers, inflammatory
responses in macrophages and dendritic cells. Specifically, the C-type lectin receptor DCSIGN internalizes M. tuberculosis by binding mannosylated lipoarabinomannan, or
ManLAM, on the bacterial cell wall. However, binding of ManLAM by the C-type lectin
receptor DC-SIGN inhibits M. tuberculosis or LPS-induced dendritic cell maturation. The
terminal mannosylation of M. tuberculosis oligosaccharides may mimic the structures
present on host mannoproteins.
Here, we demonstrate that the deletion of mannose receptor on dendritic cells
resulted in a modest decrease in the ability of trophic forms to suppress the production of
IL-6, but not TNFα and IL-1β, indicating that suppression is mediated through
mechanisms other than mannose receptor (Chapter 3). Future experiments may evaluate
the role of additional mannose-recognizing receptors in the suppression of
proinflammatory signaling, MHC class II expression, and induction of CD4+ T cell
responses.
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Other compelling questions, with accompanying speculation, include:
1. How inflammatory are the cysts?
Here, we do not evaluate the immune response to pure cysts. However, our data
suggest that stimulation with a 10 to 1 mixture of trophic forms to cysts was sufficient to
induce inflammatory responses in the dendritic cell (Chapter 5). The inflammatory
potential of the cyst to induce a signal over trophic form-mediated suppression should be
evaluated. Previous work has demonstrated that dendritic cells activated by Pneumocystis
cyst cell wall-derived β-glucans increase costimulatory molecule expression and drive T
cell polarization towards a Th1-type response (23). Despite repeated efforts, we have not
identified a reliable method to purify cysts from the lungs of mice. However, other
groups have enriched Pneumocystis cysts from the lungs of infected rats, which are
infected with a higher fungal burden than mice. Future studies could evaluate the immune
response to purified P. carinii cysts from rats, or may continue to evaluate the response to
purified Pneumocystis cell wall fragments.

2. Does the ratio of trophic forms to cysts influence the host immune response
during the course of infection?
Our data suggest that slight shifts in the ratio of trophic forms to cysts may result in
differential immune responses. For example, the addition of trophic forms to a mixed
population to create a net ratio of 20 trophic forms to one cyst reduces the expression of
IL-6 by BMDCs (Chapter 3). The in vivo effects of such shifts have not been studied,
but such research may provide intriguing details regarding the life cycle of the fungus
within its host. Over the course of infection, Pneumocystis organisms may be found at a
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typical ratio of 10 trophic forms to 1 cyst. However, this is not a steady state: cysts are
the transmittable life cycle stage, yet a large burst of trophic forms are observed during
the first week post-infection (Chapter 3). It is possible that this rapid transition may
delay recognition of inflammatory PAMPs by dendritic cells in the lung, and may prevent
preemptive clearance.
Furthermore, a fungal burden of 20 to 30 trophic forms per cyst is consistently
found in the lungs of immunocompromised mice exhibiting severe symptoms of
Pneumocystis pneumonia. It is possible that inflammatory signals within the lungs
promote a shift in the population towards an increase in suppressive trophic forms over
inflammatory cysts. This shift could extend the life of the host, albeit at the cost of
favoring the production of the non-transmittable trophic forms over the formation of
cysts.

3. What impact does the differential response to Pneumocystis life forms have
on the outcome of the infection in various models of disease?
Our data indicate that infection with trophic forms delays the initiation of innate
and adaptive immune responses. Future studies should consider the role of trophic formmediated suppression in models of various types of immunodeficiency. We found that
depletion of cysts from the lungs of RAG2-/- mice results in the formation of a small
trophic population that does not cause overt symptoms of Pneumocystis pneumonia,
including weight loss (Chapter 4). Linke et al., demonstrate that depletion of cysts
reduced inflammation in a murine model of immune reconstitution inflammatory
syndrome (24). However, the range of patients at risk for pneumocystis pneumonia
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includes those suffering from a wide range of immunodeficiencies. Does trophic formmediated suppression increase the risk of developing PcP, or, in the event of PcP, does
this suppression reduce inflammation-mediated lung damage in patients undergoing
chemotherapy, or corticosteroid treatment? Is suppression of dendritic cell responses
more successful in hosts with deficient B cell responses, such as those treated with antiCD40 antibody therapy? What is the role of trophic form-mediated suppression in
HIV/AIDs patients before and after the initiation of HAART? Here, we demonstrate that
infection with purified trophic forms leads to a delay in the initiation of immune
responses in neonatal mice compared to an infection with a mixture of organisms
(Chapter 3). What is the impact of trophic form-mediated suppression within the
developing lungs of a neonatal host? It is possible that the trophic forms reduce
inflammation-mediated lung damage in the lungs of immunocompromised hosts.
However, trophic form-mediated suppression may permit the fungal population to expand
in the absence of immune pressure. This may prove detrimental if the host develops or
regains the ability to respond to the infection, as the increased fungal burden may worsen
inflammation-mediated lung damage. Future studies will be required to explore these
possibilities.

4. What mechanisms overcome trophic form-mediated immune suppression?
Here, we demonstrate that trophic forms are sufficient to induce protective CD4+ T
cell and B cell responses leading to clearance of infection (Chapter 4). However, our
data indicate that the initiation of these immune responses is delayed if cysts are absent in
the inoculum (Chapter 3). Furthermore, we demonstrate that trophic form-loaded
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dendritic cells are unable to prime CD4+ T cell responses in vitro. The populations of
immune cells involved in overcoming this delay are unknown. It is possible that trophic
forms may not suppress other innate cells as definitively as dendritic cells. For example,
alveolar epithelial cells, macrophages, or neutrophils may be more adept than dendritic
cells at producing proinflammatory cytokines in the presence of trophic forms. The
generation of a local inflammatory environment may promote dendritic cell maturation
and activation, leading to presentation of antigen in the draining lymph nodes and the
initiation of immune responses.
Research from other members of the Garvy lab indicates that trophic forms also
suppress the ability of J774 and alveolar macrophages to express cytokines in response to
mixed P. murina organisms. However, macrophages produce proinflammatory cytokines
at an infectious dose of 10 mixed P. murina organisms per phagocyte, compared to the 50
to 1 dose required to yield production of IL-1β and IL-6 by dendritic cells. In our hands,
macrophages, but not dendritic cells, produce TNFα in response to mixed P. murina
organisms. These data suggest that macrophages may either be more responsive to the
cysts or less susceptible to suppression than dendritic cells. However, it should be noted
that in Chapter 4, the long-term carriage of trophic forms in RAG2-/- mice (which lack B
cells and T cells) failed to promote a substantial accumulation of TNFα in the BALF.
Conversely, B cells may contribute to the initial activation of antigen-presenting
cells in the lungs. Opata et al. demonstrate that B cells must be present during the first
few days post-infection for effective priming of CD4+ T cell responses to mixed P.
murina infection. This effect occurred independently of antibody production, indicating
that B cells provide additional cues for T cell activation (124). B cells are a key source of
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TNFα during the response to mixed Pneumocystis infection (125). Future studies may
characterize the role of B cells in the activation of CD4+ T cells and effector cells in
response to trophic forms.

V. Conclusions
Here, we propose that trophic forms broadly inhibit the ability of dendritic cells to
fulfill their role as antigen-presenting cells by reducing the expression of cytokines, MHC
class II, and costimulatory molecules. These data correspond with suboptimal CD4+ T
cell proliferation and polarization in vitro, and delayed CD4+ T cell responses in vivo.
The data presented herein provide compelling evidence for decades of Pneumocystis
research to be revaluated in the context of interactions between the life cycle stages and
the host immune response. The differential immune response to the life cycle stages of
Pneumocystis shapes both the induction of protective responses and the development of
inflammation-associated pathology. Manipulation of this balance may provide new
options for the management and prevention of Pneumocystis infection, while a failure to
consider this differential response may hinder future efforts. Further exploration of the
interaction between trophic forms and the host may enhance our basic understanding of
the pathways involved in immune activation and suppression. These pursuits may also
fuel the discovery of novel anti-inflammatory therapies capable of broadly dampening
cytokine production and antigen presentation.

Copyright © Heather Marie Evans 2017
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Figure 6-1 Model of trophic form-mediated suppression of dendritic cell function.
Trophic forms inhibit multiple components involved in antigen presentation by dendritic
cells, including secretion of inflammatory cytokines and expression of MHC class II and
costimulatory molecules on the cell surface. Furthermore, trophic forms suppress the
expression of multiple genes related to activation and maturation in dendritic cells.
Dendritic cells silenced by trophic forms are unable to induce CD4+ T cell responses in
vitro. This corresponds with delayed innate and adaptive responses in vivo.
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Appendix A: List of Abbreviations
AIDS
BMDC
CLR
COPD
ELISA
GM-CSF
HAART
HIV
IFNγ
IG
IκB
IL
IRIS
IT
ITAM
J774
LPS
LTA
PAMP
MHC class II
MIP
MR
NFAT
NF-κB
NLR
Pc
PcP
PRR
ROS
SCID
SIDS
TGFβ
Th
TIR
TLR
TMP-SMX
TNFα

Acquired immune deficiency syndrome
Bone marrow-derived dendritic cells
C-type lectin receptor
Chronic obstructive pulmonary disease
Enzyme-linked immunosorbent assay
Granulocyte-macrophage colony-stimulating factor
High active antiretroviral therapy
Human immunodeficiency virus
Interferon gamma
Immunoglobulin
NFκ-B inhibitor
Interleukin
Immune reconstitution inflammatory syndrome
Intratracheal
Immunoreceptor tyrosine activation motif
Macrophage cell line derived from murine tumor
Lipopolysaccharides
Lipoteichoic acid
Pathogen-associated molecular pattern
Major histocompatibility class II
Macrophage inflammatory protein
Mannose receptor
Nuclear factor of activated T-cells
Nuclear factor-κ light chain enhancer of activated B cells
NOD-like receptor
Pneumocystis
Pneumocystis Pneumonia
Pattern recognition receptor
Reactive oxygen species
Severe combined immune deficiency
Sudden infant death syndrome
Transforming growth factor β
T helper
Toll/interleukin-1 receptor
Toll-like receptor
Trimethoprim-sulfamethoxazole
Tumor necrosis factor α
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